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1. General introduction 
 
Nowadays, a great variety of substances described as hormones is known and can 
be defined in a number of ways, according to origin, functionality, chemical 
structure,… Following the classical approach, hormones are defined as chemical 
substances secreted into the bloodstream by endocrinal glands to fulfill their 
messenger function and trigger the demanded response in the targeted tissue.  
Considering that not all hormones are produced by the body itself, but can be 
administered as well, distinction is made between endogenous and exogenous 
hormones. Endogenous hormones are assimilated by the body itself, whereas 
exogenous hormones enter the organism from outside. 
Exogenous substances with hormonal activity can either be xenobiotic substances, 
which do not naturally occur in the organism itself, or homologues of endogenous 
hormones.  
The best way to categorize hormones is by chemical structure and functionality. 
Distinction is made between amine-derived substances with hormonal activity 
(examples are β-agonists, thyroid hormones), peptide hormones (examples are 
insulin, growth hormone) and steroid hormones. Since the latter are the main subject 
of this thesis, further discussion will be limited to these compounds.  
 
1.1. Definitions of steroid hormones 
 
1.1.1 Steroid nomenclature 
Steroids are characterized by a skeleton of perhydrocyclopentanophenanthrene, also 
referred to as sterane.1 It is a cyclic structure consisting of three fused cyclohexane 
rings (ring A, B and C) and one cyclopentane ring (ring D), shown in figure 1.1 with 
position numbering, containing 17 carbon atoms in total. By addition of double bonds, 
bond scissions, ring expansions or contractions in the skeleton, and/or by the 
addition of different functional groups to this core structure, a wide variety of 
compounds can be obtained, for which a specialized nomenclature is used.2 The 
objective of this paragraph is to provide the basic rules of this nomenclature, required 
to interpret correctly various terms in this thesis.  
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Figure 1.1:  Structure of perhydrocyclopentanophenanthrene, including position and ring notations 
 
When steroids are pictured as projections onto the plane of the paper, atoms or 
groups oriented downwards are noted as α, whereas substituents emerging from the 
plane are noted as β-oriented, indicated with a dashed or solid wedge, respectively. 
For substituents with an unknown orientation, or for mixtures of stereoisomers, a 
wavy line is used.2 The sterane core possesses six asymmetric carbon atoms. The 
usual orientation at the bridgeheads is 8β, 9α, 10β, 13β and 14α, and therefore does 
not need to be specified in the names or figures unless it is different. The core 
structure with this configuration, and without alkyl groups at position 10, 13 and 17 is 
referred to as gonane. When a methyl group is present in position 13, the 18-carbon 
structure is referred to as estrane, and with methyl groups in position 10 and 13, it is 
called androstane, containing 19 carbon atoms. By addition of alkyl substituents in 
position 17 of the androstane nucleus, a number of additional hydrocarbon 
backbones can be obtained, also bearing specific stem names, of which the 21-
carbon pregnane nucleus, and the 27-carbon cholestane nucleus need to be 
mentioned. The side chains in position 17 are in β-orientation, unless stated 
otherwise.2 All these structures and the stem names are included in figure 1.2.  
The configuration at bridgehead 5 needs to be specified if known, by addition of 5α or 
5β in front of the stem name. When the orientation is not known, the notation ξ is 
used.2,3  
Unsaturation of the steroid nucleus is indicated by changing –an(e) to –en(e), -
adien(e), -yn(e),... anticipated by the position of the unsaturation(s).2 Substituents of 
the steroid nucleus are noted with prefixes or suffixes, accompanied by the position 
and orientation. Alcohol groups are indicated as suffixes or prefixes to the stem 
name, -ol or hydroxy-, respectively. When multiple alcohol groups are present, this 
becomes –diol, -triol,... or dihydroxy-, trihydroxy-,... The same rules apply to ketones, 
where the prefix oxo- and the suffix –one are used. When both alcohol and ketone 
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groups are present, ketones take priority as suffixes.2,3 Alkyl substituents, on the 
other hand, can only be described using the appropriate prefix (methyl-, ethyl-,...).2 
When both a substituent and a side chain are present at position 17, the α-orientation 
of the substituent does not need to be noted.  
 
 
Gonane Estrane 
  
Androstane Pregnane 
 
Cholestane 
Figure 1.2:  Structure of the different steroid nuclei and their stem names. Position numbering is only 
provided for cholestane. 
 
Finally, beside the rules provided by the official International Union of Pure and 
Applied Chemistry (IUPAC) discussed above, a set of trivial names is often used to 
describe a number of important steroids and improve readability of a text. Some of 
these trivial names are IUPAC-approved, other are commonly used in the field. If 
these trivial names are used as a basis for naming derivatives or stereoisomers, the 
HH
H
HH
H
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derived trivial name must make the nature of the modification completely clear.2,3 To 
illustrate the system of nomenclature, all steroids of importance for this manuscript 
are presented in table 1.1, including their full systematic name, structure and possible 
trivial name.  
 
Table 1.1:  Names, structure and used abbreviation of the steroids of importance for this manuscript 
Trivial names 
IUPAC name 
Used abbreviation 
Structure 
Trivial names 
IUPAC name 
Used abbreviation 
Structure 
5-Androstene-3β,17α-diol 
Androst-5-en-3β,17α-diol 
AEdiol 
 
5β-Pregnane-3β,20β-diol 
BBB-PD 
 
5α-Pregnane-3α,20α-diol 
AAA-PD 
 
5β-Pregnanedione 
5β-Pregnane-3,20-dione 
B-PDione 
 
5α-Pregnane-3β,20α-diol 
ABA-PD 
 
((17)β-)Estradiol 
Estr-1,3,5-trien-3,17β-diol 
βE2 
 
5α-Pregnane-3α,20β-diol 
AAB-PD 
 
(17)α-Estradiol 
Estr-1,3,5-trien-3,17α-diol 
αE2 
 
 
5α-Pregnane-3β,20β-diol 
ABB-PD 
 
((17)β-)Testosterone 
17β-Hydroxyandrost-4-en-3-one 
βT 
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5α-Pregnanedione 
5α-Pregnane-3,20-dione 
A-PDione 
 
 
(17)α-Testosterone; 
Epitestosterone 
17α-hydroxyandrost-4-en-3-one 
αT 
 
 
Pregnanediol 
5β-Pregnane-3α,20α-diol 
BAA-PD 
 
Dehydroepiandrosterone 
3β-Hydroxyandrost-5-en-17-one 
DHEA 
HO
O
 
5β-Pregnane-3β,20α-diol 
BBA-PD 
 
Etiocholanolone 
3α-Hydroxy-5β-androstan-17-one 
Etio 
 
5β-Pregnane-3α,20β-diol 
BAB-PD 
 
Progesterone 
Pregn-4-en-3,20-dione 
PG 
 
 
 
1.1.2 Classification and functionality of endogenous steroid hormones 
Steroids encompass a large number of compounds, classified in different groups with 
varying functionality. Next to their endogenous functionality, a number of steroid 
hormones are well known for their growth promoting capabilities in farm animals, 
which will be discussed in the following paragraph. 
 
Sex steroid hormones, or gonadal steroids, play an important role in the regulation of 
behavior, morphogenesis and functional differentiation of the reproductive system in 
vertebrates, and are divided into three subgroups.4,5    
The first group are the male sex steroids, or androgens. Endogenous androgens are 
characterized by a 19-carbon, androstane steroid nucleus, with hydroxyl or carbonyl 
groups at position 3 and 17. They are primarily produced in the Leydig cells in the 
testes, and to a lesser extent in the ovary and the adrenal cortex, and are 
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responsible for the development of both primary and secondary sex characteristics of 
male animals.4,6 Besides their androgenic effects, they are also wellknown for their 
anabolic qualities. Used as growth promoters, they achieve body weight gain by 
increased feed conversion and nitrogen retention in animals, resulting in increased 
protein deposition at the expense of body fat.6 Although the balance between 
androgenic and anabolic characteristics is highly variable in different androgens, they 
always possess both properties, and therefore are often referred to as anabolic-
androgenic steroids (AAS).5 Testosterone is the most common example of 
endogenous androgens. 
The second group are the female sex steroids, or estrogens. Endogenous estrogens 
are characterized by a 18-carbon, estrane steroid nucleus, in which the A-ring is 
converted to a phenol structure, and with an additional hydroxyl or carbonyl group at 
position 17.6,7 They are produced in the ovaries and placenta in females, and in the 
testes in males. They are responsible for the development of primary and secondary 
female sex characteristics.4,6 In ruminants, an increased overall nitrogen retention 
and utilization, improved growth rate and lean tissue accretion are obtained under the 
influence of estrogens. However, in many other mammalian species, amongst which 
humans, growth is inhibited by female sex steroids.6 Estradiol is the best known 
example of endogenous estrogens. 
The third group are the progestagens, also referred to as gestagens or hormones of 
pregnancy. Endogenous progestagens have a 21-carbon, pregnane skeleton, and 
are synthesized in the corpus luteum, the placenta and the adrenal cortex.4,6 
Progestagens are essential for the uterine development necessary for implantation, 
blastocyst development, and maintenance of the fetus and of uterine tone during 
pregnancy.8 Although they posses anabolic qualities as well, these are less 
pronounced than for the androgens or estrogens, and progestagens are known to 
increase body fat deposition.6 Progesterone is the most common endogenous 
progestagen.  
The growth promoting results obtained through administration of synthetic analogues 
of endogenous sex steroid hormones are variable, dependent upon the 
characteristics of the animal.6 The effects are most pronounced in ruminants, as 
opposed to pigs and poultry, where much more variable results were obtained. Also 
sex and age of the animal is of importance: androgens will be more effective when 
administered to heifers or steers as opposed to bulls, whereas estrogens generally 
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work better in the latter, and treatment of veal calves at a too early age can be 
detrimental for later growth.  
Also, the nature of the treatment is a determining factor. The administered 
substances have an optimal dosage, below which the effects will be negliable, and 
above which they do not bring additional gain or might even be harmful.6 
Furthermore, combinations of two or more anabolic agents are often used. In this 
way, undesirable side effects of one agent can be mitigated by another, and a 
synergistic effect on growth or daily gain can be observed. Therefore, estradiol and 
testosterone are usually combined for the treatment of heifers, whereas a 
combination of estradiol and progesterone is more common for the treatment of 
steers, bulls and calves.6,9-14 Because endogenous steroids are rapidly metabolized, 
they are usually administered in an esterified form. In the systemic circulation, the 
esters are hydrolyzed by blood esterases, resulting in a sustained release.15 In 
countries where regulated use of synthetic analogues of endogenous sex steroid 
hormones for growth promoting purposes is permitted, treatment is usually done by 
implantation into the ear of the animal.9,11 The implantation allows a more gradual 
release of the steroids into the bloodstream, prolonging the effects over time. 
Additionally, by removing the ear after slaughter, a source of high residual 
contamination is easily avoided, as opposed to injection sites when the animals are 
treated intramuscularly.  
 
Although the focus of this study is on sex steroid hormones, a second important 
group of steroid hormones, corticosteroids, needs to be mentioned. Similar to 
progestagens, they have a pregnane nucleus. Additionally, they are characterized by 
a hydroxyl or carbonyl group at position 11, a carbonyl group at position 3 and 
position 20 and a hydroxyl group at position 21.16 Most endogenous corticosteroids 
have a double bond between carbon 4 and 5. Corticosteroids are divided into two 
groups: glucocorticoids, for example cortisol, carry a hydroxyl group at position 17, 
whereas mineralocorticoids, for example aldosterone, do not. Both examples are 
shown in figure 1.3. In the body, mineralocorticoids play an important role in the 
regulation of electrolyte and water metabolism, whereas glucocorticoids are involved 
in gluconeogenesis, glycogen deposition and protein metabolism. Additionally, 
glucocorticoids exhibit a powerful anti-inflammatory activity, leading to its widespread 
medical and veterinary use.5  
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Originally, a negative correlation between corticosteroids and growth has been 
reported in cattle and sheep, causing fat deposition and reduced protein content.6 
However, administered in combination with β-agonists or anabolic steroids, positive 
growth promoting abilities were observed due to synergetic effects. Additionally, 
treatments with low concentrations of corticosteroids were reported to improve feed 
intake, increase weight gain and reduce feed conversion ratio.16-18 
 
O
HO
OH
O
OH
 
 
 
 
Figure 1.3:  Structure of the glucocorticoid cortisol (11β,17,21-trihydroxypregn-4-en-3,20-dione) (left)  
and the mineralocorticoid aldosterone (11β,21-dihydroxypregn-4-en-3,18,20-trione) (right) 
 
1.2. Legal framework 
 
As a precautionary measure to protect consumers’ health, the use of hormonal 
substances as growth promoters has been prohibited in the European Union (EU) 
since 1988.19 Despite international pressure from countries in which restricted use of 
certain hormonal growth promoters is permitted, the EU maintained its decision 
based on risk evaluations,20,21 resulting in the currently active legislative triptych.22-24   
 
With regard to synthetic analogues of naturally occurring sex steroid hormones, their 
use is restricted as laid down in article 3a of Council directive 96/22/EC, amended 
twice,20-21 prohibiting the administration of substances having an estrogenic, 
androgenic or gestagenic action to farm or aquaculture animals.22 Exception is made 
for therapeutic veterinary use, which is strictly regulated in veterinary law. 
A second Council directive, 96/23/EC, lays down the ground rules for inspection of 
unwanted residues of substances in living animals or products thereof.23 Sex steroid 
hormones are included in annex I of this directive as substances having anabolic 
effect and unauthorized substances, group A3: steroids. The member states are 
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responsible for the implementation of these guidelines into annual national residue 
plans.  
Finally, Commission decision 2002/657/EC specifies the analytical criteria required 
for the implementation of the national residue plans.24 Group A substances can be 
monitored with qualitative methods, since no maximum residue limits (MRLs) have 
been set. Authorized confirmation methods for this group require a liquid or gas 
chromatographic separation (LC or GC), combined with mass spectrometric or infra-
red spectrometric detection (MS or IR). The identification criteria are based upon the 
comparison between the sample and a calibration standard, an external standard 
included in the same measurement series. Regarding the chromatographic 
separation, the relative retention time needs to correspond within an interval of ± 
0.5% for GC, and ± 2.5% for LC. Mass spectrometric identification is based upon the 
correspondence of the relative ion intensities, for which a specific point system is 
used based upon the exact application. For a successful identification of a group A 
substance, four identification points need to be earned.  
 
With exception of Italy and the Netherlands, which regard them as group A, most 
member states classify corticosteroids as group B substances, or veterinary drugs, 
within the subgroup 2f: other pharmacologically active substances (including 
unlicensed substances which could be used for veterinary purposes). For these 
substances, a wider range of authorized confirmation methods is described, and 
when mass spectrometry is used, three earned identification points is sufficient.24 For 
the licensed corticosteroids, prednisolone, methylprednisolone and dexamethasone, 
MRLs are also defined in various matrices.25,26 
 
In the Belgian national legislation, restrictions on the use of hormonal substances, 
and the consequences of illegal use, are laid down in the law of 15 July 1985.27 Sex 
steroid hormones are comprised under article 3§2, prohibiting the prescription and 
administration of substances with estrogenic, androgenic or gestagenic action to farm 
or aquaculture animals, with exception of legitimate veterinary treatment; the same 
prohibition is in force for corticosteroids, included in substances with hormonal action, 
described in article 3§3. The law is accompanied by a series of executive decisions 
(royal and ministerial decrees), assigning the competent authority for inspection and 
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designating suitable laboratories for the required analyses, amongst other practical 
aspects.28  
 
When evaluating the current legislation, an obvious void becomes apparent with 
regard to the inspection on illegal use of synthetic analogues of endogenous steroid 
hormones. Since the concentrations of these substances are highly variable 
according to species, sex, age and physiological state of the animal, no decision 
level for their concentration in matrices from animal origin have been set.16,25 Since 
the official analytical methods are based upon identification using MS or IR detection, 
and because these substances can also occur in the animals naturally, it is 
impossible to draw conclusions regarding abuse based on these results.16 As advised 
by the European Union Reference Laboratory (EURL), analytical approaches based 
on gas chromatography coupled to combustion-isotope ratio mass spectrometry (GC-
C-IRMS) can be used as a confirmation method to elucidate the origin of steroid 
hormones in samples from animal origin,29 which will be discussed in detail in the 
following chapters. However, these techniques are not included into Commission 
decision 2002/657/EC. It has been underlined that this decision requires an update to 
allow a harmonized approach for IRMS-based methods, amongst other reasons.30  
 
1.3. Screening strategies for endogenous sex steroid abuse 
 
The preferred analytical methods for the detection of abuse of hormonal substances 
in cattle have changed regularly throughout the years, mainly as a consequence of 
instrumental improvements and availability, combined with evolutions in sample 
preparation. At the early stage in the 1960s and 70s, thin layer chromatography 
(TLC) was the standard method for the detection of group A substances. During the 
1980s and 1990s, immunoassay techniques, such as radioimmunoassay (RIA) and 
enzyme-linked immunosorbent assay (ELISA), became popular and offered the 
means for control on a larger scale, but were later on largely replaced by the more 
definitive mass spectrometric-based techniques. Indeed, with the instruments 
becoming more robust and affordable, a shift towards GC-MS methods occurred 
during the 1980s. By the end of the 90s, LC-MS based methods became common 
good, evolving into ultra performance liquid chromatography (UPLC) more recently, 
used for screening methods including a large number of compounds. However, for 
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the confirmatory analysis after a non-compliant screening result for steroid hormones, 
GC-MS methods are still commonly applied.17 Whereas a shift back towards GC-MS 
is observed in the field of human anti-doping, this trend is not visible for the detection 
of hormone abuse in cattle yet. As stated in the previous paragraph, traditional mass 
spectrometry does not allow differentiation between endogenous sex steroids and 
synthetic analogues thereof. However, it can still be a valuable tool to screen for 
suspicious samples.  
 
1.3.1. Steroid concentrations 
Establishing threshold concentration values for endogenous sex steroids in matrices 
of animal origin is a three phase process. First, results must be obtained from a non-
treated population. Second, a statistical analysis of these ‘normal’ concentrations is 
required to propose a level above which the concentration of the substance can be 
considered as ‘abnormal’. Finally, samples from treated animals are required to 
evaluate the determined threshold. The greatest difficulties in this process lie within 
the fact that a large control population is required to provide statistically significant 
results, and that an acceptable balance is required between false positive and false 
negative outcomes.29 In the past, recommended threshold concentrations have been 
formulated by the Community Reference Laboratory (CRL) regarding 17β-
testosterone in serum samples, and 17β-estradiol in serum and muscle samples, as 
described in table 1.2.31  
 
Table 1.2: Recommended concentrations for non-compliance by the CRL 
Substances Matrix 
Recommended 
concentration 
17β-Testosterone Serum 
Male < 6 months: 10 ppb 
Male 6 - 18months: 30 ppb 
Female < 18 months: 0.5 ppb 
17β-Estradiol 
Serum 0.1 ppb 
Muscle 1 ppb 
 
Although large scale population studies resulted in suggested thresholds levels for a 
number of endogenous steroids in bovine urine,32,33 it became clear that the 
discriminating power of single steroid concentrations is limited. In sports doping 
Chapter I 
12 
 
control, the relationship between the levels of multiple steroids, or steroid profiling, is 
used as a screening strategy for anabolic abuse, which started with the ratio of 
testosterone over epitestosterone (T/E), and eventually evolved into ‘the athlete 
biological passport’, a personalized set of biomarker levels obtained through 
longitudinal study of the individual athlete.34 Unfortunately, a personalized approach 
such as ‘the animal biological passport’ is impossible due to the magnitude of the 
livestock population and the limited lifespan of the animals, and also the T/E ratio 
was proven to be an inadequate marker in bovines.35 However, steroid profiling 
based measurements of multiple end products of the bovine phase II metabolism, 
which will be discussed in chapter 2, proved to be a promising approach for future 
application.36-38 Steroid profiling is not exclusive to urine analysis: different matrices 
can be evaluated using GC-MS and LC-MS. This can be helpful in analysis where no 
urine is available, for example imported meat from countries allowing the use of 
natural steroids.39 
 
Finally, metabolomic approaches to steroid urine profiling have been described.40-42 
This emerging field of ‘omics’ research focuses on large scale and high-throughput 
measurements, in an untargeted mode, of small molecules in biological matrices.  
Traditionally, nuclear magnetic resonance (NMR) spectrometry was the technique of 
preference for this type of research, but due to recent technological advances, high 
resolution mass spectrometry (HRMS) is rapidly gaining in popularity because of its 
sensitivity and capability in structural elucidation.43 In the presented studies, urine 
samples from untreated and bovines treated with synthetic analogues of endogenous 
steroids, are analyzed with GC-MS,40  or LC-HRMS,41,42 after a minimal sample 
preparation. Afterwards, the generated urine profiles are statistically analyzed to 
reveal significant differences between the control group and the treated group. The 
presented methods allowed the successful differentiation between both groups, and 
can therefore be used as adequate screening techniques by themselves. Moreover, 
a large number of potential biomarkers, most likely steroid metabolites based on their 
mass spectra, were present. After identification, these might be implemented for 
steroid profiling purposes.40-42   
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1.3.2. Indirect screening approaches 
The above described metabolomic approach is by nature untargeted, and therefore 
not necessarily linked to steroid concentrations. Although originally mostly applied for 
medicinal and pharmaceutical research, metabolomic research has been frequently 
adopted for the investigation of steroid hormone abuse over the past decade, using 
either NMR spectrometry,44 or HRMS, for the untargeted analysis of urine,41-45 and 
serum samples.46 Additionally, holistic approaches to screen for steroid abuse are 
not limited to the metabolome, but have been extended to the proteome and 
transcriptome as well.47-50 For the first, protein fingerprinting from liver and plasma 
samples was accomplished by combining two dimensional electrophoresis (2-DE) 
protein separation with mass spectroscopic and western blotting detection, and 
allowed to effectively differentiate between treated and untreated bovines.47,48 For the 
second, untargeted gene expression analysis was performed using either 
complement DNA (cDNA) bioarray or RNA-sequencing techniques on various bovine 
tissue samples.49,50 Besides successful differentiation between treated and untreated 
animals, the studies revealed over expressed genes which are not unique to bovines, 
indicating applicability of the technique for other species and sports doping control.   
 
From the above, it is clear that administration of steroid hormones affects the levels 
of a large variety of non-steroidal molecules inside the treated animal significantly. 
These indirect biomarkers can be used to construct high-throughput analytical 
strategies, which are more suitable for screening large numbers of samples as 
opposed to the discussed untargeted approaches. For this reason, research on 
indirect biomarker approaches of all kinds (immunological parameters, blood 
chemistry parameters, peptides, proteins,…) to screen for steroid abuse gained a lot 
of interest over the past years, most of which was blood sample based.43,51-55 
However, it became clear that indirect biomarker screening faces similar challenges 
as steroid based screening: multi-biomarker profiling is required because of the 
limited discriminating power of a single compound threshold, and extended data from 
a control population and animals treated with various combinations of prohibited 
substances are needed to provide sufficiently validated methods capable of detecting 
varying hormonal abuse.43 Therefore, the bridge between controlled experiments and 
application into the field remains largely uncrossed.  
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Finally, one of the oldest screening methods for hormone abuse is histological 
survey. It has been reported that administration of steroid hormones can induce 
macroscopic and microscopic changes in specific organs, mainly in genital tract 
organs and sex accessory glands, but also in the thymus, thyroid and liver.15,56,57 
Although it is hard to convert histological observations into a practical screening tool, 
this knowledge can be useful for official veterinarians performing control upon 
slaughter when selecting samples.     
 
1.4. Outline of the current study 
 
As described, a lot of interesting different approaches remain to be further explored 
to construct screening methods to detect abuse of synthetic analogues of 
endogenous steroid hormones in cattle. However, without adequate confirmatory 
techniques, screening methods serve no purpose. As for these confirmation 
methods, far less optional routes are available. Almost two decades ago, the capacity 
of GC-C-IRMS to differentiate between treated and untreated animals was illustrated. 
Steroid preparations were shown to have different 13C/12C ratios than steroids 
produced by the animals. Therefore, the correct measurement of this carbon isotope 
ratio of steroids in urine samples, using IRMS, allows to elucidate their endogenous 
or exogenous origin. However, its application into the field for real life control 
purposes remained extremely limited. The general aim of the current research was to 
provide fully validated IRMS-based methods for the detection of abuse of synthetic 
analogues of endogenous sex steroids, which could be implemented as such for 
official control purposes. This was accomplished in a four step approach. 
 
First, an extensive literature research was performed, which is presented in chapter 
II. In this review, all relevant theoretical principles are provided, required to 
understand why it is possible to detect abuse of synthetic analogues of endogenous 
steroids based on 13C/12C ratio measurements, and which factors will influence the 
outcome of such an analysis. Afterwards, the required instrumental setup and 
necessary sample preparation techniques are discussed. Also, an overview of every 
published method regarding this application is provided. Finally, the link is made to 
doping control, where this type of analysis is more commonly applied, which proved 
to be a valuable source of information.  
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Second, based on the acquired knowledge from literature, a confirmation method to 
detect abuse of synthetic analogues of endogenous estrogens in cattle using gas 
chromatography coupled to both mass spectrometry and combustion-isotope ratio 
mass spectrometry in parallel (abbreviated as GC-(MS/C-IRMS) in this document) 
was developed, which is described in chapter III. Special attention was given to the 
method validation, and to the impact of the parallel coupled MS in the setup, which 
had not previously been described for the analysis of steroid hormones.  
 
Third, the developed method was extended to include the detection of abuse of 
synthetic analogues of androgens, as described in chapter IV. After thorough 
validation, the detection method was tested on two bovines treated with esters of 
17β-estradiol and 17β-testosterone. Finally, the detailed information from this 
administration study allowed a direct comparison with alternative confirmatory 
approaches.  
 
Fourth, the method was adapted for the detection of synthetic analogues of the third 
group of sex steroid hormones, progestagens, which is described in chapter V. After 
selection of suitable target analytes for this analysis, a number of slightly different 
analytical approaches were evaluated against each other. The most promising 
approach was validated and successfully tried on samples from bovines treated with 
progesterone.  
 
Finally, chapter VI provides the general discussion of the accomplishments, the 
global conclusions and suggestions for future research. 
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2. Use of isotope ratio mass spectrometry to differentiate 
between endogenous and synthetic homologues in 
cattle: a review 
 
Adapted from Janssens G.; Courtheyn D.; Mangelinckx S.; Prévost S.; Bichon E.; 
Monteau F.; De Poorter G.; De Kimpe N.; Le Bizec B. Anal. Chim. Acta 2013, 772, 1-
15. 
 
2.1. Abstract 
 
Although substantial technical advances have been achieved during the past 
decades to extend and facilitate the analysis of growth promoters in cattle, the 
detection of abuse of synthetic analogs of naturally occurring hormones has 
remained a challenging issue. When it became clear that the exogenous origin of 
steroid hormones could be traced based on the 13C/12C isotope ratio of the 
substances, GC-C-IRMS has been successfully implemented to this aim since the 
end of the past century. However, due to the costly character of the instrumental 
setup, the susceptibility of the equipment to break-down and the complex and time 
consuming sample preparation, this method is up until now only applied by a limited 
number of laboratories. In this review, the general principles as well as the practical 
application of GC-C-IRMS to differentiate between endogenous steroids and 
exogenously synthesized homologous compounds in cattle will be discussed in 
detail, and will be placed next to other existing and to be developed methods based 
on isotope ratio mass spectrometry. Finally, the link will be made with the field of 
sports doping, where GC-C-IRMS has been established within the World Anti-Doping 
Agency (WADA) approved methods as the official technique to differentiate between 
exogenous and endogenous steroids over the past few years.   
 
 
 
 
Chapter II 
18 
 
2.2. Introduction 
 
Since the 1930s, the positive effects of testosterone on muscle building have been 
well-known. Throughout the years, growth-promoting qualities of a great variety of 
hormonal compounds were discovered. Anabolic steroids were introduced into the 
world of sports during the 1940s and 1950s, which led to widespread abuse by the 
time detection methods became more available in the early 1970s.58,59 By that time, 
the use of steroid hormones and thyreostatics had become common practice in stock 
farming.60 However, it became clear that next to the beneficial effects of steroid 
hormones, a great number of adverse effects could be attributed to these 
substances, in particular disruption of the reproductive system.61,62 In 1981, the 
European Commission issued a first directive prohibiting the use of a number of 
hormonal substances, namely stilbenes (e.g. diethylstilbestrol (DES)) and 
thyreostatics, in stock farming.63 After careful consideration, the European 
Commission later expanded its decision, resulting in the current legislation which 
bans the use of all hormonal substances for growth promoting reasons.21,22 As other 
countries (e.g. USA, Canada, New-Zealand, Australia), allow the use of synthetic 
forms of six natural steroid hormones (estradiol, progesterone, testosterone, 
melengestrol acetate, trenbolone acetate and zeranol) as growth promoters, the use 
of these substances is fiercely controversial.  
Over the past decade, great advances have been achieved in residue detection with 
gas and liquid chromatography coupled to mass spectrometry, which allows the 
accurate and simultaneous detection of small quantities of a large number of 
prohibited substances in different matrices of animal origin.64,65 But the discordance 
between the decreasing number of positive results in samples of animal origin and 
the analysis of confiscated illegal preparations containing synthetic homologous 
compounds of natural steroid hormones reveals the shortcomings of the used 
analytical techniques when it comes to the detection of abuse of this type of 
substances.16 More specifically, the classical mass spectrometric techniques are 
unable to make the distinction between endogenous (produced by the animal itself) 
and exogenous (administered) or synthetic forms of natural steroid hormones.  
It was clarified during the 1990s that a differentiation between endogenous natural 
anabolic steroids and exogenous homologues could be made by measurement of 
13C/12C isotope ratios of these substances, both in humans and bovines.66,67 At this 
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point, gas chromatography linked to combustion-isotope ratio mass spectrometry 
(GC-C-IRMS) emerged as a promising technique to demonstrate the abuse of 
exogenous homologues of natural steroid hormones in cattle.  
The objective of this review is threefold. First, the underlying principles of the isotopic 
difference between endogenous and exogenous steroids will be explained, and how 
this can result in an applicable parameter. Next, the practical implementation of    
GC-C-IRMS as an analytical technique will be reviewed, focusing on the sample 
preparation, which is the bottleneck of GC-C-IRMS analysis. Finally, the use of     
GC-C-IRMS to differentiate between exogenous and endogenous steroids in cattle 
will be positioned in the broader picture of analysis of natural steroid hormones, 
linking it to other techniques and the other field of application, which is sports doping 
control.  
 
2.3. Underlying principles of ∆13C values 
 
To understand the difference between endogenous and exogenous homologues or 
synthetic forms of natural steroids, the difference between steroids biosynthesized in 
the animal or synthesized in laboratory/industrial conditions needs to be clarified. 
Since androgens and estrogens are the steroid hormones most commonly used as 
growth promoters, the synthesis of these compounds will be explained, given its 
relevance for IRMS.  
 
2.3.1. Bovine steroid biosynthesis 
In mammals, all steroid hormones are derived from cholesterol. Cholesterol can be 
taken up from the feed directly, or can be biosynthesized from acetyl co-enzyme A. 
By a multi-step pathway, cholesterol is converted into steroid hormones, amongst 
which androgens and estrogens, as displayed in scheme 2.1. All reactions involved in 
the biosynthesis of steroid hormones are enzyme-regulated and most of them are 
reversible. The enzymes are listed in table 2.1. The first reaction in steroid anabolism 
is the cleavage of the side chain from cholesterol, thus forming pregnenolone.  
During androgen biosynthesis, two pathways can be followed, starting from 
pregnenolone. They are referred to as the 4-ene and the 5-ene pathway. In the 4-ene 
pathway, the intermediates are characterized by a double bond between the carbons 
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at position 4 and 5, whereas the 5-ene pathway intermediates have a double bond 
between the carbons at position 5 and 6.  
In meat producing animals, 5-ene precursors of testosterone are more likely to be 
found than 4-ene precursors, with an exception for cervid species.68  
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Scheme 2.1: Representation of the biosynthetic pathways of endogenous steroids in bovines.36,68,69 
The dotted arrow indicates a multistep reaction involving different enzymes. Enzymes are printed in 
italic, the abbreviations are explained in table 2.1  
 
In the body, the adrenal cortex produces large amounts of dehydroepiandrosterone 
(DHEA). This excess DHEA is conjugated to a sulphate group, forming 
dehydroepiandrosterone sulphate (DHEA-S). The sulpho-conjugated form of DHEA is 
significantly less bioactive and so, DHEA-S can be considered as the body’s steroid 
reserve. When unconjugated, DHEA is transformed into the more active 4-
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androstenedione, which could in turn lead to the formation of testosterone after 
reduction of the 17-keto group.70,71 Estrogens are the products of the aromatization of 
androgens. One important route of estrogen production is the transformation of 
androstenedione (AED) into estrone (E1) and by further reduction of the 17-keto 
group to 17β-estradiol which is amongst the most bioactive compounds of the C18-
group. 
 
Table 2.1: Overview of the enzymes regulating the steroid pathways70 
Abbreviation Enzyme 
20,22-D 20,22-Desmolase 
17α-OH 17α-Hydroxylase 
3β-HSD 3β-Hydroxysteroid dehydrogenase,∆5,4 isomerase 
17,20-L C17,20-Lyase 
17β-HSD 17β-Hydroxysteroid dehydrogenase 
17α-HSD 17α-Hydroxysteroid dehydrogenase 
3α -HSD 3α-Hydroxysteroid dehydrogenase 
Aro Aromatase 
5β-Red 5β-Reductase 
5α-Red 5α-Reductase 
21-OH 21-Hydroxylase 
11β-OH 11β-Hydroxylase 
11β-HSD 11β-Hydroxysteroid dehydrogenase 
 
For most of them, steroid hormones circulate in the blood stream under their free 
form, with the exception of estrone sulphate and the above mentioned DHEA 
sulphate. High levels of steroids (after an administration for instance) suppress the 
release of the corresponding releasing hormone (e.g. GnRH), providing negative-
feedback control of hormone levels. The levels of the different steroid hormones in 
serum and plasma are highly dependent upon the age and gender of the animals. In 
plasma from untreated bulls, measured concentrations of 17β-testosterone ranging 
from below the detection limit up to almost 6 ng mL-1 were reported,72 whereas the 
level was approximately tenfold lower in mature females.68 The reported 17β-
estradiol levels are significantly lower, ranging from below the detection limit up to 
approximately 50 pg mL-1 in plasma from untreated bulls, and peaking at 
approximately 80 pg mL-1 in serum of untreated heifers.73 In younger animals (< six 
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months), the presence of steroids is generally lower, resulting in different compliance 
thresholds for the presence of 17β-testosterone and 17β-estradiol in serum, as 
suggested by the Community Reference Laboratory, given in table 1.2.  
It was reported that plasma levels of estrogens and gestagens are highly variable in 
heifers throughout the estrus cycle.74,75 Progesterone concentrations raised gradually 
up to approximately 10 ng mL-1 as the corpus luteum developed, whereas the 
concentration of 17β-estradiol was more variable, peaking approximately one day 
before estrus. 17β-Testosterone concentrations appeared to be unchanged during 
the estrus cycle.76  
After further metabolisation, steroid metabolites are excreted in urine mainly 
conjugated. This results in the presence of both sulpho- and glucuro-conjugated 
phase II steroid metabolites in urine and feces. The latter glucuro-conjugated steroids 
are the products of conjugation to glucuronic acid. Average concentrations of 17β-
testosterone and 17β-estradiol of 3.5 ng mL-1 and 0.21 ng mL-1, respectively, were 
reported in urine of male animals. For female animals, this was 0.58 ng mL-1 and 
0.63 ng mL-1, respectively.37 Concentrations in younger animals (< seven months) 
were significantly lower.77 However, the 17β-form of steroid hormones is usually 
metabolized to less active 17α-isomers, which will therefore be more abundant in 
urine. Indeed, in the same study, the reported average concentrations of 17α-
testosterone were 8.13 ng mL-1 and 14.30 ng mL-1, and of 17α-estradiol  79.07 ng 
mL-1 and 5.54 ng mL-1, for heifers and bulls, respectively. However, average 
concentrations of 17α-estradiol, reported from a population study in the United 
Kingdom, were tenfold lower.32 
Regarding progesterone, most of the measured urine samples were below the 
detection limit for both male and female animals.77  
Although the biosynthesis of the more active steroid hormones is similar in all 
mammalian species, important differences in the catabolic end products of the steroid 
metabolism between species are known.68 Also between bovines and humans, the 
steroid profile found in urine differs significantly. This results in a number of 
characteristic changes in steroid analysis of bovine urine compared  to human urine, 
which will be discussed later in the text.  
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2.3.2. Semisynthesis of steroid hormones 
Pharmaceutical companies mostly use semisynthetic methods for steroids, starting 
from sterols present in plant material, also called phytosterols. Soy is most frequently 
used as source of plant sterols, next to Dioscorea species, succulent plants also 
known as yams.78,79 Commonly used phytosterols are stigmasterol and diosgenin, 
originating from soy and succulent plants, respectively.80 Through a one step 
microbial degradation, androsta-1,4-diene-3,17-dione (ADD) is formed from soy 
sterols, from which conversion to other steroid hormones is possible.81 Semisynthetic 
methods are the most profitable and by far the most commonly used, as the source 
material is available in large quantities and the production process is fairly easy. 
However, semisynthesis is not the only available process for the production of steroid 
preparations. Total synthesis of steroids will be discussed in section 2.4.2.   
 
2.3.3. Origin of isotopic difference, C3 and C4 plants 
13C/12C Ratios of exogenous steroid hormones are significantly different from those of 
endogenous steroids. The reason for this difference lies within the origin of the 
molecule. As discussed above, steroid hormone preparations are produced from 
phytosterols available from plant material. Plants use atmospheric carbon under the 
form of carbon dioxide (CO2) for the biosynthesis of their compounds, amongst which 
the plant sterols. The integration of CO2 is achieved through photosynthesis. There 
exist three types of photosynthetic pathways. 
 
C3 Plants incorporate CO2 by using a natural process which is named the Calvin 
cycle. In this pathway, CO2 is incorporated by being attached onto a five carbon 
counting sugar molecule which is subsequently split, leading to the formation of 
intermediates composed of three carbon atoms. This cycle is regulated by a number 
of enzymes. The enzyme ribulose-1,5-diphosphate carboxylase is responsible for the 
fixation of CO2. Since this enzyme has a greater binding capacity for 12CO2 over 
13CO2, it discriminates against incorporation of the heavy carbon isotope. This way, 
plant material of C3 plants becomes enriched in 12C. Typical C3 plants are wheat and 
soy.  
The incorporation of CO2 by C4 plants is done by a process called the Hatch-Slack-
cycle. In this pathway, CO2 is attached to phosphoenolpyruvate leading to 
intermediates composed of four carbon atoms. The enzyme responsible for the 
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fixation of CO2 is phosphoenolpyruvate carboxylase, which incorporates 13CO2 and 
12CO2 without substantial preference. The actual substrate for the enzyme is not CO2, 
but hydrogen carbonate (HCO3-) formed through dissolution of CO2 in a slightly basic 
medium. Thus, in this pathway, the incorporation of CO2 is mainly limited by its 
diffusion into the leaf and its dissolution in water. This process has a far less 
pronounced effect on the 13C/12C ratio compared to the pathway involving ribulose-
1,5-diphosphate carboxylase. This results in a lower discrimination against the heavy 
carbon isotope, leading to organic compounds with a higher 13C/12C ratio in 
comparison to C3 plants. Maize is a typical C4 plant. 
A third type of plants uses the Crassulacean Acid Metabolism (CAM). This 
mechanism uses a combination of both the Calvin- and the Hatch-Slack-cycle, 
resulting in plant material with a 13C/12C ratio which is usually, but not always, higher 
than those of C3 plants. The pineapple is a typical CAM plant.82  
 
The plants which are used for the production of exogenous steroid hormones are 
typically C3 plants, while food and feed, out of which endogenous steroids are 
produced, typically are composed of a mixture of C3 and C4 plants. Since the 
exogenous steroids are formed out of a single carbon source, being a C3 plant, it can 
be understood that the exogenous steroids will be more enriched in 12C than 
endogenous steroids.83,84 
 
After administration of exogenously produced gonadic steroids, the measured 13C/12C 
isotope ratio of the corresponding steroid metabolites will be the consequence of the 
13C/12C values of both the endogenously produced and the administered steroids, 
which is represented in scheme 2.2. As mentioned before, the intake of exogenous 
steroids has a negative effect on the endogenous steroid production. Since the 
exogenously produced steroids are enriched in 12C, compared to endogenously 
produced homologous compounds, and because of hindered endogenous 
production, the measured 13C/12C ratio will be significantly lower in case of 
administration of exogenous steroids compared to when no steroids were 
administered and the 13C/12C isotope ratio of the metabolite is solely dependent upon 
the endogenous production. This forms the basic principle to differentiate between 
endogenous steroids and exogenously synthesized homologous compounds using 
IRMS. However, despite the negative feedback mechanism, significant endogenous 
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production can still occur after administration. The higher the endogenous production 
of the steroid hormone, the less pronounced the effect of the administration will be on 
the measured 13C/12C isotope ratio. This process, also referred to as endogenous 
dilution, can be a seriously limiting factor for the detectability of treatment with 
synthetic homologues of endogenous steroids. 
  
 
Scheme 2.2: Representation of the observed carbon isotope ratios and the relation to endogenous 
steroids and exogenous homologues. AS stands for “Amount of the steroid”  
 
2.3.4. δ13C values 
2.3.4.1. Definition 
The 13C/12C (= R) isotope ratios are expressed in regard to a reference standard as 
δ13C values per mille, according to the following formula: 
 
δ13C[‰] = (((13C/12C)sample – (13C/12C)std)/ (13C/12C)std)   x 103 = ((Rsample – Rstd)/Rstd) x 103 
 
The reference standard for carbon is a calcium carbonate,85 also referred to as Pee 
Dee Belemnite (PDB). The PDB formations are skeletal remains of mollusks that are 
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deposited in South Carolina (USA), and that have an R value or Rref of 
0.011237199.86 Since stocks of PDB are not available anymore, a new standard, 
called Vienna Pee Dee Belemnite (VPDB), was suggested, having a δ13C value of 
+1.95‰ relative to PDB.82 In the meantime VPDB is generally accepted as a 
standard, and as such, the currently used formula expressing δ13C values in promille 
with respect to VPDB becomes: 
δ13CVPDB = ((Rsample - RVPDB)/RVPDB)) x 103 = (RSample/RVPDB – 1) x 103 
 
2.3.4.2. Factors influencing exogenous δ13C values 
The possible methodologies to differentiate between endogenous natural steroids 
and exogenously synthesized preparations of homologous compounds are based on 
the source material of the preparations, a single C3 plant source, which results in 
substances relatively enriched in 12C in comparison to their endogenously produced 
counterparts. This hypothesis is supported by results of analysis of preparations and 
bulk materials in which δ13C values ranging from -25.9 ‰ down to -32.8 ‰ were 
measured.67,87 However, in a more recent study on testosterone products, 9% of the 
analysed preparations possessed δ13C values smaller than -25.9 ‰, which are within 
the endogenous range.88 All of these samples were illegal steroid preparations, 
confiscated in 2009 at border-level seizures. These results suggest that another 
source material for the production of steroid preparations might be available.  
Although, at the moment, semisynthesis from plant material is the production method 
of choice, it is not the only possibility. In 1959, the total enantioselective synthesis of 
steroids was first brought to industrial production. The reaction of 6-methoxy-1-
tetralone with vinylmagnesium bromide and 2-methylcyclopentane-1,3-dione to form 
an intermediate with a sterane core formed the basic structure of all steroid 
molecules, which eventually led to the production of estrone.89 The reaction was 
referred to as the Torgov reaction, after its discoverer. The Torgov reaction was 
responsible for large-scale industrial production of steroid hormones in the USSR. 
and Germany, and still provides the foundation of the reaction currently used for the 
production of pharmaceutical steroid hormones at factories of Schering in Berlin.90  
Unfortunately, no information on the carbon isotopic content of these substances is 
available to our knowledge, but this process might be responsible for the deviating 
δ13C value of -22.7 ‰ measured in an old preparation of boldenone.91 
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Therefore, continuous attention must be paid to the influence of production methods 
on carbon isotope ratios of preparations. Rapidly evolving knowledge on the 
biosynthesis of cholesterols and other sterols in prokaryotic and eukaryotic 
organisms might lead to the availability of new sources for steroid hormones.92  
 
2.3.4.3. Factors influencing endogenous δ13C values 
When evaluating the δ13C values of endogenous steroid hormones in different 
animals and humans, significant individual differences are observed. Factors known 
to cause these differences are described below.  
The most important cause, both for humans and bovines,84,93,94 is the diet, in 
correspondence with the principle “you are what you eat”. The larger the portion of C4 
plants in the diet, the more the endogenous steroids will be enriched in 13C. Both 
studies on bovines provided δ13C values of the urinary steroids within a range of         
-19‰ to -23‰ in case of a C4 plant diet, and -24‰ to -32‰ in case of a C3 plant diet. 
For humans, regional differences in δ13C values are observed as well, but these can 
be explained by the corresponding differences in diet.95,96 Logically, the range of the 
δ13C values of the endogenous steroids in case of a C3 plant diet, and of the steroidal 
preparations is largely the same. This poses a critical problem, since it makes 
distinction between endogenous steroids and administered synthetic homologues 
extremely difficult.  
Neither the breed of animal, nor the age, was found to have an influence on the 
endogenous δ13C values. However, it was noticed that the age does play a role in the 
detection of steroid abuse. Younger animals have a lower endogenous production of 
steroid hormones than older ones. When preparations are administered, the 
measured δ13C values are determined by both the δ13C values of the exogenous and 
endogenous steroids and in relation to the amount in which they are present. Thus, 
when the endogenous production is low, exogenous steroids make up a larger 
portion of the total steroid content, and their influence on the measured δ13C values 
will be more pronounced. This facilitates detection of abuse.94 
In humans, a difference in δ13C values between males and females in an 
experimental group was observed, with the steroid hormones in females being more 
enriched in 12C. This was probably caused by the extended use of oral 
contraceptives, which are in fact exogenous steroid hormones, in the females 
subgroup.95  
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Since a number of bacteria are capable of the bioconversion of sterols and steroids,97 
concerns have been raised about phytosterols, present in animal feed, which could 
be converted into steroids in the intestinal track. The direct absorption of these 
steroids might have a direct influence on the measured δ13C values.86,91 However, 
until now there is no evidence of such an event altering the measured values. 
Additionally, microbial contamination after sampling can impact the measured δ13C 
values, which is discussed in detail in paragraph 2.4.2.1. 
 
2.3.5. Endogenous reference compounds and ∆13C values 
Due to the mentioned variability in individual δ13C values, it is hard to set a threshold 
δ13C value for the differentiation between endogenous steroids and synthetic 
derivatives. This problem is solved by measuring δ13C values of both metabolites and 
precursors of steroid hormones in urine. The δ13C values of the chosen precursor 
molecules should not be influenced by the administered exogenous compound. 
These components are called Endogenous Reference Compounds (ERCs). In 
theory, the δ13C value of the ERC is not significantly different from the δ13C value of 
endogenous steroids.98 The difference between the δ13C values of the ERC and the 
metabolite is defined as the ∆13C value. The ∆13C value is an unambiguous 
parameter for the presence of exogenous steroids. When no steroids are 
administered, δ13C values of metabolites and precursors will be close to each other, 
which results in a low ∆13C value. When synthetic steroid hormones are 
administered, ∆13C values will be higher. This difference is represented in figure 2.1. 
In the past, for sports doping control, a value of more than 3‰ was considered as the 
demonstration of the presence of exogenous steroids.99 For cattle, however, an 
official ∆13C threshold value has not been designated. Still, research data suggests 
that the 3‰ threshold value could also be implemented for bovine urine 
samples.100,101 ∆13C values of an untreated reference population do not exceed a 
value of 2‰, and measured ∆13C values of positive samples significantly exceed 
values of 10‰. However, it needs to be noted that a universal 3‰ compliance 
threshold is no longer applied by the WADA. More details on recent changes in the 
WADA technical documents are provided in paragraph 2.4.3. 
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Figure 2.1: Visualization of ∆13C value and the effect of (a) non-administration, (b) administration of 
exogenous steroid hormones. ERC stands for Endogenous Reference Compound, M for metabolite  
 
Sufficient knowledge of the metabolic pathways of steroid hormones, described in 
section 2.3.1, is necessary for the adequate selection of ERCs, as well as the 
information on their natural abundance. DHEA and androst-5-ene-3β,17α-diol are 
tested and approved as ERCs for the detection of estradiol and testosterone abuse in 
cattle. The most often used testosterone metabolites in bovine species are 
etiocholanolone, epitestosterone and 5α-androstane-3β,17α-diol.100 17α-Estradiol is 
the target metabolite for 17β-estradiol (and esters) administration.101   
Even though there is no direct evidence, it is suspected that DHEA might be used as 
a growth promoter in cattle.102 In this case, an additional ERC to the detection of 
DHEA abuse has to be selected. Because a number of steps in the steroid pathways 
are hypothetical and not always fully understood,103 it is important to verify always 
adequacy of an ERC – metabolite combination with analytical data of an 
administration study.  
One method on human urine was published in literature, in which no ERC was 
used.104 The aim was to simplify the analysis to provide a rapid screening method, in 
which δ13C values of approximately -28‰ and lower are considered suspicious.  
 
After the residues of the administered compounds are excreted from the body, or in 
case of significant endogenous dilution, as discussed in paragraph 2.3.3, the 
detection of the administration will no longer be possible. The detectability, as well as 
the time frame for detection, are largely dependent upon the exact nature and 
quantity of the administered substance, as well as the method of administration. Data 
on this subject in bovines are relatively scarce. However, the detectability of a single 
intramuscular administration of 250 mg of testosterone enanthate was evaluated.67 
By means of the simultaneous analysis of two different testosterone metabolites, 
epitestosterone and etiocholanolone, the administration could be detected up to three 
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weeks after injection. Treatment of bovines with a single intramuscular injection of 
estradial valerate, dosed at 0.05 mg/kg, was detectable up to two weeks after 
administration.101 However, information is lacking in this study to further evaluate in 
detail the evolution of the ∆13C values in time, and no urine samples taken later than 
two weeks after administration were  analysed.  
 
Finally, it needs to be stressed that, although exceeding a ∆13C based threshold is an 
unambiguous confirmation of non-compliance, this is not necessarily true the other 
way around. As the portion of C4 plant material in the feed decreases, the δ13C value 
of the ERCs decreases as well. When C4 plant material is completely removed from 
the feeding regime, the δ13C values of both the ERCs and metabolites will be close 
together even in case of treatment, thus severely compromising the discriminating 
power of the method and enlarging the possibility of false negative results. 
 
2.4. Analytical implementation of GC-C-IRMS for the differentiation 
between endogenous steroid hormones and synthetic 
homologues 
 
Although the theory is straightforward, the practical application of carbon isotope 
measurement of steroids in bovine urine is a demanding task. In this chapter, first the 
instrumental setup for carbon isotope ratio measurement will be presented. Next, 
sample preparation, which is the main bottleneck of the analysis, will be discussed. 
Finally, a number of quality control measures will be listed. 
 
2.4.1. IRMS setup for measurement of steroid hormones, GC-C-IRMS 
In the instrumental development, two major breakthroughs were necessary to provide 
a system allowing the carbon isotopic measurement of steroids in samples. The first 
was the direct coupling of a gas chromatograph (GC) to a combustion furnace.105,106 
The second was the development of a multicollector detection system, allowing the 
simultaneous detection of the same compound bearing different isotopes. The 
coupling of a multicollector isotope ratio mass spectrometer (IRMS) to a GC via an 
online combustion system allowed the continuous measurement of carbon isotope 
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ratios, which was first accomplished by Barrie et al. using a dual collector type 
IRMS.107  
 
After preparation, the sample first enters this system by injection onto the GC. The 
function of the GC is to obtain separation of analytes from each other and from matrix 
impurities. The analytes need to be free from any co-elutions, since they can alter the 
δ13C values. Next, the output of the GC is directly linked to a combustion oven, since 
the IRMS measures the isotopic content in the form of CO2 gas. In the combustion 
oven, the steroids are converted to CO2 and H2O. It is essential that all of the analyte 
is converted and sent to the IRMS, as incomplete combustion can result in incorrect 
measurements. To ensure complete combustion, the reaction is performed at very 
high temperatures, near 1000°C. Then, the combustion oven is linked to a water trap, 
to ensure that only carbon dioxide continues to the IRMS. When water enters the 
IRMS, it could result in the formation of HCO2+ by protonation of carbon dioxide, and 
thus interfere with the isotopic measurement. This water trap can be a membrane 
based filter with a Nafion membrane or a cryogenic trap.70 After the water trap, the 
CO2 gas is directed to the IRMS through the gas inlet, into the ion source. In the ion 
source, CO2+● ions are generated in a high vacuum by the impact of electrons. 
Finally, these ions are transmitted to the detector.  
The IRMS of nowadays is a magnetic sector instrument, which contains three 
Faraday cups as detector. This will allow the simultaneous measurements of three 
types of CO2+● ions, with m/z 44, 45 and 46. There is only one type of ion present 
with m/z 44, 12C16O2+●. Corresponding to m/z 45, three different ion isotopomers will 
be collected: 13C16O16O+●, 12C17O16O+● and 12C16O17O+●. In the third Faraday cup, five 
isotopomers with m/z 46 will be collected: 12C18O16O+●, 12C16O18O+●, 12C17O17O+●, 
13C17O16O+● and 13C16O17O+●. According to the relative abundance, the 17O 
isotopomers at m/z 46 are considered negligible. Thus, the signal at the Faraday cup 
for m/z 46 measures 12C18O16O+● and 12C16O18O+●. Next, the 18O abundance, 
determined from the ratio of m/z 46/44, combined with an assumed relationship 
between the 17O and 18O isotopic abundances, allows to calculate the contribution of 
12C17O16O+● and 12C16O17O+● to the signal at m/z 45.98 This procedure is referred to 
as the 17O correction. The first to apply an 17O correction was Craig, using the 
following formula for the relation between the quantities of the different oxygen 
isomers: 17O/16O = K(18O/16O)a with a = 0.516, and K = 0.0099235.108 Nowadays, 
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alternative 17O corrections are available, leading to slightly different results over a 
range of less than 0.1‰.109   
 
Since the steroids are completely converted into CO2 and H2O during combustion, 
GC-C-IRMS provides no information on the identity of the measured compound. 
Therefore, an additional GC-MS analysis is in order. However, it has been argued 
that this is an insufficient measure to assure identification of the combusted 
compound.110 A setup has been developed, in which the sample is split after GC and 
send to MS and C-IRMS simultaneously, which allows identification of the analyte 
and measurement of its δ13C values at the same time (figure 2.2).111,112 There is 
currently no official abbreviation to describe this setup, and therefore, an unofficial 
abbreviation, GC-(MS/C-IRMS), will be used in this document to describe this 
coupling.  
 
 
Figure 2.2: Schematic picture of GC-(MS/C-IRMS) instrumental setup (©Thermo Fisher Scientific) 
 
2.4.2. Sample preparation 
Nowadays, the greatest difficulty in isotope analysis is to obtain purified samples with 
few interferences. The analyte peaks in GC should be free of any co-elution.  
In this chapter, the different techniques used in the cleanup procedure prior to      
GC-C-IRMS will be overviewed and discussed. Next, the published strategies 
employed for the analysis of bovine urine will be presented.  
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2.4.2.1. Evaluation of employed preparation techniques 
A number of analytical techniques are used in every method for steroid sample 
preparation prior to GC-C-IRMS. These techniques are in analogy with the methods 
used in sample preparation for regular GC-MS. However, it is of utmost importance 
that the δ13C values of the analytes are not influenced by a natural phenomenon due 
to the mode of sample preparation,  which can sometimes lead to kinetic or isotopic 
fractionation.   
 
Samples 
The first part of every analysis is sampling. Low concentration of target analytes in 
urine and successive purification steps require large sample volumes, sized up to 50 
mL. Only one method using another matrix, namely bile, is described in the 
literature.113  
Proper storage of urine samples is required. When urine samples are not stored 
properly, chemical, enzymatic and microbial degradations take place. In human urine, 
it has been observed that microbial contamination will induce hydrolysis of 
glucuronide and sulphate conjugates, followed by modifications of the steroid 
structure by oxidoreduction.114,115 It has been proved that long term improper storage 
of human urine samples led to changing δ13C values.116 To this aim, samples were 
stored at room temperature for several weeks. Then, the samples were inoculated 
with old urine samples which already showed severe symptoms of degradation. Prior 
to analysis, the samples were once again stored at elevated temperatures for a 
week. Afterwards, significant changes in δ13C values were observed. These changes 
were mainly noticed in free and sulphoconjugated steroids. Therefore, it is advised to 
use  glucuroconjugated steroids for isotopic measurement when samples show signs 
of degradation.116 The reasons for the fractionation could not be identified, and since 
proper storage is a key issue, further study on this topic is needed. Cooled storage of 
the urine samples was adviced, however, more detailed information on optimal 
preservation of the samples was not reported.  
 
Hydrolysis 
Only a small fraction of the steroids is eliminated unconjugated in urine. The majority 
is either glucuroconjugated or sulphoconjugated  and requires deconjugation during 
the analysis.  
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Deconjugation of the glucuroconjugates can be done enzymatically, and is often 
performed using β-glucuronidase from E. coli in a phosphate buffer, maintaining a 
stable pH. Enzymes from Helix pomatia,67,117 and Abalone entrails,94 can be used as 
well to perform this hydrolysis, but this can degrade to some extent the steroid, 
leading to a different structure.  Results with a higher reproducibility are observed 
with E. coli glucuronidase.118 Also, the use of β-glucuronidase from P. canaliculata 
was reported for the hydrolysis of steroids in horse urine.119  
Glucuronidase from Helix pomatia is also capable of hydrolysing sulphoconjugated 
steroids. However, this capacity is limited and most frequently, a chemical approach 
is used to this aim. The cleavage of the sulphate by chemical solvolysis is usually 
obtained by the addition of concentrated sulphuric acid in ethyl acetate, both for 
bovine and human samples.84,101,120 No isotope fractionation during hydrolysis has 
been reported so far. 
Contrary to the described sample preparation of bovine urine for GC-C-IRMS, solid 
phase extraction is performed prior to hydrolysis in a significant number of methods 
reported for the preparation of human urine.118,121-127 This is a common practice for 
the sample preparation prior to regular GC-MS analysis, since matrix interferences 
might limit the activity of the used enzymes. A partial deconjugation may lead to an 
underestimation of the concentration of the steroids, which can lead to quantification 
errors.128 The 13C/12C value may be affected as well.  
 
Solid phase extraction (SPE) 
Often, a combination of SPEs is used during sample preparation. Most frequently, 
C18 columns are utilised, sometimes in combination with silica columns. Use of an 
OASIS HLB stationary phase has been reported as well.129 An advantage of SPE is 
its practical applicability in every laboratory since it requires limited space, no 
additional equipment and is easy to handle. Although no influence on δ13C values by 
SPE treatment has been reported for steroids,130 fractionation has been reported for 
other applications.131,132 For the treatment of human urine, C18 columns are used as 
well, with only a few publications employing another stationary phase, namely 
Sephadex LH20.126,133 
Next to the use of SPE to eliminate matrix impurities, it has been used as a tool to 
split the steroids in human urine by gradual elution from the SPE column.80,121 The 
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separation of analytes into different subsamples can facilitate the GC procedure 
before IRMS measurement.  
 
Liquid-liquid extraction (LLE) 
Liquid-liquid extraction (LLE) is commonly performed to extract the steroids from an 
aqueous solution. The use of successive LLEs under different pH conditions has 
been reported as a means to separate androgens from estrogens.100,101 Because of 
their phenolic steroid structure, estrogens are deprotonated at a high pH and reside 
as soluble phenolate in the aqueous phase, allowing the selective extraction of 
unconjugated androgens using an organic extraction solvent. After extraction, the pH 
of the aqueous phase  is adjusted, allowing the extraction of unconjugated estrogens.  
 
    
 
Figure 2.3:  Graphic representation of the distribution of  δ13C values of steroids in a HPLC-peak. On 
the left side, the distribution of DHEA and 17α-estradiol on a N(CH3)2 stationary phase are displayed; 
on the right side, the distribution of DHEA-acetate and 17α-estradiol acetate on a C18 stationary phase 
are displayed101 
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High Performance Liquid Chromatography (HPLC) 
When available, high performance liquid chromatography or HPLC is the sample 
preparation method of preference. It allows specific separation of analytes by 
selection of a target fractionation window. Generally, reversed phase HPLC with a 
C18 column is employed, but use of straight phase HPLC with an aminopropyl 
column,67 and a 3-(dimethylamino)propyl column has been reported as well.100,101,129  
However, there is a downside to the application of semi-preparative HPLC since it 
has been demonstrated that it could lead to isotopic fractionation.134,135 The heavier 
isotopomers display a different retention behaviour on column than the lighter 
isotopomers, resulting in varying elution times in accordance with the 13C/12C ratio of 
the molecules. This is illustrated in figure 2.3. Thus, when an analyte is only partially 
collected due to a too narrow fractionating window, isotopic fractionation occurs. 
Therefore, the retention times have to be verified with each HPLC injection series by 
standard injection of the target analytes.101 Additionally, the retention times can be 
evaluated in every sample by the addition of an internal standard, as described in the 
following chapters. For the observed difference in behavior of DHEA and 17α-
estradiol on the N(CH3)2 stationary phase, visible in figure 2.3, there is currently no 
explanation. 
 
Immunoaffinity chromatography (IAC) 
Immunochemical methods are frequently utilised in sample preparation for steroid 
analysis other than GC-C-IRMS.85,133,136,137 In immunoaffinity chromatography (IAC), 
antibodies are immobilized on a stationary phase and target analytes are retained on 
column by specific antibody recognition. It was hoped that due to its great analyte 
specificity, a one step IAC cleanup method would replace existing multi step cleanup 
procedures prior to GC-C-IRMS, thus significantly simplifying the analysis. The 
applicability was investigated in both animal bile samples and human urine 
samples.113,138 An IAC cleanup proved to be insufficient for the bile samples, with too 
many impurities still present during GC. Even though no isotopic fractionation was 
observed in the human urine samples, LC sample preparation was preferred over 
IAC because with LC, multiple analytes can be separated at the same time, in 
contrast to IAC where a different stationary phase is required for the specific isolation 
of each analyte.  
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Derivatization  
Steroids are usually derivatized prior to GC-analysis. During this process, hydroxyl 
groups are esterified to decrease the polarity of the molecule and increase the 
volatility. Derivatization significantly improves the peak shape during GC separation. 
In contrast to regular GC-MS analysis,139,140 the number of derivatization options is 
limited in combination with GC-C-IRMS for several reasons.  
 
First of all, the number of carbon atoms added to the molecule by derivatization 
needs to be minimized, since they affect the isotopic measurement. At the moment, 
acetylation is the derivatization method of preference, adding an acetyl group to each 
derivatization site of the steroid (hydroxyl functions). Commonly,100,101 acetylation is 
performed by the addition of pyridine and acetic anhydride, but a number of 
publications reported acetylation without pyridine.67,84 
The influence of the acetate moieties on the measured δ13C
 
value of the acetylated 
steroids is corrected as follows: 
 
DOH = DOAc + 2m (DOAc − DAc)/n 
 
DOH is the δ13C value of the underivatized steroids, DOAc is the δ13C value of the 
acetylated steroids, DAc is the δ13C value of the acetylating reagent, n the number of 
carbon atoms in a molecule and m is the number of hydroxyl groups to be 
acetylated.120,121,123,130 To facilitate the calculation of ∆13C values, it is advised to 
compare precursors and metabolites with an equal number of carbon atoms and 
derivatization sites, which eliminates the need for this correction. 
 
The use of O-trimethylsilylation to replace acetylation was investigated. The 
advantage of trimethylsilylation over acetylation is an even better behavior of the 
compounds in GC, and a more controllable derivatization reaction. The disadvantage 
is the addition of three carbon atoms per derivatization site, thus affecting the isotopic 
measurement more than acetylation.117 It has also been reported that silicon deposits 
originating from the silylation reagent might deactivate the combustion oven.141  
Derivatization reagents containing fluorine atoms are unsuited for use in combination 
with C-IRMS, since fluorides released upon combustion might compromise the 
efficiency of the combustion furnace as well.122,142 
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In some methods used on human urine, steroids are analyzed without 
derivatization,143,144 but generally, the chromatographic behaviour of steroids 
containing more than one hydroxyl group is insufficient to meet the chromatographic 
criteria required for IRMS analysis.  
 
The use of hydropyrolysis - pyrolysis at elevated temperatures in the presence of 
hydrogen gas and a platinum or molybdenum catalyst - before GC-C-IRMS 
measurement has been suggested.139 During hydropyrolysis, all functional groups 
are stripped from the steroid, but the carbon skeleton is left intact. This technique 
would eliminate the need for derivatization and its associated problems. 
Hydropyrolysis on steroids has been studied, but no easily applicable method is 
currently available.145,146 Still, hydropyrolysis might be a useful technique for future 
application.  
 
The effects of an adaptation of the GC-C-IRMS system, replacing the traditional back 
flush system after GC by a precolumn solvent removal, has been investigated. Such 
a system would improve chromatography drastically, eliminating the need to 
derivatize the steroids.147   
 
Gas Chromatography coupled to Mass Spectrometry (GC-MS) 
Analysis using GC-MS needs to be performed before GC-C-IRMS analysis for three 
reasons.  
First of all, it is used for the identification of the compounds. As mentioned before, 
GC-C-IRMS only provides information on the isotope ratio of the measured 
compound. The identification is done according to the legal criteria.24 Therefore, an 
internal standard is added before injection to assess the relative retention times of 
the analytes. Suggested internal standards are 19-nortestosterone and 
ethynyltestosterone in bovine urine,67,117 and 5α-androstane-3β-ol in human urine.125 
Secondly, the quality of the prepared sample is observed. It needs to be ensured that 
the peaks are free of any impurity or co-elution before GC-C-IRMS measurement. 
The mass spectrum of the analytes is compared to a standard solution and/or a 
spiked extracted aqueous sample, injected in the same series.67,82,84  
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Finally, GC-MS is used to determine the concentration of the targeted steroid 
precursors and metabolites. The concentration is estimated by comparison with an 
internal standard.67 An estimation of the concentration is required to either 
concentrate or dilute the sample to match the IRMS linear range operational area of 
the employed IRMS device.  
 
For these reasons, it is understandable that the GC parameters, as well as the used 
column, of the GC-MS measurement need to be identical to those used in the       
GC-C-IRMS system. As for the performance of the GC-analysis, there are a few 
precautions in regard to regular steroid GC-MS analysis. 
As mentioned above, baseline separation of the analytes is the objective of the GC 
step. This is the determining factor when setting the GC oven temperature program 
and deciding the dimensions of the column. Temperature gradient or carrier gas flow 
rate do not attribute to isotopic fractionation effects.148  
When measuring analytes with a low concentration, the impact of column bleeding on 
the δ13C values may become significant and the automatic correction performed by 
the IRMS’s software may become inadequate. Therefore, not all columns are suitable 
for GC-C-IRMS analysis and the use of columns with low-bleed specification is 
advised. 
Split injection has to be avoided as differences in boiling point might induce isotopic 
fractionation.82 Also, the splitless time needs to be evaluated for each analyte and 
deactivation of the liner is essential to prevent memory effects.94 The number of 
publications in which programmed temperature vaporizer (PTV) large volume 
injection is used is limited, but isotopic fractionation caused by large volume injection 
has not been reported so far.84,113 Use of PTV injection might hold some advantages. 
The fact that the solvent is not brought onto the column improves the 
chromatography, which reduces the need for derivatization.113 Also, the injection of 
larger volumes allows the reduction of the required sample volume.84  
 
With all the above kept in mind, it needs to be said that GC in itself does influence the 
13C/12C ratio in a very specific way. It is observed that 13C containing molecules 
migrate slightly more rapidly than U-12C species on the GC-column.149 This effect is 
known as the chromatographic isotope effect, which is caused by interactions 
between solute and stationary phase, dominated by van der Waals dispersion 
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forces.150 Therefore, different 13C/12C ratios will be measured at the beginning and at 
the end of the peak. Thus, a correct and complete integration over the peak in its 
entirety is essential for correct IRMS measurements. In order to achieve this, the 
peak needs to be perfectly baseline separated first. It has to be noted that when 
baseline separation is only just reached in GC-MS, this might not be sufficient for 
IRMS. In GC-C-IRMS, the sample passes through a number of capillaries and the 
combustion furnace after being eluted from GC. This causes band broadening which 
may cause barely separated peaks to remerge.  Second, since the peak at m/z 45 
appears slightly before the one at m/z 44, both signals need to be integrated 
separately. Third, in combination with defining the peak, the background needs to be 
defined in a consequent way, so that all measurements can be corrected accordingly. 
Finally, it is of utmost importance that the peak integration is performed in a 
consequent and identical way for every analyte measured in a sample. Since δ13C 
values of different ERCs and metabolites are compared, inconsistent measurements 
of an ERC and a metabolite might have a serious influence on the calculated ∆13C 
value. Therefore, the use of software is preferred over manual peak integrations, 
since this eliminates a human bias factor.110,151  
 
2.4.2.2. Integrated analytical sample preparation strategies for the differentiation 
between endogenous steroids and synthetic homologues in bovine 
urine 
Now that the different steps of sample preparation prior to GC-C-IRMS have been 
presented, the art is to combine the right elements into an efficient and effective 
analytical strategy. In the following part, a brief summary of the different published 
analytical methods for the differentiation between endogenous steroids and synthetic 
homologues in bovine urine is given. An overview providing more detail on the 
methods is represented in table 2.2. 
The first analytical procedure for the differentiation between endogenous steroids 
and synthetic homologues in bovine urine was published in 1998 by Ferchaud et 
al.,67 and consisted of an enzymatic hydrolysis, two SPEs, two subsequent liquid-
liquid extractions (LLEs) and one HPLC cleanup. A different derivatization method 
was used for the GC-MS analysis and the GC-C-IRMS analysis. The measured 
analytes were DHEA as ERC, and etiocholanolone and epitestosterone as 
metabolites of testosterone. In the following two publications, the method was fine 
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tuned with a number of minor adaptations. The hydrolysis method was adapted,94 
and subsequently, a new derivatization method was introduced, using N-methyl-N-
(trimethylsilyl)trifluoroacetamide (MSTFA)/NH4I/dithiothreitol (DTT)/CH3CN for both 
GC-MS and GC-C-IRMS.117 In this report, the use of androst-5-ene-3β,17α-diol as an 
additional ERC and epiandrosterone and 5α-androstane-3β,17α-diol as additional 
metabolites of testosterone was suggested.  
Another method, published by Balizs et al., contains a significant number of 
differences.84 In a first step, glucuronides were hydrolyzed with β-glucuronidase from 
E. coli. Afterwards, sulphuric acid and ethyl acetate were used to deconjugate the 
sulphated compounds. Additionally, a combination of two semi-preparative HPLC 
fractionations was introduced. Finally, DHEA, epitestosterone, 17β-testosterone and 
etiocholanolone were measured. 
In 2005, a method for the detection of the administration of exogenous estrogens 
was presented,101 containing a complex and very thorough analytical strategy making 
use of multiple LLEs, SPEs and HPLC purifications. After hydrolysis using β-
glucuronidase from E. coli and a SPE with a C18 cartridge, the sample was divided 
into three fractions using two successive LLEs. In an alkaline environment, the 
deconjugated androgens reside in the organic phase, being extracted as “fraction A”. 
“Fraction E” containing the estrogens was isolated at a lower pH. The sulphated 
compounds remain in the aqueous phase, called the sulphate fraction or “fraction S”. 
Afterwards, each of the fractions was further purified separately. Another novelty in 
this procedure was the use of an additional HPLC fractionation after the derivatization 
of the steroids when the GC-MS analysis pointed out that co-elution of the target 
peaks was still occurring or when a sufficient level of purity was not reached. 
Androst-5-ene-3β,17α-diol served as the endogenous reference compound (ERC), 
while 17α-estradiol was the measured analyte for estrogen administration.  
Later, additional measurement of 5α-androstane-3β,17α-diol and etiocholanolone as 
testosterone metabolites in the same method resulted in a complete strategy to 
detect both androgen and estrogen abuse in cattle.100   
Finally, it has to be mentioned that, even though corticosteroids have only received 
little attention in regard to IRMS-analysis, a method to detect administration of 
glucocorticoids in cattle has been developed,129 with DHEA as ERC and cortisol as 
metabolite.  
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Table 2.2:  Overview of the main characteristics of the different sample preparation methods for the differentiation between endogenous and exogenous 
steroids in bovine urine, in chronological order according to the date of publication 
reference 
sample 
volume 
hydrolysis  
solid phase 
extraction (SPE) 
liquid-liquid 
extraction (LLE) 
high performance liquid 
chromatography (HPLC) derivatization  sample preparation, sequence of preparative techniques in the described method 
[67] 50 mL Helix pomatia juice 
1: C18 stationary 
phase 
two subsequent 
LLEs with a sodium 
hydroxide solution 
aminopropyl stationary phase 
(for GC-MS): MSTFA-TMIS 
Hydrolysis - SPE1 - LLE - SPE2 - HPLC - Derivatization 
2: silica stationary 
phase 
(for GC-C-IRMS): acetic 
anhydride 
[94] 50 mL Abalone entrails 
1: C18 stationary 
phase 
two subsequent LLE 
with a sodium 
hydroxide solution 
aminopropyl stationary phase 
(for GC-MS): MSTFA-TMIS 
Hydrolysis - SPE1 - LLE - SPE2 - HPLC - Derivatization 
2: silica stationary 
phase 
(for GC-C-IRMS): acetic 
anhydride 
[117] 50 mL Helix pomatia juice 
1: C18 stationary 
phase 
two subsequent LLE 
with a sodium 
hydroxide solution 
aminopropyl stationary phase 
MSTFA/NH4I/DTT/CH3CN 
(1000/5/0.25/100, v/w/w/v) Hydrolysis  - SPE1 - LLE - SPE2 - HPLC - Derivatization 2: silica stationary 
phase 
[84] 20 mL 
1: β-
glucuronidase E. 
coli C18 stationary phase   
1: C18 stationary phase 
acetic anhydride Hydrolysis1 - SPE – Hydrolysis2 - HPLC1 - HPLC2 - Derivatization 
2: sulphuric acid 
and ethyl acetate 
2: C18 stationary phase (different 
gradient mobile phase) 
[101] 20 mL 
1: β-
glucuronidase E. 
coli 
1: C18 stationary 
phase 
two subsequent LLE 
resulting in three 
fractions (fraction A, 
fraction E and 
fraction S) 
1: 3-(dimethylamino)propyl 
stationary phase 
pyridine and acetic anhydride Hydrolysis1 - SPE1 - LLE 
fraction A and E: SPE2 - HPLC1 - Derivatization - HPLC2 
2: sulphuric acid 
and ethyl acetate 
2: silica stationary 
phase 
2: C18 stationary phase fraction S: Hydrolysis2 - SPE1 - SPE2 - HPLC1 - Derivatization - HPLC2 
[100] 20 mL 
1: β-
glucuronidase E. 
coli 
1: C18 stationary 
phase 
two subsequent LLE 
resulting in three 
fractions (fraction A, 
fraction E and 
fraction S) 
1: 3-(dimethylamino)propyl 
stationary phase 
pyridine and acetic anhydride Hydrolysis1 - SPE1 - LLE 
fraction A and E: SPE2 - HPLC1 - Derivatization - HPLC2 
2: sulphuric acid 
and ethyl acetate 
2: silica stationary 
phase 
2: C18 stationary phase fraction S: SPE1 - Hydrolysis2 - SPE2 - HPLC1 - Derivatization - HPLC2 
[129] 
1: 20 mL  
1: Helix pomatia 
juice 1: OASIS 
two subsequent LLE 
resulting in three 
fractions (fraction A, 
fraction E and 
fraction S). Only 
fraction S is 
analysed further  
1: 3-(dimethylamino)propyl 
stationary phase 
1: oxidation with potassium 
dichromate and acetonitrile 
1: Hydrolysis1 - SPE1 - Derivatization1 - HPLC2 
2: 20 mL   
2: β-
glucuronidase E. 
coli 
2: C18 stationary 
phase 
2: C18 stationary phase 2: pyridine and acetic anhydride 2: Hydrolysis2 - SPE2 - LLE - SPE2 - Hydrolysis3 - SPE3 - HPLC1 – Derivatization2 - HPLC2 
3: sulphuric acid 
and ethyl acetate 
3: silica stationary 
phase 
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2.4.3. Control measures 
As the performance criteria of GC-C-IRMS analysis are not uniformly dictated, and 
because of the complexity of the sample preparation methods, a number of 
measures, which are not necessary for validation of GC-MS methods, are in order to 
verify the functionality of the method and to assure the correctness of the results.30 It 
is not within the objective of this review to provide detailed information and guidelines 
on the validation of GC-C-IRMS methods, because different approaches to this issue 
are possible. However, in the following chapter a number of issues will be addressed 
which should be integrated in every validation or quality control system regarding 
steroid analysis using GC-C-IRMS. In the past few years, the WADA revised their 
guidelines with regard to doping control analyses using GC-C-IRMS.152,153 As 
discussed in paragraph 2.5.2, there are many similarities between the use of IRMS 
for doping control in athletes and for growth promoter control in cattle, and therefore, 
these documents are a very valuable source of information when designing quality 
control and validation procedures for this application.  
 
Instrumental performance 
The IRMS instrument measures the δ13C values by comparison to the reference CO2 
gas, present in the system. In order to obtain correct values, this reference gas needs 
to be calibrated. This was usually performed using a certified alkane mixture.80,121 
Nowadays, however, it is advised to perform calibration using certified material that 
resembles the target analytes as much as possible.82 Since steroids behave rather 
differently during gas chromatography than alkanes, this might lead to an erroneous 
calibration.129 Additionally, in the most recent version of the WADA technical 
document, in force since the beginning of 2016, it is recommended to use a mixture 
of steroids covering the range of δ13C values normally found in urine samples.153 
Prior to analysis, a number of measures to ensure an adequate operation status of 
the IRMS system are required. Stability of the instrument is checked by introducing a 
number of CO2 pulses of equal quantity and verifying if the measured deviation of 
δ13C values is within range.   
The IRMS instrument has a linear range of measurement which is defined by the 
manufacturer. For a classical type instrument, δ13C value measurements with signal 
intensities between 1 and 10 nA at m/z 44 are considered reliable,112,154,155 or values 
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above 0.8 mV depending on the type of instrument.156 Before every injection series, 
the linear performance of the IRMS apparatus is verified by introducing a series of 
CO2 pulses with rising intensities. The correlation coefficient of the measured 
concentrations is the indication for the linearity.121,129 
The system needs to be checked for leaks. This can be accomplished by performing 
a scan to detect background gases, for example m/z 40 for argon or m/z 18 for 
water.82 It needs to be added that an unexplained drift in δ13C values over a longer 
period of time has been reported.157 
 
Compound specific linear range and limit of quantification 
It has been reported that GC-C-IRMS linearity is compound-dependent, meaning that 
for each substance, correct measurements can only be obtained within a limited and 
specific concentration range. Therefore, it is advisable to verify the range for each 
analyte by a series of standard injections at various concentrations.154,156 As a 
criterion, the most recent WADA guidelines state that the measured δ13C values may 
not deviate more than 0.5‰ of the mean value within the linear range.153  
In relation to this, the same document describes that the limit of quantification (LOQ), 
described as the lowest concentration in urine which still provides a measurable 
signal in the linear range with a standard deviation (SD) smaller than 1‰, needs to 
be determined for all measured analytes.  
 
Measurement uncertainty 
Since 2014, the WADA guidelines dictate that the estimated combined standard 
measurement uncertainty must be below 1‰ for every analyte, but it does not 
describe in detail how this should be calculated. Next to the within lab reproducibility, 
the method and system bias are the most important factors contributing to the 
measurement uncertainty. The method bias, or the isotopic fractionation caused by 
the sample preparation, is usually evaluated by comparing the δ13C values of steroid 
standards of the target analytes and extracted spiked aqueous samples. In case of 
absence of isotopic fractionation, the values need to be the same within a statistical 
variation.82 The system or calibration bias, also referred to as trueness, is evaluated 
through the difference between the measured and certified values of steroid 
standards with known and traceable δ13CVPDB values. Ideally, both method and 
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system bias can be evaluated simultaneously, through the measurement of urine 
samples containing steroids with known δ13CVPDB values.  
 
Compliance criteria (threshold ∆13C values) 
In recent years, the WADA abandoned a universal 3‰ criterion for all ERC-
metabolite couples to declare a sample non-compliant, and moved to a more specific 
set of non-compliance criteria, as illustrated in table 2.3. Since no official criteria are 
currently available for the evaluation of bovine urine samples, threshold ∆13C values 
for every ERC-metabolite couple need to be determined during the method 
validation. To this aim, a sufficient amount of samples from a non-treated control 
population need to be analyzed. The compliance threshold can be calculated as the 
mean ∆13C value plus three times the standard deviation (µ + 3 x SD).152 Whereas 
the 2014 WADA guidelines included a control population based threshold value as an 
additional non-compliance criterion, this was changed to a laboratory performance 
criterion in the new version.  
 
Table 2.3: IRMS thresholds according to WADA requirements 2016153  
 ∆
13CERC-Metabolite 
Metabolite: βT αT Androsterone Etio 5α-androstane-3α,17β-diol 
and/or 
5β-androstane-3α,17β-diol 
Boldenone 
(metabolites) 
and 
formestane 
Case 1 >3‰    >3‰ (either diol)  
Case 2 
    >3‰ (both diols)  
Case 3 
 >4‰     
Case 4 
  >3‰    
Case 5 
   >4‰   
Case 6 
  2-3‰  >3‰ (either diol)  
Case 7 
   3-4‰ >3‰ (either diol)  
Case 8 
    >4‰ and δ≤-27‰ (first diol)  
Case 9 
     >4‰ 
 
Routine control measures 
A number of measures were already mentioned above, such as injection of standard 
solutions to verify peak purity and the use of internal standards to assess stability. 
Additionally, it is suggested to inject a solvent blank in the beginning of a sequence, 
to check absence of contamination. The injection of an extracted water-blank sample 
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is suggested to help identifying the presence of impurities. Finally, it is advised to 
include positive and negative control samples to verify the aptitude of the method.82 
 
2.5. Detection of abuse of synthetic homologues of endogenous 
steroids, the greater picture 
 
Research into methods for the differentiation between endogenous steroids and 
synthetic homologues stretches beyond the carbon isotope ratio analysis of bovine 
urine. The aim of this chapter is to briefly present other applications, allowing 
positioning of the information into a broader frame. First, other isotope based 
techniques to differentiate between endogenous steroids and exogenous 
homologues in cattle will be described. Second, the detection of abuse of synthetic 
forms of endogenous steroids in men will be presented by highlighting the similarities 
and differences between sports doping control and detection of growth promoter 
abuse, both using GC-C-IRMS.  
 
2.5.1. Other isotope ratio mass spectrometric methods for the 
differentiation between endogenous steroids and synthetic 
homologues  
Next to carbon isotope ratio measurement, GC coupled to IRMS can also be used to 
determine the deuterium/hydrogen (D/H) ratio of steroids. During the development of 
a setup to perform this analysis, a number of problems were encountered. The 
quantitative conversion of the analytes to hydrogen gas (H2) proved to be difficult, but 
was eventually resolved by the use of high-temperature conversion (TC), during 
which the analytes are pyrolysed at temperatures of approximately 1400°C. Also, the 
low abundance of deuterium in combination with the presence of helium (He) as the 
carrier gas made precise measurements of the ions with an m/z ratio of 3 nearly 
impossible. This problem was resolved by augmenting the analyte concentration and 
by adding lenses in the detector to filter out He.158  
Although gas chromatography-high-temperature conversion-isotope ratio mass 
spectrometry (GC-TC-IRMS) has not yet been used to detect D/H ratios of steroids in 
bovine urine, a method has already been developed for the measurement of human 
urine samples.159 A number of significant differences between D/H and 13C/12C ratios 
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need to be kept in mind. First of all, the carbon isotope ratio of endogenous steroids 
depends on the diet, whereas the D/H ratio is largely influenced by the drinking 
water. Also, constant conditions of sample preparation are important, since hydrogen 
atoms of hydroxyl groups can equilibrate with the ambient atmosphere. It has been 
suggested that D/H ratio measurement might provide a powerful tool to be used 
together with 13C/12C ratio measurement, especially in cases where the ∆13C value is 
near the threshold value. Due to the large relative mass difference between D and H 
in comparison with 13C and 12C, more pronounced isotopic effects are expected, 
which could result in significant δD signatures.88,159 Piper et al. calculated the first 
reference-population based threshold values and were able to successfully 
differentiate between compliant and non-compliant samples, even in a case where 
this was not possible based on the δ13C values.160 
 
Although GC-C-IRMS is the most widespread method for carbon isotope 
measurement, it is not the only option available. Initially, the coupling of LC to IRMS 
proved to be more difficult than that of GC to IRMS. However, an interface to achieve 
this coupling, based on a wet chemical oxidation of organic compounds to CO2, has 
been commercially available since 2004. But still, LC-IRMS encountered a number of 
limitations, which hindered the practical application. The main restriction is the 
impossibility to apply organic mobile phases. These mobile phases contribute to the 
formation of CO2, detected simultaneously with the analytes. Using pure water as the 
mobile phase, the required baseline separation of analytes was difficult to achieve. 
This problem was recently overcome by the development of temperature-
programmed high-performance liquid chromatography.161 Using temperature 
gradients and HPLC at elevated temperatures, analyte separation can be 
significantly improved. Since the isotopic accuracy of temperature-programmed 
HPLC-IRMS seems to be less affected by errors compared to GC-C-IRMS,162 this 
technique could be promising for the future carbon isotope measurement of steroids. 
 
Finally, multidimensional gas chromatography coupled to combustion isotope ratio 
mass spectrometry (MDGC-C-IRMS) for the detection of exogenous steroids in urine 
has been suggested. The use of multiple GC columns in series greatly improves the 
separation capacity, therefore eliminating the need for an extended sample 
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preparation. To this aim, a prototype instrumental setup was designed to perform 
comprehensive two-dimensional gas chromatography combustion isotope ratio mass 
spectrometry (GCxGC-C-IRMS).163 For the coupling of the two GC columns, a 
longitudinally modulated cryogenic system (LMCS) was used. This allows the 
components eluting from the first column to be cryogenically trapped and 
continuously transferred as a narrow band onto the second column in two to ten 
seconds intervals, resulting in a secondary chromatogram every two to ten seconds. 
However, extensive adaptations to the combustion reactor, back flush system, water 
trap and capillaries were required in order  to minimize peak broadening and make 
the setup functional. Also, no software for the interpretation of steroid peaks which 
were sliced by the LMCS was available and needed to be written.164 Still, promising 
results were obtained by testing the setup with steroid standards. Afterwards, the 
system was further refined, and human urine samples were successfully analyzed 
using a sample preparation method from which HPLC purification could be 
eliminated. Still, due to the complex nature of the setup and its lacking commercial 
availability, GCxGC-C-IRMS is not easily applicable.   
 
2.5.2. Differentiation between endogenous steroids and synthetic 
derivatives in men 
Synthetic forms of endogenous steroids are not only abused as growth promoters in 
cattle, but as horseracing and sports doping agent as well. In the field of sports 
doping, GC-C-IRMS is also used as the preferred method for the unambiguous 
differentiation between endogenous anabolic steroids and synthetic homologues. 
Since the same doping regulations are applied worldwide, and since the World Anti-
Doping Agency (WADA) recently obliged all of its laboratories to be able to perform 
GC-C-IRMS analysis, this application is more investigated and documented than the 
growth promoter abuse, which is mainly a European issue. Because of the large 
similarities between both applications, this research contains a valuable source of 
information when designing new strategies for cleaning up bovine urine samples, as 
illustrated upon discussing sample preparation techniques.  
However, awareness of the differences is in order. While DHEA is considered an 
ERC in bovine urine, its abuse as doping product is known and as such it is not 
suited as a reference. For doping control, 17α-testosterone, pregnanediol, 11β-
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hydroxyandrosterone, 5α-androst-16-en-3β-ol and 11-ketoetiocholanolone are 
commonly utilized as the ERCs, androsterone, etiocholanolone, 5α-androstane-
3α,17β-diol and 5β-androstane-3α,17β-diol function as metabolites.123,130 This shows 
that even though the steroid metabolism is similar in all mammalian species, 
important differences between humans and bovines need to be kept in mind, 
especially when it comes to metabolites of testosterone. Since there is no abuse of 
estrogens as doping, its metabolites are not analyzed. 
Furthermore, bovine urine is considered a more difficult matrix than human urine, and 
therefore demands more extensive sample preparation,84 although the amount of 
urine available is usually higher than in human sports doping testing. 
 
Since doping control research has greatly expanded during recent years, it holds a 
number of applications not yet available to routine growth promoter control.  
While WADA provides a clear list of criteria with regard to GC-C-IRMS analysis and 
results, these are completely lacking in current European legislation, causing 
unclarity and legal disputes.30  
While rapid screening criteria for suspicious bovine urine samples are still being 
investigated, steroid profiling in athletes is far more developed and actively 
applied.165,166 In the past, samples with a ratio of testosterone over epitestosterone 
(T/E) larger than 4 were considered atypical,99 and threshold values for DHEA, 
testosterone and epitestosterone were set as well. More recent, ‘the athlete biological 
passport’, a personalized set of biomarker levels obtained through longitudinal study 
of the individual athlete, was developed to identify atypical samples.34 
The availability of adequate reference material facilitates method development and 
interlaboratory comparison of results.167 In the field of sports doping, reference 
standards are now available,168 and a protocol for calibration of the reference gas is 
present.169 Next to that, matrix-based reference material is being evaluated at the 
moment.170 Currently, the number of laboratories performing routine GC-C-IRMS 
analysis on bovine urine is very limited, but as the number might increase in the 
future, such developments will be required.   
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2.6. Conclusions 
 
Gas chromatography coupled to combustion-isotope ratio mass spectrometry offers a 
unique method for the unambiguous differentiation between natural hormones and 
homologous synthetic compounds in cattle. The advantage of being able to detect 
exogenous steroids in an undisputable way gravely outweighs the difficulties of the 
complex sample preparation methods. Still, extensive study will be required in 
facilitating the implementation and broadening the application of this technique.  
Recent evolutions in high throughput sample preparation methods, such as solid 
phase micro extraction (SPME), supported and immobilized liquid extraction and 
robotic liquid handlers, can provide powerful means to simplify and speed up the 
analysis, which remains up until now laborious and time consuming.  
Next to evolutions in sample preparation, technical improvements in IRMS 
technology holds promises for future applications. Enhancement of the sensitivity of 
carbon isotopic measurement would greatly improve the detection of steroid abuse 
and could allow smaller sample volumes. Also, recent developments in liquid 
chromatography coupled to isotope ratio mass spectrometry (LC-IRMS) could 
provide new strategies for the future. Finally, the use of hydrogen IRMS for the 
differentiation between endogenous steroids and exogenous homologues shows 
promising first results, although further elaboration is required.   
It can be hoped that the increased attention and recent evolutions concerning       
GC-C-IRMS in doping control will boost the development in the field of growth 
promoter detection. 
It is clear, however, that parallel to the further development of GC-C-IRMS as a 
highly specialized confirmation method, the development of targeted steroid profiling 
to provide applicable screening strategies is necessary in order to isolate suspicious 
samples for isotope ratio analysis.   
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3. Application of gas chromatography-(mass 
spectrometry/combustion-isotope ratio mass 
spectrometry) (GC-(MS/C-IRMS)) to detect the abuse of 
17β-estradiol in cattle 
 
Adapted from Janssens G.; Mangelinckx S.; Courtheyn D.; Prévost S.; De Poorter G.; 
De Kimpe N.; Le Bizec B. J. Agric. Food Chem. 2013, 61, 7242-7249. 
 
3.1. Abstract 
 
Although the ability to differentiate between endogenous steroids and synthetic 
homologues based on their 13C/12C isotopic ratio has been known for over a decade, 
this technique has been scarcely implemented for food safety purposes. In this study, 
a method was developed using gas chromatography-(mass 
spectrometry/combustion-isotope ratio mass spectrometry) (GC-(MS/C-IRMS)) to 
demonstrate the abuse of 17β-estradiol in cattle, by comparison of the 13C/12C ratios 
of the main metabolite 17α-estradiol and an endogenous reference compound 
(ERC), 5-androstene-3β,17α-diol, in bovine urine. The intermediate precision was 
determined as 0.46‰ and 0.26‰ for 5-androstene-3β,17α-diol and 17α-estradiol, 
respectively. To the best of our knowledge, this is the first reported use of             
GC-(MS/C-IRMS) for the analysis of steroid compounds for food safety issues.  
 
3.2. Introduction 
 
The influence of steroid hormones on muscle/meat building has been known for over 
70 years, which led to widespread use in both sports and stock farming, respectively. 
While their immediate effect on animals from the farmer's point of view is clear, risk 
assessment was subjected to debates because of divergent opinions at the 
international levels, e.g. Codex Committee on Residue of Veterinary Drugs in Foods 
(CCRVDF) and Scientific Committee on Veterinary Measures relating to Public 
Health (SCVPH). Whereas hormones are licensed in various countries worldwide, 
they are banned for use as growth promoters in the European Union since 1988.19 As 
a result, monitoring the abuse of steroid hormones in large scale surveillance 
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programs for food safety reasons is mandatory for all member states.23 When looking 
at the results of these monitoring plans from 2000 up to 2010,171 an annual average 
of approximately 8% of the non-compliances for steroids (group A3) are attributable 
to 17β-estradiol.  However, these monitoring programs are still based on the classical 
approach using either GC-MS or LC-MS, which are unable to provide unambiguous 
results when it comes to the detection of synthetic analogues of naturally occurring 
steroid hormones in urine. In case of estradiol, a population study on the presence of 
natural steroids in bovine urine in the UK showed that when setting a concentration 
threshold value for 17α-estradiol in bovine urine to indicate 17β-estradiol abuse, a 
confirmatory analysis is required since there is an overlap in the concentration of 
17α-estradiol between treated and non-treated animals.32 Since it became clear 
during the late 1990s that a distinction could be made between endogenous steroids 
and exogenous homologues based on their carbon isotopic composition (13C/12C) – 
reported as δ13C values (‰) – analyses using gas chromatography-combustion-
isotope ratio mass spectrometry (GC-C-IRMS) have been adopted in the field of 
sports doping control and food safety.67,84,94,100,101,113,117,129,130,172 Exogenous steroids 
which are synthesized from plant material are enriched in 12C compared to 
endogenously produced steroids because the source material originates from plant 
species which are naturally low in 13C content. The δ13C values of exogenous 
steroids are usually lower than -30‰, whereas δ13C values of endogenous steroids 
reflect the diet and are usually above -28‰. Because of the individual variability of 
the δ13C values, mostly caused by differences in diet, both precursors, also called 
endogenous reference compounds (ERCs), and metabolites of the targeted steroid 
hormone are measured. Only the δ13C values of the metabolites are influenced by 
the administration of the exogenous steroid and therefore, the difference between the 
δ13C value of the ERC and the metabolite, expressed as ∆13C (‰), provides proof of 
administration. Still, in the field of food safety, the use of GC-C-IRMS to differentiate 
between endogenous steroid hormones and synthetic homologues in cattle has only 
been applied scarcely until now172, and the number of published methods is slowly 
growing. 67,84,94,100,101,113,117,129 
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In this chapter, a method for the detection of 17β-estradiol administration to cattle is 
presented using gas chromatography-(mass spectrometry/combustion-isotope ratio 
mass spectrometry) (GC-(MS/C-IRMS)) for the measurement of 5-androstene-
3β,17α-diol as ERC and 17α-estradiol as metabolite in urine. Sample preparation 
was based on the previously published method,101 with minor adaptations to adjust to 
the current laboratory situation and to allow further automation. 
 
3.3. Material and methods 
 
3.3.1. Urine samples 
Non-compliant samples 
One male and one female bovine, aged between 18 and 24 months and weighing 
approximately 400 kg, were treated with a single intramuscular injection containing 1 
mg/kg body weight testosterone (administered as 1.194 mg/kg testosterone 
propionate) and 0.2 mg/kg body weight estradiol (administered as 0.276 mg/kg 17β-
estradiol-3-benzoate). Urine samples were collected before and during the first 27 
days after administration and stored frozen at -21°C. Afterwards, the samples were 
stored at -85°C until assay. 
 
Compliant samples 
Twenty-nine urine samples of pregnant cows were collected at different farms to be 
used as reference population samples. The samples were stored at -85°C until 
assay. 
 
Spiked samples 
Routine samples in which no 17α-estradiol could be detected and with 
concentrations of 5-androstene-3β,17α-diol below 5 ppb, were used for the 
preparation of samples spiked with 17α-estradiol and 5-androstene-3β,17α-diol, to be 
used for validation and quality control.  
 
3.3.2. Reagents and chemicals  
All reagents and solvents were of analytical grade and were provided by Sigma-
Aldrich (Bornem, Belgium). The solvents for liquid chromatography were of LC- and 
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HPLC-grade from Biosolve (Valkenswaard, the Netherlands).  17β-Testosterone 
acetate was supplied by Sigma-Aldrich (Bornem, Belgium). Other steroids were 
obtained from Steraloids (Wilton, NY, USA). SPE C18 cartridges were obtained from 
Achrom (Zulte, Belgium). β-Glucuronidase was from Escherichia coli from Roche 
Diagnostics GmbH (Mannheim, Germany). Pyridine and acetic anhydride used in 
derivatization reactions were from Sigma-Aldrich (Bornem, Belgium).  
 
3.3.3. Instrumentation 
HPLC-UV 
During sample preparation, two subsequent HPLC purifications were performed. The 
first system used was a Waters Alliance 2690 equipped with a UV-detector (diode 
array detector, DAD), operated between 205 and 235 nm, and an automated fraction 
collector. The system was set up with a C18 functionalized precolumn (Grace Alltima 
C18; 7.5 mm x 3 mm; 5 µm) and a C18 functionalized column (Grace Alltima C18; 250 
mm x 3 mm; 5 µm). An isocratic method was used with a rinsing phase at the end of 
the run. A mobile phase made of H2O/MeOH (95/5; v/v) (solvent A) and MeOH 
(solvent B) was used, held at a constant composition (A:B; v/v) of 37:63. The flow 
rate was set at 0.6 mL/min, column temperature at 40°C and the injected volume was 
100 µL. The second Waters Alliance 2690 system was equipped with two diol 
functionalized columns (LiChrospher Diol; 250 mm x 4 mm; 5 µm) in series. An 
isocratic method was used with a mobile phase of isooctane/isopropanol (85/15; v/v) 
and a rinsing phase at the end of the run. The flow rate was set at 1 mL/min, column 
temperature at 40°C and the injected volume was 100 µL. 
 
GC-(MS/C-IRMS) 
The samples were analyzed with a Thermo Trace GC Ultra gas chromatograph, 
equipped with a RXI 5 SIL MS column (Restek – 30 m; 0.25 mm ID; 0.25 µm df) and 
a Thermo Scientific TriPlus autosampler. After GC, the sample was split by means of 
a T-piece, which was coupled to a Thermo DSQ II single quadrupole mass 
spectrometer at one end, and to a Thermo MAT 253 isotope ratio mass 
spectrometer, via the Thermo Scientific GC Isolink, at the other end.  Gas flows were 
regulated using the Thermo Scientific Conflo IV interface. Eight µL was injected at 20 
µL/sec into the injector in programmed temperature vaporizer mode. The initial 
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injector temperature was 100°C, which was held for 0.05 min with a vent flow of 20 
mL/min. The temperature was raised at 8°C/min and held at 280°C for 2 min during 
sample transfer on column. The initial GC oven temperature was 110°C, which was 
held for 1.5 min. The temperature was then raised to 280°C at 8°C/min and held for 2 
min. Finally, the temperature was raised to 320°C at 50°C/min and held for 3 
minutes. The carrier gas was helium at a constant flow rate of 1.5 mL/min. The 
temperature of the transfer line was set at 300°C. The steroids were detected on MS 
using full scan mode (m/z 50 to 400). The combustion furnace was set at 950°C and 
was oxidized prior to each series of analyses for 1h. The combustion gases were 
passed through a Nafion membrane filter for water removal. After ionization, the ions 
with m/z 44, 45 and 46 were magnetically separated and simultaneously measured in 
three Faraday collectors. The CO2 reference gas was calibrated with a mixture of 
steroids with certified and traceable δ13CVPDB values, measured with an elemental 
analyzer (5-androstene-3β,17α-diol monoacetate (-27.0‰), β-testosterone acetate (-
30.5‰) and dehydroepiandrosterone (DHEA) acetate (-32.1‰)). Carbon isotope 
ratios of the compounds were expressed relative to Vienna Pee Dee Belemnite 
(VPDB). The shift of the δ13CVPDB value due to the formation of acetates is corrected 
as follows: 
DOH = DOAc + 2m (DOAc − DAc)/n 
DOH is the δ13CVPDB value of the underivatized steroids, DOAc the δ13CVPDB value of the 
acetylated steroids, DAc the δ13CVPDB value of the acetylating reagent, n the number 
of carbon atoms in a molecule and m is the number of hydroxyl groups to be 
acetylated100.  
 
3.3.4. Sample preparation 
A schematic overview of the analytical strategy is presented in scheme 3.1. The urine 
samples were centrifuged (15 min, 3113 g) prior to analysis, to avoid obstruction of 
the solid phase extraction (SPE) cartridges in a later stage. To 10 mL of the 
centrifuged urine sample, 3 mL phosphate buffer 0.8 M (pH 6.8) and 50 µL 
glucuronidase from E. coli were added. Hydrolysis was performed for 15h at 37°C. 
Then, the sample was brought onto a C18 SPE column, which was first conditioned 
with 6 mL of methanol and 6 mL of H2O. The column was subsequently washed with 
6 mL H2O and 5 mL H2O/acetonitrile (ACN) (80/20; v/v), and eluted using 8 mL 
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H2O/ACN (10/90; v/v). The eluted sample was evaporated to approximately 300 µL 
under a nitrogen stream at 40°C, and 0.5 mL of 1 M sodium hydroxide was added. 
Next, a liquid-liquid extraction (LLE) was performed using 4 mL of n-pentane/diethyl 
ether (92.5/7.5; v/v). The organic layer was kept and labeled “fraction A”, containing 
androgenic steroids, amongst which the targeted ERC 5-androstene-3β,17α-diol. 
Next, the pH of the aqueous layer was adjusted using glacial acetic acid and a 
second liquid-liquid extraction using 4 mL of n-pentane/diethyl ether (92.5/7.5; v/v) 
was performed. The organic layer was kept and labeled “fraction E”, containing 
estrogenic steroids, amongst which the target metabolite 17α-estradiol. Both fractions 
were evaporated under a nitrogen stream at 37°C after the addition of 100 µL of 
glycerol solution (10% in methanol) to serve as a keeper solution, and mixed with 70 
µL of water and 40 µL of fluoxymesterone in methanol (50 ng/µL) as internal 
standard. Prior to injection onto the first HPLC-system, the fractionation windows for 
the ERC and metabolite were determined through the threefold injection of a 
standard solution containing fluoxymesterone, 17α-estradiol, 5-androstene-3β,17α-
diol and 17β-testosterone. The collected fractions “A” and “E”, containing 5-
androstene-3β,17α-diol and 17α-estradiol, respectively, were evaporated under a 
nitrogen stream at 37°C and dissolved in 120 µL of isopropanol/isooctane (10/90; 
v/v). An aliquot of 20 µL of a medroxyprogesterone standard solution (100 ng/µL) 
was added as internal standard, used for both verification of the retention time and 
estimation of the analyte concentration during the second HPLC purification. The 
samples were injected after calculating the fractionation windows with the threefold 
injection of a standard solution containing medroxyprogesterone, 17α-estradiol, 5-
androstene-3β,17α-diol and 17β-testosterone. The collected fractions were 
evaporated to dryness under a nitrogen stream at 40°C and 25 µL of both acetic 
anhydride and pyridine were added. The derivatization was done overnight at room 
temperature in a closed vial. Afterwards, the sample was evaporated to dryness 
under a gentle nitrogen stream at 40°C and the residue was dissolved in the 
appropriate volume of isooctane to provide measurement within the linear range of 
the IRMS apparatus. Finally, after the addition of noretiocholanolone acetate (4 
ng/µL) as external standard, the two fractions were injected onto GC-(MS/C-IRMS) 
for further characterization of δ13CVPDB of 5-androstene-3β,17α-diol diacetate and 
17α-estradiol diacetate.  
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Scheme 3.1. Analytical strategy for the extraction and purification of 17α-estradiol and the 
endogenous reference compound 5-androstene-3β,17α-diol. LLE stands for liquid-liquid extraction 
 
3.4. Results and discussion 
 
3.4.1. Sample preparation and analysis 
The presented sample preparation method is based on the previously published 
method by Buisson et al.,101 with a number of adaptations to speed up the process or 
to allow further automation in the future. First, only 5-androstene-3β,17α-diol was 
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measured as ERC. By not measuring dehydroepiandrosterone (DHEA), the necessity 
for the time consuming analysis of the sulphoconjugated steroids was eliminated.  
Second, one SPE purification step and the two preparative HPLC steps were 
replaced by just two subsequent HPLC purifications prior to derivatization. Because 
the use of a 3-(dimethylamino)propyl-functionalized silica gel column resulted in 
unstable retention times – after a sudden shift, the retention times of the analytes 
differed significantly – a diol functionalized stationary phase was selected for the 
second HPLC purification. Even though a cleanup procedure without the straight 
phase HPLC purification provided accurate results, the addition of the second HPLC 
preparation step was preferred to further reduce the risk of impurities coeluting with 
the analytes. The additional effect of this HPLC step on the sample cleanup is 
illustrated in figure 3.1.  
 
Figure 3.1. MS chromatograms of the androgen fraction of a urine sample of a pregnant cow after the 
complete sample preparation procedure (above) and after sample preparation without straight phase 
HPLC purification (below), showing the internal standard noretiocholanolone acetate (NEC) and 5-
androstene-3β,17α-diol (AEdiol). The data were produced in full scan mode (m/z 50 – 400). 
AEdiol 
AEdiol 
NEC 
NEC 
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Figure 3.2. IRMS chromatograms (m/z = 44) of a positive bovine urine sample, showing the internal 
standard noretiocholanolone acetate (NEC), the metabolite 17α-estradiol diacetate (αE2) (above) and 
the ERC 5-androstene-3β,17α-diol (AEdiol) (below).  
 
Third, by replacing the previously used splitless injection by programmed 
temperature vaporization (PTV)-injection, the required sample volume was 
successfully reduced from 20 mL to 10 mL.  Finally, the separate GC-MS analysis, 
which was until now required prior to each GC-C-IRMS analysis of steroids, could be 
eliminated. By estimating the concentration of the analytes by means of UV-detection 
during the final HPLC step, the dilution factor of the sample could be successfully 
determined to obtain measurements well within the linear working range of the C-
AEdiol 
NEC 
NEC 
αE2 
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IRMS-apparatus. Additionally, by means of the parallel coupled MS in the             
GC-(MS/C-IRMS) setup, the analytes could be successfully identified and controlled 
for purity simultaneous with the isotope ratio measurement, thus avoiding possible 
criticism on GC-C-IRMS that identification is not done during the same injection as 
isotope ratio measurement.110 The resulting IRMS chromatograms of a urine sample 
of a treated animal after sample preparation are shown in figure 3.2. The rectangular 
peaks at the beginning and end of the chromatogram are pulses of the used CO2 
reference gas. The fifth CO2 pulse is used by the software for the normalization of the 
measurements. The resulting chromatograms are clean and the analyte peaks are 
baseline separated and free of any coelutions, demonstrating the performance of the 
purification method. However, due to the necessary extensive sample preparation, 
the yield of the analytes is highly variable. The recovery of the sample preparation 
was calculated under reproducibility conditions at different concentrations, and 
ranged from 40% to 80% for 5-androstene-3β,17α-diol and from 40% to 76% for 17α-
estradiol.  
 
3.4.2. Method validation 
GC-C-IRMS has been accepted as the confirmation method for the differentiation 
between endogenous steroid hormones and synthetic homologues. Still, official 
guidelines for the validation of IRMS analysis are currently lacking. However, the 
sample cleanup procedures remain complex, with many different purification steps 
involved. Since every cleanup step introduces a risk on isotopic fractionation, the 
robustness assessment was mandatory.   
 
Linear working range 
The range in which the isotope ratio mass spectrometer produces accurate 
measurements of δ13CVPDB values was determined by a series of injections of 17α–
estradiol diacetate and 5-androstene-3β,17α-diol diacetate in increasing amounts, 
from 2.5 ng up to 80 ng on column, in sixfold at each level. To determine the linear 
range, a combination of three criteria was applied. First, the standard deviation (SD) 
of the repeated injection at each individual concentration level needs to be smaller 
than 0.5‰. Second, the difference between the lowest and highest measured 
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δ13CVPDB value needs to be smaller than 1.25‰. Third, the standard deviation over 
the entire range must be below 0.75‰ as well.  
The injections of 5 ng, corresponding with peak intensities just below 500 mV, clearly 
show deviating δ13CVPDB values and a larger spreading of the results, hence the lower 
limit of the linear range lies between 500 mV and 1000 mV, corresponding with 
approximately 7 ng of the steroids on column. For the injection of 80 ng of 5-
androstene-3β,17α-diol diacetate, lower δ13CVPDB values are observed, which might 
be due to peak fronting. The injection of 2.5 ng did not yield measurable results. 
Using the mentioned criteria, the compound specific linearity ranged from 
approximately 7 ng to 60 ng on column for AEdiol, and 7 ng to 80 ng on column for 
αE2, as can be seen in figure 3.3. The measured standard deviation within the linear 
domain were 0.23‰ and 0.13‰ for 5-androstene-3β,17α-diol diacetate and 17α–
estradiol diacetate, respectively. 
 
Intermediate precision or within lab reproducibility 
To determine the intermediate precision, a blank urine sample was spiked with 5-
androstene-3β,17α-diol and 17α-estradiol at 200 µg L-1. The sample was divided into 
12 subsamples which were analyzed by three different operators on three different 
dates, over a time span of two months. The first series consisted of 6 subsamples, 
the second series of 2 subsamples and the third series of 4 subsamples. The results 
are presented in table 3.1. The sample standard deviation (S.D.) (n=12) of the 
δ13CVPDB were 0.46‰ and 0.26‰ for 5-androstene-3β,17α-diol and 17α–estradiol, 
respectively. Standard deviations beneath 0.5‰ are considered acceptable.117,123,172  
 
Isotope fractionation or method bias 
The δ13CVPDB values after sample preparation of six water samples spiked at 200 µg 
L-1 with 5-androstene-3β,17α-diol and 17α–estradiol were compared with those of 
four standard injections, not subjected to sample preparation, to assess the isotope 
fractionation occurring during sample preparation. The mean difference between the 
δ13CVPDB values was 0.33‰ for 5-androstene-3β,17α-diol and 0.04‰ for 17α–
estradiol. In comparison with results from the literature for a similar experiment with 
other steroids,84 these differences are significantly lower than previously reported 
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values, leading to the conclusion that the isotope fractionation – if any – is 
acceptable.  
 
 
 
Figure 3.3. δ13CVPDB values (expressed in ‰) of 17α-estradiol diacetate (αE2) (lower) and 5-
androstene-3β,17α-diol diacetate (AEdiol) (upper) and the corresponding peak intensities (expressed 
in mV) for the injected amounts of 5 ng, 10 ng, 15 ng, 20 ng, 32 ng, 50 ng and 80 ng on column (six 
injections for each amount). Vertical error bars represent the SD (‰), horizontal error bars represent 
the range (mV). 
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Table 3.2. Intermediate precision of the δ13CVPDB values (expressed in ‰, not corrected for the acetate 
moiety) of a spiked urine sample [200 ppb of 17α-estradiol (αE2) and 5-androstene-3β,17α-diol 
(AEdiol)], analyzed on three different days. 
 
δ
13CVPDB  AEdiol (mean ± S.D.)(‰) δ13CVPDB  αE2 (mean ± S.D.)(‰) 
Series 1 (n=6) -32.86 ± 0.27 -31.53 ± 0.15 
Series 2 (n=2) -33.16 ± 0.01 -32.02 ± 0.24 
Series 3 (n=4) -33.75 ± 0.18 -31.92 ± 0.07 
Mean (n=12) -33.26 -31.82 
S.D. (n=12) 0.46 0.26 
 
Trueness or system bias 
The trueness, or system bias, was evaluated by the injection of standards of 
dehydroepiandrosterone acetate (-31.9‰) and 17β-testosterone acetate (-30.3‰) 
with traceable and certified δ13CVPDB values, obtained through EA-IRMS analysis by 
an accredited laboratory. These standards were included into six separate series of 
measurement, and allowed to evaluate the system bias. The mean difference 
between the certified and the measured δ13CVPDB values was 0.88‰ and 0.25‰ for 
dehydroepiandrosterone acetate and 17β-testosterone acetate, respectively, 
resulting in an average system bias of 0.57‰.  
 
Specificity  
Ten reference standards, ten spiked water samples, sixteen spiked urine samples 
and fifteen urine samples collected from pregnant cows were analyzed according to 
the described method. For all samples, the identification of 5-androstene-3β,17α-diol 
and 17α–estradiol was done according to the legal criteria,24 by comparison of 
retention time and the abundance of six fragment ion ratios of the analytes with those 
of a standard injected in the same series. This way, the four identification points 
required to identify Group A substances using mass spectrometry, as described in 
paragraph 1.2, are obtained. The typical MS-spectra of 5-androstene-3β,17α-diol and 
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17α–estradiol are depicted in figure 3.4. For all the samples, the analytes could be 
correctly identified and no impurities or coelutions were observed.  
Complementary, the MS-data were evaluated using AMDIS-software. This program 
employs specific algorithms on the MS-data to detect interfering peaks hidden 
beneath others.  Additionally, AMDIS compared the MS-data of the analytes with that 
of a standard injection in the same series, to provide a “Net Match”-factor and a 
“Purity”-factor for all the samples. The objective was to study if these “factors” could 
be used as a criterion for the evaluation of both the identity and the purity of the 
analytes. In the AMDIS-data, the “Net Match”-factor ranged from 92 to 100 and the 
“Purity”-factor from 88 to 97. For future analysis, the use of fragment ion abundance 
ratios will only be required if the “Net Match”-factor is below a threshold value of 92 
and if the “Purity”-factor is below a threshold value of 88.  
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Figure 3.4. MS-spectra of 17α-estradiol diacetate (αE2) (above) and 5-androstene-3β,17α-diol 
(AEdiol) (below). Fragmentation was done by electron ionization with an ion source temperature of 
250°C. The data were produced in full scan mode (m/z 50 – 400). 
 
Non-compliant threshold value 
In the past, for doping control purposes, the World Anti Doping Agency (WADA) used 
a threshold value of ∆13C
 
>3‰ for non-compliant samples, but moved recently to a 
more detailed decision system, for specific ERC-metabolite couples, as discussed in 
chapter 2. However, 17α-estradiol is not of interest for anti-doping analyses, and for 
bovine samples, no official compliance criteria currently exist. To determine a suited 
threshold value for this specific application, ∆13CVPDB values were determined in a 
compliant control population of 29 pregnant cows. Pregnant cows’ urine is preferred 
in this case, since the concentrations of 17α–estradiol in regular samples are often 
AEdiol 
αE2 
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too low for reliable measurement with C-IRMS. The data obtained from the samples 
of the compliant control population allowed to calculate a ∆13CVPDB threshold of 
2.32‰ as the mean value plus three times the standard deviation (µ + 3 x SD). To 
add an additional safety margin, the applied threshold value above which samples 
are evaluated as non-compliant, was set at 3‰.  
To verify the adequacy of the developed method and the determined threshold value, 
six urine samples collected from treated animals were analyzed according to the 
described procedure. The resulting δ13CVPDB values are presented in table 3.2. All 
∆13C values are above 14‰, clearly illustrating the potential of the method to detect 
positive samples, as well as the validity of the used threshold value.  
 
Table 3.3. δ13CVPDB values (expressed in ‰) of 17α-estradiol and 5-androstene-3β,17α-diol in six non-
compliant urine samples of bovines treated with 17β-estradiol. 
Sample N° δ13CVPDB  AEdiol (‰) δ13CVPDB  αE2 (‰) ∆13CVPDB  (AEdiol- αE2) (‰) 
1 -15.57 -30.23 14.66 
2 -15.64 -30.15 14.51 
3 -15.26 -29.99 14.73 
4 -15.45 -30.24 14.79 
5 -15.17 -30.11 14.94 
6 -15.38 -30.08 14.70 
 
3.4.3. MS detector influence on isotope ratio measurement 
To evaluate the influence of the parallel coupled MS on the isotope ratio mass 
spectrometers’ measurements, the experiment performed to determine the linear 
range, as described above, was repeated twice, once after uncoupling the mass 
spectrometer and again after recoupling. The results for 17α–estradiol diacetate and 
5-androstene-3β,17α-diol diacetate of the three carbon isotope ratio measurement 
series are presented in figure 3.5. No differences in δ13CVPDB values between the 
three series, other than those caused by natural spreading of the results, could be 
observed. The repeatability of the standard injections at different concentrations 
without and with the MS coupled in the setup revealed neither significant differences 
in precision nor accuracy. 
Chapter III 
67 
 
 
 
 
Figure 3.5. δ13CVPDB values (expressed in ‰) of 17α-estradiol diacetate (αE2) (lower) and 5-
androstene-3β,17α-diol diacetate (AEdiol) (upper) and the corresponding amounts (expressed in ng) 
for the injected amounts of 5 ng, 10 ng, 15 ng, 20 ng, 32 ng, 50 ng and 80 ng on column (mean values 
of six injections for each amount). Series 1 and series 3 were performed with a GC-(MS/C-IRMS) 
setup, series 2 with a GC-C-IRMS setup.  
 
Since the same sample amount is split between the MS and the IRMS in the         
GC-(MS/C-IRMS) setup, the measured peak intensities for the GC-C-IRMS setup 
generally were slightly higher. However, the difference is limited and causes no 
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significant disadvantages within the regular  range of the measurements, between 10 
ng and 40 ng on column, as illustrated in figure 3.6. 
 
 
 
Figure 3.6. Average peak intensities (expressed in mV) and the corresponding amounts on column 
(expressed in ng) of 17α-estradiol diacetate (lower) (on the right) and 5-androstene-3β,17α-diol 
diacetate (AEdiol) (upper). Series 1 and series 3 were performed with a GC-(MS/C-IRMS) setup, 
series 2 with a GC-C-IRMS setup.  
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3.5. Conclusions 
 
GC-(MS/C-IRMS) offers a powerful tool for the detection of steroid abuse. It is clear, 
however, that the described procedure needs to be extended in the future to include 
a number of additional metabolites and ERCs to allow simultaneous detection of 
abuse of a broader range of steroids. Still, analysis with GC-(MS/C-IRMS) is 
relatively complex, the sensibility of the apparatus is limited and the sample 
preparation remains laborious and time consuming, making the application for routine 
analyses limited to experienced laboratories. Therefore, adequate screening 
procedures need to be worked out to complement the C-IRMS confirmatory analyses. 
Publications on using profiles of direct metabolites of steroids for screening of steroid 
abuse indicate that applicable strategies will be available soon,36,174,175 and  research 
into the use of indirect biomarkers holds interesting promises for future 
application.40,42,46,174-178 GC-MS and LC-MS analyses based on both targeted and 
untargeted profiling would provide rapid and powerful screening  methods, to be used 
in combination with GC-(MS/C-IRMS) confirmation methods. 
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4. Simultaneous detection of androgen and estrogen 
abuse in bovines by gas chromatography-(mass 
spectrometry/combustion-isotope ratio mass 
spectrometry) (GC-(MS/C-IRMS)) evaluated against 
alternative methods 
 
Adapted from Janssens G.; Mangelinckx S.; Courtheyn D.; De Kimpe N.; Matthijs B.; 
Le Bizec B. J. Agric. Food Chem. 2015, 63, 7574-7581. 
 
4.1. Abstract 
 
The administration of synthetic homologues of naturally occurring steroids can be 
demonstrated by measuring 13C/12C isotopic ratios of their urinary metabolites. Gas 
chromatography-(mass spectrometry/combustion-isotope ratio mass spectrometry) 
(GC-(MS/C-IRMS)) was used in this study to appraise in a global approach isotopic 
deviations of two 17β-testosterone metabolites (17α-testosterone and 
etiocholanolone) and one 17β-estradiol metabolite (17α-estradiol) together with those 
of 5-androstene-3β,17α-diol as endogenous reference compound (ERC). 
Intermediate precisions of 0.35‰, 1.05‰, 0.35‰ and 0.21‰, respectively, were 
observed (n=8). To assess the performance of the analytical method, a bull and a 
heifer were treated with 17β-testosterone propionate and 17β-estradiol-3-benzoate. 
The method permitted the demonstration of 17β-estradiol treatment up to 24 days. 
For 17β-testosterone treatment, the detection windows were 3 days and 24 days for 
the bull and the heifer, respectively. The potential of GC-(MS/C-IRMS) to 
demonstrate natural steroid abuse for urinary steroids was eventually compared to 
those of mass spectrometry (LC-MS/MS) when measuring intact steroid esters in 
blood and hair. 
 
4.2. Introduction 
 
The positive effects of steroids on weight gain and feed conversion are well known 
since the middle of the past century, after which they were readily used in stock 
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farming for fattening purposes and in sports for muscle building. Eventually, the use 
of these substances was restricted, and until today, remains prohibited as a growth 
promoter in the European Union.22 Therefore, the abuse of steroid hormones is 
monitored in mandatory surveillance programs for food safety in all the EU member 
states.23 For the official control laboratories, analytical guidelines and performance 
criteria are available, demanding that a positive screening result is followed by a 
confirmatory analysis using gas or liquid chromatography coupled to mass 
spectrometry (GC-MS or LC-MS).24 However, using GC or LC-MS, the distinction 
between endogenous steroids, produced by the animals themselves, or synthetic 
homologues derived from them, which can be administered, is commonly difficult 
because they will be detected as structurally identical compounds. Also, an 
unambiguous assessment of the origin of the urinary metabolites based on their 
concentrations is hard to accomplish because of the large variations between 
individual animals.16 Gas chromatography-combustion-isotope ratio mass 
spectrometry (GC-C-IRMS) was developed in the late 90’s to offer an alternative to 
historical quantitative approaches.64,67,101 Very recently, the European Union 
Reference Laboratory (EURL) advised to make use of GC-C-IRMS to demonstrate 
the origin of steroids in urine samples.29  
Steroid preparations are usually synthesized from phytosterols originating from plant 
sources which are relatively enriched in 12C, with carbon isotope ratios, expressed 
relative to Vienna Pee Dee Belemnite (VPDB) as δ13CVPDB values, usually lower than 
-30‰. In comparison, endogenously produced steroids have a 13C/12C ratio which 
reflects that of the mixture of plant materials in the feed, with δ13CVPDB values usually 
above -28‰. Because of the fact that it is difficult to set non-compliance δ13CVPDB 
threshold values due to large individual differences between animals, both 
endogenous reference compounds (ERCs) and metabolites of the targeted steroid 
hormones are measured. Since the ERC is not impacted by the steroid treatment, a 
substantial δ13C difference between ERC and metabolite may be observed for a 
certain period of time post administration. The ∆13CVPDB (‰) is the cornerstone of the 
abuse demonstration. While this technique is nowadays mandatory for accredited 
WADA laboratories,130,153 it is applied in the food safety arena to a minor extent.172 
The first aim of the presented research was to develop a common analytical 
backbone able to provide carbon isotopic measurements for main metabolites of 17β-
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testosterone (βT), namely etiocholanolone (Etio) and 17α-testosterone (αT), and of 
17β-estradiol (βE2), namely 17α-estradiol (αE2), thus allowing the simultaneous 
detection of abuse of synthetic homologues of androgenic and estrogenic steroid 
hormones. The second aim was to apply the validated method for an experimental 
study involving treatment of a bull and a heifer, determining the detection window 
capability of the analytical approach and allowing a direct comparison with other 
strategies including the monitoring of steroid esters in blood.  
 
4.3. Material and methods 
 
4.3.1. Chemicals  
All reagents and solvents were of analytical grade and were provided by Sigma-
Aldrich (Bornem, Belgium). The solvents for liquid chromatography were of LC- and 
HPLC-grade from Biosolve (Valkenswaard, the Netherlands).  17β-Testosterone 
acetate was supplied by Sigma-Aldrich (Bornem, Belgium). Other steroids were 
obtained from Steraloids (Wilton, NY, USA). SPE C18 cartridges were provided by 
Achrom (Zulte, Belgium). Escherichia coli β-glucuronidase was from Roche 
Diagnostics GmbH (Mannheim, Germany). Dry pyridine and acetic anhydride were 
from Sigma-Aldrich (Bornem, Belgium).  
 
4.3.2. Sample description 
Animal experiment 
One male and one female bovine (Belgian white-and-red breed), aged 22 and 19 
months and weighing 310 kg and 269 kg, respectively, were used for an 
administration study. After arrival at the farm until the end of the experiment, they 
were fed with a typical feed concentrate (2.0 kg daily), which contained mainly C3 
plant material with added vitamins and minerals, and had access to dried grass, 
chopped corn and water ad libitum. It needs to be noted that the amount of chopped 
corn, consumed by the animals, was significantly larger than that of the feed 
concentrate and the dried grass. After 21 days, they were treated with a single 
intramuscular injection into the dorsal neck muscles, containing 1 mg kg-1 bw 
testosterone (administered as 1.194 mg kg-1 17β-testosterone propionate (βTP)) and 
0.2 mg kg-1 bw estradiol (administered as 0.276 mg kg-1 17β-estradiol-3-benzoate 
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(βE2B)) as an oil based preparation. Urine samples were collected before and during 
the first 27 days after administration, and stored frozen at -21 °C. When all the 
samples were collected, they were stored at -85 °C in a monitored temperature 
environment until assay. 
The animal experiment was performed at the Faculty of Veterinary Medicine of  
Ghent University (B), in line with the guidelines of the ethical committee, with 
approval code EC2011/163.  
 
Compliant samples 
Eleven urine samples of non-treated pregnant cows were collected at different farms. 
Additionally, twelve urine samples from animals, a priori non-treated according to 
routine analyses, were added to obtain a sufficiently large reference population. The 
samples were stored at -85 °C in a monitored temperature environment until assay. 
 
Spiked samples 
A urine sample which contained low concentrations of AEdiol (12.4 µg L-1), Etio (3.5 
µg L-1), αE2 (not present) and αT (0.45 µg L-1), was spiked with these substances at 
100 µg L-1 and divided into eight subsamples to be used during the method 
validation.  
 
4.3.3. GC-(MS/C-IRMS) sample preparation and analysis 
To provide adequate GC-(MS/C-IRMS) data, an extensive sample preparation is 
necessary to definitely avoid signal interferences that may generate inaccuracy in the 
13C/12C measurement. After hydrolysis for 15 h with β-glucuronidase at 37 °C and pH 
6.8, the urine samples, with a volume of 10 mL, are brought onto a C18 solid phase 
extraction (SPE) column, conditioned with 6 mL of methanol and 6 mL of H2O. Next, 
the column was washed with 6 mL H2O and 5 mL H2O/acetonitrile (ACN) (80/20; v/v), 
and finally the sample was eluted with 8 mL H2O/ACN (10/90; v/v). Then, two 
subsequent liquid-liquid extractions (LLEs) with 4 mL n-pentane/diethyl ether 
(92.5:7.5; v/v) at different pH (pH 14 and pH 5.2) are performed to separate 
estrogenic and androgenic steroids. The extracts are further purified using a reversed 
phase HPLC-fractionation followed by a normal phase for particular fractions 
containing target compounds. The four obtained fractions containing the isolated 
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targeted analytes (αE2, AEdiol, Etio and αT) are eventually acetylated overnight at 
room temperature with pyridine and acetic anhydride before separate injection into 
the GC-(MS/C-IRMS), with noretiocholanolone being added as internal standard. 
Details of the sample preparation procedure and instrumental setup are described in 
a previous published work.179 However, a limited number of adjustments, described 
below, have been introduced in the original analytical backbone to include a wider 
range of steroid metabolites, including those of 17β-testosterone.  
 
Sample preparation   
The volume of the glycerol solution, used as a keeper after the LLE steps, was 
reduced from 100 µL to 30 µL. Medroxyprogesterone replaced fluoxymesterone as 
the internal standard in the estrogen fraction during reversed phase HPLC. Finally, 
progesterone was used as internal standard during the normal phase HPLC step 
instead of medroxyprogesterone. Because of the weak UV-detector response for 
Etio, a progesterone standard was used instead to determine the adequate 
fractionation windows during the HPLC steps.  
 
HPLC-UV 
For the reversed phase HPLC, the C18 functionalized pre-column and analytical 
column were replaced by a Kinetex (Security Guard Ultra C18 for 2.1 mm ID) and a 
Kinetex C18 column (XB-C18; 250 mm x 4.6 mm; 5 µm), respectively. The 
chromatographic conditions were slightly altered: column temperature was changed 
from 40 °C to 50 °C, flow rate from 0.6 mL min-1 to 0.8 mL min-1 and mobile phase 
composition from 37:63 to 35:65 (A:B; v/v), with H2O/MeOH (95:5; v/v) as solvent A 
and MeOH as solvent B. 
The normal phase HPLC-setup, using two diol functionalized columns in series 
(LiChrospher Diol; 250 mm × 4 mm; 5 µm) and a constant mobile phase of 
isooctane/isopropanol (85:15; v/v), was left unchanged.  
 
GC-(MS/C-IRMS) 
The T-pieces, used to split the sample after the GC-column to the mass spectrometer 
and isotope ratio mass spectrometer for simultaneous detection, were replaced by 
SilFlows (TM SGE Analytical Science). The RXI 5 SIL MS column (Restek −30 m; 0.25 
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mm i.d.; 0.25 µm df) GC-column was replaced by an Optima 17MS column (Machery 
Nagel – 30 m; 0.25 mm i.d.; 0.25 µm df). The injection and GC program were 
adapted accordingly. The initial injector temperature was set at 100 °C, which was 
held for 0.10 min with a vent flow of 20 mL min-1. The temperature was raised at 8 
°C min-1 and held at 320 °C for 2 min during sample transfer on column. The initial 
GC oven temperature was 110 °C, which was held for 1.5 min. The temperature was 
then subsequently raised to 220 °C at 30 °C min-1, to 270 °C at 6 °C min-1 and to 300 
°C at 2 °C min-1. Finally, the temperature was raised to 330 °C at 50 °C min-1 and 
held for 3 min. The carrier gas was helium at a constant flow rate of 1.2 mL min-1. 
The injection volume of 8 µL was left unchanged.  
 
4.3.4. LC-MS/MS sample preparation and analysis 
LC-MS/MS analysis 
The quantitative analyses performed in this study were carried out on a Thermo 
Accela HPLC system coupled to a Thermo TSQ Quantum Ultra triple quadrupole 
mass spectrometer.  
The LC was equipped with a C18 column (Kinetex C18; 2.1 mm x 150 mm; 1.7 µm) at 
a temperature of 70 °C. Solvent A was prepared by adding 400 µL of acetic acid to 
1600 g of MeOH. For the preparation of solvent B, 1600 g of H2O was mixed with 320 
g of MeOH and 400 µL of acetic acid. Initially, the mobile phase composition was set 
at 35:65 (A:B; v/v). Between 1 and 4 min, the composition was linearly increased to 
50:50 (A:B; v/v). During the following minute, the composition changed to 75:25 (A:B; 
v/v). After a final rapid increase in 10 s, the mobile phase was held at 95:5 (A:B; v/v). 
The triple quadrupole was operated in the electrospray ionization mode, and the 
signals were recorded in the selected reaction monitoring mode (SRM). 
Prior to sample analysis, a solvent blank and two standard solutions containing 20 
ng mL-1 of the analytes (αE2, αT, AEdiol and Etio) in H2O/MeOH (56:44; v/v) were 
injected, all with added internal standard (1 ng mL-1 of 17β-testosterone-d2 (Ds at 
position 16) and 40 ng mL-1 of 17β-estradiol-d3 (Ds at position 16 and 17). This 
protocol was performed in order to calculate the one-point calibration curve covering 
0 to 40 ng mL-1. 
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Sample preparation 
The sample preparation protocol used for this analysis, was very similar to the 
protocol used prior to GC-(MS/C-IRMS) described above, but adapted to a sample 
volume of 5 mL and omitting a number of steps. Since there was no need to isolate 
the different analytes for quantification, the alkaline LLE and the two HPLC-
purifications were unnecessary. Also, there was no need to derivatize the 
compounds. Thus, the sample preparation consists of a hydrolysis with β-
glucuronidase, followed by one SPE and one LLE purification step. Finally, the 
extract was reconstituted in 125 µL of MeOH/H2O (80:20; v/v) of which 10 µL was 
injected into the LC-MS/MS. Samples were spiked at 2 ng mL-1 with 17β-
testosterone-d2 and at 80 ng mL-1 with 17β-estradiol-d3 to serve as internal standard 
for the quantification of the androgens and estrogens, respectively.  
 
4.3.5. Analysis of the preparation  
The administered βE2B and βTP were dissolved separately in methanol to prepare 
standard solutions of 10 ng µL-1. Next, 100 µL of each solution were hydrolyzed using 
2 mL of 1 M NaOH in MeOH. After 15 min at 65 °C, 8 mL of 2 M formic acid in H2O 
were added to stop the hydrolysis. Then, the samples were brought onto a SPE C18 
column, washed with 6 mL of H2O and eluted two times with 4 mL of MeOH. The 
eluate was evaporated to dryness under a nitrogen stream at 37 °C and reconstituted 
into 40 µL of MeOH and 70 µL of H2O. Afterwards, a reversed phase HPLC 
fractionation and an acetylation step were performed identical to those used during 
the preparation of the urine samples. Finally, the samples were reconstituted into 80 
µL of isooctane and analyzed with GC-(MS/C-IRMS). 
 
4.4. Results and discussion 
 
4.4.1. Analytical strategies used 
GC-(MS/C-IRMS) method 
The primary objective of the current research was to develop a method allowing the 
detection of βT abuse. Based on the literature,35,67,100 Etio and αT were retained as 
diagnostic markers of βT administration. During the two HPLC steps, separate 
fractions for both metabolites were successfully collected, resulting in very pure 
extracts suitable for IRMS analysis, as illustrated in figure 4.1.  
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Finally, in combination with the already included fractions from a previous study,179 
the method allows for the simultaneous detection of estrogen and androgen abuse, 
with αE2 as metabolite of βE2 and AEdiol as endogenous reference compound 
(ERC) for both βE2 and βT. The extraction yield for αT and Etio was between 36 and 
69%, and between 31 and 71%, respectively, which is very similar to the yield of 
AEdiol and αE2, previously published.179  
 
 
Figure 4.1. IRMS chromatograms (m/z = 44) of a compliant bovine urine sample, showing the internal 
standard noretiocholanolone acetate (NEC), 17α-testosterone (αT) (above) and etiocholanolone (Etio) 
(below). 
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HPLC-MS/MS method 
While performing the analysis for the routine detection of estrogen abuse in 2013, it 
became clear that the majority of the received urine samples did not contain a 
sufficient quantity of αE2 to provide an IRMS measurement within the linear range. 
This is in line with findings from the literature, placing an average concentration of 
αE2 at around 6000 pg mL-1 for heifers, and less than 500 pg mL-1 for bulls.32,73 
Therefore, a quantitative screening method with a similar but severely simplified 
sample preparation was initially developed to assess which samples contained more 
than 20 ng mL-1, necessary to provide IRMS-analysis within the linear range, filtering 
out large numbers of samples and avoiding unnecessary work.   
Afterwards, when including the testosterone metabolites into the method, the 
quantitative screening gained a second functionality. Because of the low UV-
absorption of Etio, it was not possible to determine the adequate dilution of this 
fraction for IRMS analysis based on the UV-detection during the straight phase HPLC 
fractionation, as it is done for the other analytes. However, it was possible to 
determine the dilution and provide measurement within the linear range based on the 
LC-MS/MS output.  
Finally, it must be pointed out that, although this method provides accurate and 
reproducible results in the lower concentration range, a linear calibration curve only 
provided a perfect match (R2 > 0.99) up to 50 ng mL-1. Concentrations between 50 
and 100 ng mL-1, mentioned with regard to the animal experiment, should be 
considered as an approximation, whereas even higher concentrations must be 
interpreted as “elevated”. Still, these data were found valuable to include.  
 
Hydrolysis of the steroid preparations 
The existence of steroid preparations having δ13CVPDB values similar to endogenous 
steroids has recently been reported for sports doping products.88,180-182 To assure 
that the δ13CVPDB values of the preparations used during the animal experiment were 
not within the endogenous range, the preparations were analyzed prior to treatment. 
An alkaline hydrolysis protocol for preparations, based on present experience at the 
laboratory and similar to published methods,180,182 was used. To confirm complete 
hydrolysis of the preparations and avoid any potential influence on the δ13CVPDB 
values, the absence of intact steroid esters was verified by UV-detection during the 
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HPLC-separation. The measured δ13CVPDB values, corrected for the acetate moieties, 
after hydrolysis were -32.13‰ and -31.70‰ for βE2 and βT, respectively, which is 
significantly different from endogenous values and should allow the detection of the 
administration.  
 
4.4.2. Method validation 
The method validation was performed similar to the previous study,179 as described in 
chapter III, and the most important results are summarized in table 4.1 and figure 4.2.  
 
Table 4.1. Summary of the method validation results of 5-androstene-3β,17α-diol (AEdiol), 17α-
estradiol (αE2), 17α-testosterone (αT) and etiocholanolone (Etio) 
Validation parameter 
AEdiol 
(ERC) 
αE2 αT Etio 
AMDIS ‘Net Match’ factor (specificity) 94 90 94 99 
AMDIS ‘Purity’ factor 91 88 81 87 
Linear range (ng of analyte on column) (min – max) 7.5 - 50 15 - 80 10 - 80 10 - 80 
Intermediate precision (‰) (sample standard deviation (n=8)) 0.21 0.35 0.35 1.05 
Mean difference between spiked water samples and 
standards (method bias) (‰) (n=8)  
0.18 0.66 0.33 0.05 
Trueness (average system bias) (‰) 0.57 0.57 0.57 0.57 
Combined measurement uncertainty (%) 0.70 0.99 0.80 1.23 
 
The validation results for AEdiol and αE2 were comparable to those obtained during 
the previous study, and for αT, similar results were obtained. For Etio, however, two 
results stand out. First, the intermediate precision was noticeably higher than for the 
other compounds. Still, similar and even higher values have been considered 
acceptable both in published methods for sports doping control,123,125 and lifestock 
control,84,113 although reported for other steroids or matrices. For the determination of 
the intermediate precision during the initial validation, the eight spiked urine 
subsamples were analyzed two by two in four separate measurement series, 
performed by three different analysts over a time span of three months. To 
reevaluate the result for Etio afterwards, the measurements of the compliant control 
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sample for routine analyses, analyzed in 14 different measurement series over a time 
span of eight months, were assessed. The calculated intermediate precision based 
on these data (n=14) was 0.76‰, which is significantly better. 
Second, the non-compliance ∆13CVPDB threshold value, based on 21 measurements 
from untreated cows, executed in five series of measurement over a time span of four 
months, and calculated as the mean value plus three times the standard deviation (µ 
+ 3 x SD), as described in chapter III, was 3.47‰. This is above the 3‰ threshold 
value applied for doping control in the past, as is displayed in figure 4.2. Remarkably, 
similar observations have been made with regard to sports doping control, where a 
number of reference population studies indicated that a 3‰ threshold is too low in 
certain cases.123,125 Because of these observations, the new guidelines of the World 
Anti Doping Agency (WADA) describe a more detailed list of compliance criteria, with 
different combinations of threshold values for specific ERC-metabolite combinations 
including an elevated threshold for the metabolite Etio. Additionally, each laboratory 
for sports doping control must perform a reference population study to determine if 
their performance is good enough to apply these criteria.153 The presented findings 
suggest similar precaution must be used for the analysis of bovine urine. Therefore, 
the applied threshold for routine analysis was fixed at 3‰ for the couples αE2-AEdiol 
and αT-AEdiol, and at 4‰ for Etio-AEdiol.  
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Figure 4.2. ∆13CVPDB values (expressed in ‰) of 17α-estradiol (αE2) (upper), 17α-testosterone (αT) 
(middle) and etiocholanolone (Etio) (lower), with 5-androstene-3β,17α-diol (AEdiol) as endogenous 
reference compound, from a compliant control population 
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Specificity of the method was verified according to legal criteria,24 identical as 
described in paragraph 3.4.2, and the absence of impurities and coelutions was 
verified by inspection of the MS data. Additionally, AMDIS, specialized software to 
evaluate peak purity and identification of the analyte peaks, was used for this 
purpose.   
No calculations of measurement uncertainty could be found in publications regarding 
the use of GC-C-IRMS to detect steroid abuse in cattle. Although information on this 
subject is scarce in publications regarding sports doping control as well, the work of 
Polet et al. pays detailed attention to the subject.183 One of the suggested 
approaches is to estimate the combined measurement uncertainty as the square root 
of the sum of the squares of the different uncertainty components attributing to the 
measurement uncertainty, according to the following formula:  
 
√u(calibration bias)2 + u(reference value)2 + u(method precision)2 
 
This approach was used to estimate the combined measurement uncertainty for each 
analyte, of which the results are included in table 4.1. U(calibration bias) corresponds 
with the measured system bias, as calculated in chapter III, and u(method precision) 
corresponds with the intermediate precision, both also included in table 4.1. 
U(reference value) is the SD on the certified steroids used to perform the calibration, 
specified as 0.3‰ by the supplier on the certificate. Finally, since the method bias 
also contributes to the measurement uncertainty, it was included in the calculation as 
well.  
 
4.4.3. Results of the animal experiment 
An administration study was required to assess the potential of the developed 
method to detect steroid abuse in cattle, and to adequately evaluate the 
pharmacokinetics and the detection window after administration. Trying to observe 
gender differences, a male and female animal were treated. Prior to treatment, the 
diet of both animals was kept constant for three weeks, to assure stable δ13CVPDB 
values for the ERC during the experiment. Finally, the animals were treated with 400 
mg of βT and 80 mg of βE2, injected as a propionate and benzoate ester, 
Chapter IV 
84 
 
 
respectively. While a typical approved dosage in the USA, administered by implant, is 
20-45 mg per animal for βE2, and 140-200 mg for βT,11 laboratory experience with 
the analysis of injection sites indicated dosages sometimes up to several hundred mg 
more. The selected treatment holds the middle ground between both scenarios. As 
other studies reported detection windows up to three weeks, as discussed in chapter 
II, samples were collected until 27 days after administration to be able to provide 
detailed pharmacokinetic data on the treatment.  
Of course, the low number of treated animals is a seriously limiting factor. It is 
impossible to draw final conclusions regarding the influence of gender, based on 
measurements of only one male and one female animal. The same can be said 
regarding the determined detection windows: a much larger number of treated 
animals, and a variation of different treatments, are required to obtain statistically 
relevant data. Therefore, these results should be regarded as preliminary. However, 
they did allow to take an interesting glance at the examined parameters, and add 
important additional information on a subject for which only a limited number of 
animal studies have been published so far.   
 
Effect of the treatment on measured δ13CVPDB values 
The δ13CVPDB values of the four measured analytes in the urine samples after 
treatment are displayed in figure 4.3.  
The measured δ13CVPDB values of AEdiol remain stable after treatment at -15.49 ± 
0.49‰ and -14.80 ± 0.57‰ in the male and female, respectively, confirming the 
functionality as a reference compound for both androgens and estrogens, as already 
described elsewhere.100,101 This enriched level for endogenous values fits well with 
the reported measurements from cattle fed with a diet containing a high percentage 
of maize.100,101 As expected, the results suggest that gender does not influence the 
endogenous 13C/12C ratio of the ERC significantly.  
Already the first day after treatment, the δ13CVPDB of the metabolites of both βE2 and 
βT approached their lowest values, contrary to previous testosterone administration 
studies, in which a more gradual decline over a time span of several days was 
described.67,94,117 This difference can be contributed to the currently used 
preparation, 17β-testosterone propionate, which is known to have a more rapid and 
shorter lasting effect because of the short carbon chain length of the ester, as 
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opposed to 17β-testosterone enanthate, although influence of other factors such as 
age, weight or type of feed of the animals cannot be excluded.  
 
 
 
Figure 4.3. δ13CVPDB values (expressed in ‰) of 5-androstene-3β,17α-diol (AEdiol), 17α-estradiol 
(αE2), 17α-testosterone (αT) and etiocholanolone (Etio) in the urine samples from a bull (upper) and a 
heifer (lower) after treatment with 17β-testosterone propionate and 17β-estradiol benzoate. 
 
The δ13CVPDB values of αE2 remain stable after injection, at -30.13 ± 0.24‰ and         
-29.90 ± 0.70‰ for the male and female, respectively. The small difference in value 
between the used preparation and the urine samples indicate a very low endogenous 
Chapter IV 
86 
 
 
production of estrogens and therefore, the treatment remained visible until the end of 
the experiment, 27 days after administration. 
However, regarding the androgen metabolites, differences between both animals are 
more pronounced. The difference between the injected testosterone δ13CVPDB value 
and the more depleted δ13CVPDB value in the various female urine samples is close to 
zero for both Etio and αT. It would indicate that the contribution of the endogenous 
steroids in the female is insignificant versus the concentration of exogenous residues. 
For the male, the relative concentration contribution of the endogenous steroids is 
rather high as attested by the difference observed between δ13CVPDB values of the 
injected testosterone and the most depleted level of Etio found in the urine samples 
after treatment (6‰). 
As a consequence, while βTP treatment could be proven up to 24 days after injection 
in the female, this was limited to three days for the male. The very small detection 
window for 17β-testosterone treatment forms a serious limitation when applying it to 
detect such abuse for official control purposes. However, since βE2 was proven to be 
a more powerful growth promoter in male animals than βT, both substances can be 
expected to be administered together to enhance the effects.184 Still, the detection of 
βE2 administration has its boundaries as well. While endogenous dilution determines 
the detection window for the androgens, it is limited for the estrogens by their 
abundance in the urine samples (figure 4.4). While the results 27 days after 
administrations still indicate the administration in both animals, the measurements 
are just below the linear range of the IRMS and would have been discarded during 
routine analysis.  
When evaluating the results for both testosterone metabolites, the carbon enrichment 
was prolonged in Etio, compared to αT for which the 13C/12C ratio returned to the 
endogenous value within two days after treatment in the bull, making it a less suitable 
metabolite in male animals.100 In the heifer, however, the ∆13CVPDB value for αT 
remained above the threshold for up to 17 days, thus proving its usefulness.  
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Figure 4.4. Concentrations (expressed in ng mL-1), measured with LC-MS/MS, of 5-androstene-
3β,17α-diol (AEdiol), 17α-estradiol (αE2), 17α-testosterone (αT) and etiocholanolone (Etio) in the urine 
samples from a bull (upper) and a heifer (lower) after treatment with 17β-testosterone propionate and 
17β-estradiol benzoate. 
 
Effect of the feeding on measured δ13CVPDB values 
After the animals were obtained, their feeding regime was kept constant during the 
entire experiment. The treatment was only performed after 21 days, to assure that 
the measurements of the ERC after treatment were stable and reflected the current 
diet. Urine samples were collected during this adaptation period as well, of which the 
results are displayed in figure 4.5. In the samples from the bull, an upward trend in 
measured δ13CVPDB values is visible, which corresponds with the described effect of 
an enlarged portion of maize in the feed.84,94 The values of both the ERC and the 
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metabolites shift simultaneously, with the ∆13CVPDB values never exceeding 0.89‰. 
However, this trend is not very pronounced, since apparently the previous diet 
already contained a significant portion of C4 plant material, and for the heifer, this 
trend was only visible for AEdiol. Unfortunately, the four target analytes could not be 
measured simultaneously in any of the samples before treatment, and for αE2, none 
of the samples contained a sufficient amount to provide an adequate result. 
It is clear that the feeding regime in this experiment created an ideal situation for the 
treatment to be detectable. As discussed in chapter II, as the portion of C4 plant 
material in the feed decreases, the δ13CVPDB values of the ERC, AEdiol in this case, 
will decrease as well. Eventually, the difference in δ13CVPDB values between AEdiol 
and the administered substances will become so small, that it will no longer be 
possible to establish the treatment through the measured ∆13CVPDB values. 
 
 
Figure 4.5. δ13CVPDB values (expressed in ‰) of 5-androstene-3β,17α-diol (AEdiol), 17α-testosterone 
(αT) and etiocholanolone (Etio) in the urine samples from a bull (left) and a heifer (right) after changing 
the feed composition. 
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Comparison to other detection methods  
As an alternative to the analysis of urine samples with IRMS, abuse of synthetic 
homologues of naturally occurring steroid hormones in cattle can also be proven by 
detection of the intact steroid esters, used for the treatment, in hair or blood samples, 
using other mass spectrometric techniques.185 During the administration study, serum 
samples were collected at different times from both animals for the detection and 
quantification of βTP and βE2B using ultra high performance liquid chromatography-
tandem mass spectrometry. The used method, as well as the obtained results from 
these and other treated animals, were discussed by Kaabia et al.186 The amount of 
βE2B in the serum samples increases rapidly already one day after injection, and 
only starts decreasing between 9 and 13 days after injection in both animals. A good 
correspondence can be observed between the kinetic curve of βE2B in serum and 
the concentration of αE2 in the urine samples of both animals (figure 4.6). βE2B 
remained detectible up to 17 days after administration. Unfortunately, no βTP was 
detected in the samples from the bull. However, in samples from three other heifers 
which received a similar treatment, βTP remained detectable up to 2 days, indicating 
a high esterase activity. 
Thus, the detection window for the administration of both substances was wider when 
using the GC-(MS/C-IRMS) approach, while the difference between both analyses 
was most pronounced when looking at testosterone abuse in the heifer, which could 
be detected up to 17 days longer compared to the analysis of the serum samples. 
However, it is expected that the IRMS detection windows will become narrower as 
the relative portion of C3 plant material in the feed increases, whereas a dietary 
change would not affect the presence of the administered steroid esters in serum. 
Also, the analytical method for the analysis of the plasma samples is significantly less 
complex and time consuming than the sample preparation prior to IRMS analysis.  
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Figure 4.6. Concentrations of 17β-estradiol benzoate (βE2B) in plasma (expressed in pg mL-1) and 
17α-estradiol (αE2) in urine (expressed in ng mL-1) from a bull (upper) and a heifer (lower) after 
treatment with 17β-testosterone propionate and 17β-estradiol-3-benzoate. Adapted from Kaabia et 
al.186 
 
As mentioned above, a third way to undisputedly demonstrate the abuse of synthetic 
homologues of naturally occurring steroid hormones, is by detection of the intact 
steroid esters in hair. Unfortunately, no hair samples were analyzed during the 
current study. However, detection methods using GC-MS/MS and LC-MS/MS, and 
results from administration studies with esters of βT and βE2 are available.185,187-189  
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Regarding a single intramuscular βE2B administration, detection windows from two 
weeks up to 70 days have been reported.185,187 Regarding βTP, no data could be 
produced on the successful detection of its incorporation into bovine hair after 
treatment, although this could have been due to the low dosage used in the study.189 
Nevertheless, in studies using other esters of testosterone, detection windows similar 
to those reported above for βE2B were observed, up to 70 days after treatment.185,189 
Even though this method offers great perspectives due to its large detection 
windows, the result is highly variable and influenced by additional factors such as 
pigmentation of the hair and sampling distance from the injection site. It is clear that 
GC-(MS/C-IRMS) is an excellent technique for the detection of abuse of homologues 
of naturally occurring steroids, and that the method presented is well functioning. 
However, the inclusion of additional ERCs would provide an even more powerful 
result, and since different steroids are often abused together, the addition of 
metabolites of other substances to the analysis would broaden the scope and 
detection possibilities. Still, as illustrated by this study, the technique is limited by 
both the abundance of steroids in urine samples and the required complex sample 
preparation. Therefore, this technique is complementary to the detection of steroid 
esters in blood, for which a far less laborious and time consuming sample preparation 
can be used, and in hair, which could offer a larger timeframe for detection. 
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5. The use of gas chromatography-(mass 
spectrometry/combustion-isotope ratio mass 
spectrometry) (GC-(MS/C-IRMS)) to demonstrate 
progesterone treatment in bovines 
 
Adapted from Janssens G.; Mangelinckx S.; Courtheyn D.; De Kimpe N.; Matthijs B.; 
Le Bizec B. 2015, submitted to J. Chromatogr. A. 
 
5.1. Abstract 
 
Currently, no analytical method is available to demonstrate progesterone 
administration in biological samples collected from rearing animals, and therefore, 
tracking the abuse of this popular growth promoter is arduous. In this study, a method 
is presented to reveal progesterone (PG) treatment on the basis of carbon isotope 
measurement of 5β-pregnane-3α,20α-diol (BAA-PD), a major PG metabolite 
excreted in bovine urine, by gas chromatography-(mass spectrometry/combustion-
isotope ratio mass spectrometry) (GC-(MS/C-IRMS)). 5-Androstene-3β,17α-diol 
(AEdiol) is used as endogenous reference compound. Intermediate precisions (n=11) 
of 0.56‰ and 0.68‰ have been determined for AEdiol and BAA-PD, respectively. 
The analytical method was used for the very first time to successfully differentiate 
urine samples collected from treated and untreated animals. Unexpectedly, 
characterization of urine samples collected from animals treated with 17β-
testosterone and 17β-estradiol indicated that the 13C/12C ratio of BAA-PD was 
affected by the treatment.   
 
5.2. Introduction 
 
As a measure to meet consumer’s demands, the use of hormonal substances as 
growth promoter in stock farming is prohibited within the European Union.22 Abuse of 
these substances is actively monitored,23 for which specific analytical guidelines are 
in place.24 While these surveillance programs are adequate for the detection of 
xenobiotic residues, they fall short when it comes to tracing administration of  sexual 
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hormones in cattle. For the latter, two main analytical options are currently 
implemented by European Member States. First, residues of the administered steroid 
esters, which are considered xenobiotic, can be detected in blood, hair and injection 
sites for a certain period of time after administration using GC-MS or LC-MS based 
methods.185-190 Second, because the 13C/12C isotope ratio, expressed relative to 
Vienna Pee Dee Belemnite (VPDB) as δ13CVPDB values, of steroid preparations is 
usually different from that of endogenously produced steroids, abuse can be detected 
in bovine urine samples using gas chromatography coupled to combustion-isotope 
ratio mass spectrometry (GC-C-IRMS). Because it is difficult to set threshold values 
which indicate the treatment, at least two analytes are measured with IRMS: an 
endogenous reference compound (ERC), of which the δ13CVPDB value is not affected 
by the steroid treatment, and a metabolite of the administered substance. When the 
difference between the δ13CVPDB values of the ERC and the metabolite, the ∆13CVPDB 
value, exceeds a threshold determined through the statistical evaluation of results of 
samples from a compliant population, the treatment is analytically and 
administratively demonstrated.67,100,101,172,179,191 
Progesterone, however, remains largely overlooked by current analytical methods, 
despite indications of its abuse through results from material samples and 
preparations.9,192 In 15% of the preparations, confiscated by the Belgian authorities at 
farms from 2010 until 2015 and found positive for hormonal substances, 
progesterone was found. In veterinary practice, progestagens are commonly used for 
reproductive performance in cows, regulating estrus and thus facilitating insemination 
at the farm. In itself, progesterone is a less potent growth promoter than androgens 
or estrogens, but still, in heifers, it can be used to eliminate heat to obtain better 
growth and improved feed conversion.10 But more importantly, because of its anti-
estrogenic activity, it is often administered together with estradiol, canceling out some 
of the unwanted side-effects from the latter.10 In the USA, where regulated 
administration of certain growth promoters is permitted, both substances are 
combined in implants at 10 mg estradiol and 100 mg progesterone for calves, and 
twice this dosage for steers and bulls,193 providing good growth promoting    
results.12-14  
The aim of this study is to provide an original analytical method for the unambiguous 
demonstration of progesterone abuse in samples from animal origin. A                  
Chapter V 
95 
 
 
GC-(MS/C-IRMS) approach was developed on bovine urine according to a three-
stage process. Suitable candidate target analytes were investigated; an overview is 
given in table 5.1 together with their chemical structures and abbreviations. 
Afterwards, two analytical protocols were designed and evaluated against each 
other. Eventually, the capacity of the most efficient protocol was validated before use 
on incurred urine samples collected from treated and untreated cattle.   
 
Table 5.1. Overview of the steroids of interest in this chapter, the used abbreviations and the 
structures. 
Structure 
Name 
Abbreviation 
Structure 
Name 
Abbreviation 
Structure 
Name 
Abbreviation 
Structure 
Name 
Abbreviation 
5-Androstene-3β,17α-diol 
AEdiol 
 
H
OH
HO
5α-Pregnane-3α,20β-diol 
AAB-PD 
 
H
OH
HO
5β-Pregnane-3α,20α-diol 
BAA-PD 
 
H
OH
HO
5β-Pregnane-3β,20β-diol 
BBB-PD 
 
H
OH
HO
5α-Pregnane-3α,20α-diol 
AAA-PD 
 
H
OH
HO
5α-Pregnane-3β,20β-diol 
ABB-PD 
 
H
OH
HO
5β-Pregnane-3β,20α-diol 
BBA-PD 
 
5β-Pregnane-3,20-dione 
B-PDione 
 
H
OH
HO
5α-Pregnane-3β,20α-diol 
ABA-PD 
5α-Pregnane-3,20-dione 
A-PDione 
5β-Pregnane-3α,20β-diol 
BAB-PD 
Progesterone 
PG 
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5.3. Material and methods 
 
5.3.1. Reagents and chemicals  
All reagents and solvents were of analytical grade and were supplied by Sigma-
Aldrich (Bornem, Belgium). Liquid chromatography solvents were of LC- and HPLC-
grade from Biosolve (Valkenswaard, the Netherlands). 17β-Testosterone acetate was 
obtained from Sigma-Aldrich (Bornem, Belgium). Other used steroids were 
purchased from Steraloids (Wilton, NY, USA). SPE C18 cartridges were from Achrom 
(Zulte, Belgium). Escherichia coli K12 β-glucuronidase was provided by Roche 
Diagnostics GmbH (Mannheim, Germany). Dry pyridine and acetic anhydride were 
obtained from Sigma-Aldrich (Bornem, Belgium).  
 
5.3.2. Samples 
Non-compliant samples 
To provide non-compliant samples, three female bovines were treated with 
progesterone (PG) at the Centre d’Economie Rurale (CER groupe) (Marloie, 
Belgium). The approval code from the ethical commission for the experiment was 
CE/Santé/ET/004. Cow A and B were of the Holstein breed, aged four years and 
weighing 565 kg and 529 kg, respectively. They received daily 2 kg of a typical 
feeding concentrate (corn (18.5%), dried sugar beet pulp (11.6%), soy meal (9.3%), 
palm-kernel expeller (9.2%), wheat meal (8.3%), colza meal (8.3%), alfalfa (7.6%), 
spelt wheat (7.0%), gluten feed from corn (5.0%), sunflower meal (4.0%), gluten feed 
from wheat (3.0%), barley (2.5%), vinasse (2.3%), calcium carbonate (1.6%), 
molashine (1.0%), sodium chloride (0.6%), premix (0.3%)), and had access to hay 
and water at libitum. The animals were treated with two injections, with a 24 h 
interval, into the dorsal neck muscle, containing 200 mg PG in an ethanol based 
preparation. Urine samples were collected at time intervals of 12 h, starting at the 
time of the first administration until 24 h after the last. The samples were stored at -
85°C in a monitored temperature environment until assay. 
Cow C, of the Belgian blue mixed breed, aged six years and weighing 624 kg, was 
kept on a stable feeding regime, consisting of dried grass and chopped corn, for two 
weeks before treatment. The animal received three injections into the dorsal neck 
muscle, with a 24 h interval, containing 1 g PG as an ethanol based preparation. 
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Urine samples were collected at the time of the treatments and 12 h thereafter. 
Afterwards, samples were collected daily until 1 week after the first treatment. The 
samples were stored at -85°C in a monitored temperature environment until assay. 
 
Compliant samples 
Eighteen urine samples from non-treated pregnant cows were collected at different 
farms. Additionally, 14 urine samples from animals, demonstrated as non-treated 
according to official routine analysis, were included to increase the individual number 
of the reference population (i.e. compliant). The samples were stored at -85°C in a 
monitored temperature environment until assay. 
 
Spiked samples 
A urine sample containing low concentrations of 5-androstene-3β,17α-diol (AEdiol) 
(2.7 µg L-1) and exempt from 5β-pregnane-3α,20α-diol (BAA-PD), was spiked with 
these substances at 100 µg L-1, and divided into 11 subsamples, respectively, to be 
further used during the method validation.  
 
Samples from cattle treated with testosterone and estradiol 
Additionally, urine samples from a bull and heifer treated with a single intramuscular 
injection of 17β-testosterone propionate and 17β-estradiol benzoate, presented and 
discussed in a previous publication,191 were also used for this study.  
 
5.3.3. Instrumentation 
HPLC-UV 
Two different HPLC setups were used during sample preparation. Reversed phase 
HPLC was performed on a Waters Alliance 2690 system, coupled to a UV-detector 
(diode array detector, DAD) measuring from 205 to 235 nm, and subsequently to an 
automated fraction collector. The system was equipped with a precolumn (Kinetex 
Security Guard Ultra C18 for 2.1 mm ID) and a C18 functionalized analytical column 
(Kinetex XB-C18; 250 mm x 4.6 mm; 5 µm), held at 50°C. An HPLC method was 
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developed on the basis of a mobile phase composition (A:B; v/v) of 35:65, with 
H2O/MeOH (95/5; v/v) as solvent A and MeOH as solvent B. After elution of the 
analytes, the mobile phase composition (A:B; v/v) was changed to 0:100 as a rinsing 
phase at the end of the run. A constant flow rate of 0.8 mL min-1 and an injection 
volume of 100 µL were used.  
For normal phase HPLC, another Waters Alliance 2690 system, set up with UV 
detector, fraction collector and two diol functionalized columns (LiChrospher Diol; 250 
mm x 4 mm; 5 µm) in series, was used. A constant mobile phase composition of 
isooctane/isopropanol (85/15; v/v) was preferred for method A and B, but for fraction 
PDC in method C, as described under 5.3.4, a constant composition of 
isooctane/isopropanol (95/5; v/v) was used, both with a rinsing phase at the end of 
the run. A flow rate of 1 mL min-1, a column temperature of 40°C and an injected 
volume of 100 µL were selected. 
 
GC-(MS/C-IRMS) 
For GC-(MS/C-IRMS) analyses, a Thermo Trace GC Ultra gas chromatograph, 
equipped with a Thermo Scientific Triplus autosampler, was connected to both a 
Thermo DSQ II single quadrupole mass spectrometer and a Thermo MAT 253 
isotope ratio mass spectrometer, via the Thermo Scientific GC Isolink. To achieve the 
parallel coupling of the two detectors, the signal was split after GC using two SilFlows 
(TM SGE Analytical Science). The system was equipped with an Optima 17MS 
column (Machery Nagel – 30 m; 0.25 mm i.d.; 0.25 µm df) and gas flows were 
controlled using the Thermo Scientific Conflo IV interface. Helium was used as carrier 
gas at a flow rate of 1.2 mL min-1. After injection of 8 µL, at 20 µL s-1, the injector 
temperature was held at 100°C for 0.10 min, with a vent flow operating at 20 mL min-
1
. Then, the temperature was increased at 8°C min-1 up to 320°C and held 2 min. The 
GC oven was held at its initial temperature of 110°C for 1.5 min. Next, the 
temperature was raised to 220°C at 30°C min-1, to 270°C at 6°C min-1, to 300°C at 
2°C min-1 and finally to 330°C at 50°C min-1, which was held for 3 min. The transfer 
line temperature was set at 300°C. Approximately 5% of the GC eluate was 
transmitted to a quadrupole mass analyzer for characterization; the steroid signals 
were acquired in the MS full scan mode (m/z 50 to 400) after electron ionization (70 
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EV). The main split fraction was carried out to a combustion furnace, perfectly 
conditioned (1 h of oxidation before use) and maintained at 950°C. Next, by passing 
through a Nafion membrane, water was removed from the gaseous eluate. Electron 
ionization was used to convert carbon dioxide (CO2) into the corresponding ionized 
species characterized by an odd number of electrons (CO2+●). Finally, isotopomer’s 
species at m/z 44, 45 and 46 were simultaneously measured in separated Faraday 
cups. From these data, δ13CVPDB values of the analytes were calculated after 
calibration of the CO2 reference gas, which was executed by injection of 17β-
testosterone acetate and dehydroepiandrosterone (DHEA) acetate with known and 
certified δ13CVPDB values. When steroids were measured after acetylation, the shift of 
the δ13CVPDB value, caused by the acetate moieties, was corrected using the formula  
DOH = DOAc + 2m (DOAc − DAc)/n,  
in which DOH is the δ13CVPDB value of the underivatized steroid, DOAc the δ13CVPDB 
value of the acetylated steroids, DAc the δ13CVPDB value of the acetic anhydride used 
for the derivatisation, n the number of carbon atoms in the molecule and m the 
number of hydroxyl groups which were acetylated. 67,100,101,172,179,191 
 
5.3.4. Sample preparation 
In this study, three different sample preparation procedures were used, method A, 
method B and method C, of which an overview is given in scheme 5.1. However, the 
analytical protocol prior to the preparative HPLC steps is identical for all three.  
 
First, the urine samples were centrifuged (15 min, 3113 g) to avoid obstruction of the 
SPE cartridges later on. Ten milliliters of the sample were hydrolyzed at 37°C, after 
addition of 50 µL glucuronidase from E. coli and 3 mL phosphate buffer 0.8 M to 
maintain a pH of 6.8. After 15 h, the sample was loaded onto a C18 SPE column, 
which was previously successively conditioned by 6 mL of MeOH and 6 mL of H2O. 
After stationary phase washing with 6 mL of H2O and 5 mL of H2O/acetonitrile (ACN) 
(80/20; v/v), target analytes were eluted with 8 mL of H2O/ACN (5/95; v/v). Next, the 
eluted sample was evaporated to approximately 300 µL under a nitrogen stream at 
45°C, before adding 0.5 mL of 1 M sodium hydroxide. Then, a liquid-liquid extraction 
(LLE) was performed using two times 4 mL of n-pentane/diethyl ether (92.5/7.5; v/v). 
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Scheme 5.1. Analytical protocol of the sample preparation for the three used methods, A, B and C. 
Content of the fractions (PDA1; PDA2; PDB1; PDB2; PDB3; PDC; A) is defined in table 5.2 and table 
5.3. LLE stands for liquid-liquid extraction. 
Afterwards, 30 µL of a glycerol solution (10% in methanol) was added to the 
combined organic layers to serve as a keeper. The sample was evaporated at 37°C 
under a nitrogen stream, and reconstituted into 80 µL of H2O and 40 µL of 
fluoxymesterone in methanol (50 ng/µL), used as internal standard specifically during 
the reversed phase chromatography step.  
The collecting windows for targeted analytes on the reversed phase HPLC system 
were first determined through three successive injections of a standard solution 
containing fluoxymesterone, AEdiol, PG and testosterone propionate. The collected 
fractions for all three methods are defined in table 5.2. 
 
 
Urine sample 
Hydrolysis: glucuronidase (E. coli) 
LLE NaOH/n-pentane + diethyl ether (pH 14) 
SPE C18 
HPLC C18 
HPLC diol
 
HPLC diol
 
HPLC diol
 
HPLC diol
 
Acetylation
 
Acetylation
 
Acetylation
 
Oxidation
 
GC-(MS/C-IRMS)
 
GC-(MS/C-IRMS)
 
GC-(MS/C-IRMS)
 
PDA1
 
PDA2
 
PDB1
 
PDB2
 
PDB3
 
PDB1
 
PDB2
 
PDB3
 
PDC
 
A
 
A
 
Centrifugate 
N2 
N2 
N2 
N2 
N2 
N2 
N2 
N2 
N2 
N2 
N2 N2 N2 
N2 N2 N2 N2 
N2 N2 N2 N2 
N2 
N2 N2 
N2 N2 
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Table 5.2. Description of the collected fractions using reversed phase HPLC. 
Method A 
Fraction start time – end time (min) Collected analytes 
PDA1 14.30 – 18.00 ABA-PD; BBA-PD 
PDA2 23.00 – 28.30 AAA-PD; AAB-PD; ABB-PD; BAA-PD; BAB-PD; BBB-PD 
Method B and C 
A 9.61 – 11.44 AEdiol 
PDB1 15.30 – 18.00 BBA-PD 
PDB2 23.30 – 26.30 BAA-PD; BBB-PD 
PDB3 26.31 – 28.30 BAB-PD 
 
For method A and B, 20 µL of a PG standard solution in ethanol (10 ng/µL) was 
added to serve as internal standard during the normal phase HPLC purification. Next, 
the fractions were evaporated to dryness under a nitrogen stream at 37°C and 
dissolved in 120 µL of isooctane/isopropanol (90:10; v/v) before injection in the 
second HPLC system, after calculation of the fractionation windows by a threefold 
standard injection containing PG and AEdiol. The fractions, collected during the 
normal phase HPLC purification as described in table 5.3, were evaporated to 
dryness under a nitrogen stream at 37°C, and 25 µL of both acetic anhydride and 
pyridine were added. After acetylation overnight at room temperature, the fractions 
were again evaporated to dryness under a nitrogen stream at 37°C. Finally, the 
fractions were dissolved in 30 µL of isooctane, containing 19-noretiocholanolone-3-
acetate (4 ng/µL) as internal standard, before injection onto the GC-(MS/C-IRMS). 
 
While method A and B only differ in the fractions collected during the HPLC steps, 
method C employs a different strategy. Fractions PDB1, PDB2 and PDB3, collected 
during reversed phase chromatography, were recombined and evaporated to dryness 
at 45°C under a nitrogen stream. The residue was dissolved in 50 µL of acetonitrile, 
and 50 µL of the oxidizing reagent, K2Cr2O7 dissolved at 50 g/L in H2O/H2SO4 (90:10; 
v/v), was added. After 30 min at 37°C, the oxidation was stopped by adding 900 µL of 
aqueous Na2CO3, at a concentration of 11 g/L. Then, the analytes were extracted 
using 1.5 mL of isooctane. 
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The extract was further washed with 250 µL of H2O and after centrifugation for 3 min 
at 2300 g, the organic layer was isolated. For the normal phase HPLC purification, 20 
µL of a PG standard solution in methanol (10 ng/µL) was added to the sample extract 
as the internal standard, before evaporation to dryness under a nitrogen stream at 
37°C. After being dissolved in 120 µL of isooctane/isopropanol (95:5; v/v), the extract 
was injected onto the second HPLC system, loaded with a diol-functionalized column. 
The fraction labeled “PDC”, containing 5β-pregnanedione (B-PDione), was collected 
as specified in table 5.3. Finally, this oxidized fraction was evaporated to dryness 
under a nitrogen stream at 40°C and dissolved in 30 µL of isooctane, containing 
noretiocholanolone acetate (4 ng/µL) as internal standard, before injection onto    
GC-(MS/C-IRMS).  
Fraction “A”, containing AEdiol, was treated as described in method B.  
 
Table 5.3. Description of the collected fractions using normal phase HPLC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Method A 
Fraction start time – end time (min) Collected analytes 
PDA1 9.15 – 12.30 ABA-PD; BBA-PD 
PDA2 8.65 – 13.30 
AAA-PD; AAB-PD; ABB-
PD; BAA-PD; BAB-PD; 
BBB-PD 
Method B 
A 11.78 – 13.75 AEdiol 
PDB1 9.15 – 11.80 BBA-PD 
PDB2 11.15 – 13.30 BAA-PD 
PDB3 9.65 – 12.80 BAB-PD 
Method C 
A 11.78 – 13.75 AEdiol 
PDC 8.15 – 10.80 B-PDione 
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5.4. Results and discussion 
 
5.4.1. Selection of suitable reference compounds and metabolites 
Because the use of IRMS to demonstrate PG treatment in cattle has not yet been 
described, the first step in the current study was the selection of suitable ERCs and 
metabolites. For the demonstration of abuse of estrogens and androgens in bovines, 
both dehydroepiandrosterone (DHEA) and 5-androstene-3β,17α-diol (AEdiol) have 
been reported as suitable ERCs.100,101,179,191 Because DHEA is mainly present in 
urine as a sulpho-conjugate, AEdiol was retained in this study to avoid additional 
cleanup steps. Unfortunately, very limited information was available regarding the 
abundance of urinary PG metabolites in bovines, and post-administration data are 
nonexistent.32,194 Because pregnanediol glucuronide was reported to be present in 
bovine urine as an early pregnancy indicator,195 and since 5β-pregnane-3α,20α-diol 
(BAA-PD) is known to be a major PG metabolite in human urine, used for doping 
control purposes since 1999,118 and currently the mandatory ERC by the World Anti-
Doping Agency,152 pregnanediols (PDs) were selected as candidate target 
metabolites.  
 
First, endogenous occurrence of the eight PD isomers in urine samples from non-
treated animals, 11 pregnant cows, which are expected to have a more active PG 
metabolism because of its functionality as a pregnancy regulating hormone,195 and 
14 non-pregnant cows, was assessed using method A described under 5.3.4. 
Although fraction PDA2, of which a chromatogram is shown in figure 5.1, contained 
too many impurities to determine adequate δ13CVPDB values, the comparison of the 
intensities of the different PDs was possible, and the results are visualized in figure 
5.2.  
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Figure 5.1. IRMS chromatogram (m/z = 44) of fraction PDA2 from a compliant urine sample (left), with 
a close up of the part containing the six pregnanediols (AAA-, BAA-, AAB-, ABB-, BAB- and BBB-PD) 
(right).  
 
  
Figure 5.2. Overview of the abundances of the 8 different PD isomers in 25 urine samples from non-
treated cows (left), and the difference between samples from pregnant and non-pregnant animals 
(right).  
 
These indicate that overall, in the endogenous profile, the 5β-PDs are of larger 
importance than the less abundant 5α-isomers. More specifically, BAA-PD was the 
most abundant PD-isomer, followed by BAB-, BBA- and ABB-PD, which was later on 
confirmed by the analysis of the urine samples before and after treatment of cow A, B 
and C (figure 5.3).  
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Figure 5.3. Overview of the abundance of the 8 different pregnanediol isomers in urine samples from 
cow A (upper), B (middle) and C (lower), before and after treatment with progesterone.  
However, even though all results point towards the same main metabolites, 
significant differences between the animals were observed. Although the signal 
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intensities of the four most abundant PDs clearly increase in samples from cow B 
after treatment, they are still only present at a low level, most certainly when 
compared to cow A, in which only ABB-PD remains low in abundance. As for cow C, 
while being treated with a five times higher dose of PG than the other two animals, 
the PD-levels remain below those of cow A, with exception of ABB-PD. Finally, it 
needs to be added that the presence of progesterone in the samples from the treated 
animals was assessed as well, using the LC-MS/MS method described in a previous 
publication.191 The concentrations were comparable with those described for routine 
samples from bovines, not exceeding 4 µg L-1 except for two samples.77 In urine 
samples from cow C, elevated progesterone concentrations of 16 and 10.5 µg L-1 
were measured 12 hours after the first treatment and 72 hours after the third 
treatment, respectively. Still, this indicated that the progesterone level in urine from 
treated animals is generally too low to provide accurate IRMS-measurements.  
 
5.4.2. Development and evaluation of two analytical strategies 
Method B: measuring 1 ERC and 3 metabolites after acetylation 
Most published analytical methods for the detection of steroid abuse with IRMS 
combine hydrolysis, solid phase extraction (SPE), liquid-liquid extraction (LLE), 
preparative HPLC and acetylation steps in their sample preparation protocol.130,172 
For the development of method B, as described under 2.4, a similar analytical 
strategy was adopted for the measurement of AEdiol as ERC, and BAA-, BBA- and 
BAB-PD as metabolites of PG. A cleanup procedure for AEdiol was already 
developed,191 and the described protocol prior to the HPLC steps, as well as the 
acetylation procedure, proved to be equally suitable for the PDs. To avoid losses 
during the LLE, the extraction volume of pentane/diethyl ether was raised from one 
time to two times 4 mL.  
For the HPLC purification steps of the PDs, the fractionation windows were 
established by separate injections of the three PD standards, collecting fractions at 
regular intervals and evaluating their presence in those fractions using GC-MS. 
Although all analytes could be collected in separate fractions during reversed phase 
HPLC, the extracts contained too much co-extracted interferences to be interpretable 
by GC-(MS/C-IRMS). An additional normal phase HPLC purification of the separate 
fractions was used to overcome this problem, and allowed the successful 
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measurement of the δ13CVPDB values of all four targeted analytes after acetylation, as 
illustrated in figure 5.4.  
 
 
Figure 5.4. IRMS chromatograms (m/z = 44) of a compliant urine sample, showing the fraction 
containing BBA-PD (upper left), BAA-PD (upper right) and BAB-PD (lower left) obtained using method 
B, and the fraction containing B-PDione (lower right) obtained after oxidation of the PDs using method 
C. 
 
Method C: measuring one ERC and the oxidation product of four metabolites 
In an attempt to provide a simplified analytical strategy, an oxidation procedure was 
developed. The oxidation of the targeted analytes holds two important advantages. 
First, the oxidized steroids do not require a derivatization prior to GC-(MS/C-IRMS) 
analysis, and therefore eliminate the necessary correction of the δ13CVPDB values. 
Second, the eight PD-isomers are converted to two oxidation products, 5α- and 5β-
pregnane-3,20-dione (A- and B-PDione, respectively), thus reducing the number of 
analytes to be investigated.  
BBA-PD 
BAA-PD 
BAB-PD 
B-PDione 
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Since oxidation with K2Cr2O7 proved to be effective for the analysis of corticosteroids 
with GC-C-IRMS,129,196 the application of a similar procedure was considered 
relevant. The time optimum, at the given temperature and reagent concentration, was 
based upon the observations done on AAA-, BAA-, ABA- and BBA-PD. The oxidation 
was conducted at 2, 5, 10, 15, 20, 40 and 60 min whereas duration of the reaction 
was assessed from 5 min to 120 min. An optimum was found at 30 min; the absence 
of underivatized PDs was checked. An additional cleanup step relying on a normal 
phase HPLC separation was set up to isolate B-PDione. An illustration of an IRMS 
chromatogram is shown in figure 5.4. 
Unexpectedly, the protocol was not suitable for the oxidation of AEdiol. The oxidation 
of the hydroxyl group at position 17 occurred very rapidly, and was almost complete 
after two minutes. However, an oxidation of the hydroxyl group at position 3 was not 
observed. Therefore, a sample preparation procedure for AEdiol identical to method 
B, using an acetylation, was preferred.  
To compare the performance of both methods, six samples, three being collected 
from untreated bovines and three from a progesterone treated cow, were analyzed 
using both method B and C. The results, represented in figure 5.5, clearly indicate 
that both methods are capable of distinguishing between compliant (samples 1-3) 
and non-compliant samples (samples 4-6): for the non-compliant samples, the 
difference between the δ13CVPDB value of AEdiol (ERC) and that of the metabolites 
clearly exceeds the compliance threshold of 3‰ (described in 3.4.1., and validated 
for the application of progesterone under 5.4.4.). But more importantly, the δ13CVPDB 
values obtained with both methods are highly similar. Remarkably, even though four 
PDs contribute to the formation of B-PDione, its signal intensity was lower than that 
of BAA-PD in four of the six samples, and never significantly higher.  
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Figure 5.5. δ13CVPDB values of urine samples from untreated (sample 1-3) and treated (sample 4-6) 
cows, analyzed with both method B (AEdiol, BAA-, BBA- and BAB-PD) and method C (B-PDione). 
Measurements below the limit of quantification are not shown. 
 
5.4.3. Method validation 
Because BAA-PD was the PD-isomer giving the most intense IRMS signal in all the 
samples, and because the oxidation procedure eventually provided no added value, 
it was decided to validate the method based on the measurement of AEdiol as ERC 
and BAA-PD as metabolite, derived from method B.   
The intermediate precision was determined by the measurement of the 11 
subsamples of the spiked urine sample, distributed into 7 series of analysis, 
performed by three different operators over a time span of five months. The sample 
standard deviation (sd) (n=11) of the δ13CVPDB values were 0.56‰ and 0.68‰ for 
AEdiol and BAA-PD, respectively, which is acceptable and similar to published 
results for other steroids.117,179,191 
To verify the absence of isotope fractionation during sample preparation, a water 
sample spiked at 100 µg L-1 with both AEdiol and BAA-PD, was included into the 7 
series of analysis mentioned above. In each series, the difference between the 
δ13CVPDB values of the water sample and those of a standard injection was 
calculated. The mean of this difference was 0.20‰ and 0.27‰ for AEdiol and BAA-
PD, respectively, indicating that the δ13CVPDB values are not altered in a significant 
way by the sample preparation.84,179,191 
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For all the spiked samples mentioned above, as well as for all the urine samples 
described under 5.3.2, the identification of AEdiol and BAA-PD was done according 
to internationally recognized analytical criteria,24 by comparison of the abundance of 
six fragment ion ratios of the analytes with those of a reference standard injected in 
the same series, identically as discussed in paragraph 3.4.2. Identification of target 
analytes in every sample was checked, while verification of the absence of coeluting 
impurities permitted to document the method specificity. This was also verified using 
AMDIS®, a software application which compares the generated mass spectra from 
the samples to those of injected standards. It allows the automatic evaluation of the 
compound identity as well as peak purity. Based on the gathered data, the AMDIS® 
“Net Match” and “Purity” threshold values were set at 94 and 91, respectively, the 
lowest obtained values for both analytes, which still corresponded with manually 
verified correct mass spectra.  
To determine the linear range of the IRMS for the analytes, standards were injected 
in sixfold at different concentrations, from 2.5 up to 80 ng on column. The same 
criteria as described in chapter III were used to determine the linear range. For 
AEdiol, the linear range was between 750 and 5500 mV, corresponding with 7 ng 
and 50 ng on column, respectively.179,191 For BAA-PD, the measured δ13CVPDB values 
were very stable, with a standard deviation of 0.21‰, from approximately 12.5 ng up 
to 80 ng on column, corresponding to signals from 500 up to 4000 mV (m/z=44), 
which is similar to previously reported values for androgens and estrogens.179,191  
Finally, the extraction yield of the method is highly comparable with that of the 
androgens and estrogens, discussed in paragraph 3.4.1 and 4.4.1, also 
corresponding with an LOQ of 20 ng mL-1. 
 
5.4.4. Results from treated and untreated cattle 
Results from a compliant control population 
29 samples from non-treated cows were successfully analyzed using the validated 
method, of which the results are depicted in figure 5.6. From these results, the 
threshold ∆13CVPDB value for compliancy for the ERC - metabolite couple AEdiol - 
BAA-PD was calculated, as the mean value plus three times the standard 
deviation.152 The obtained value was 2.90‰, and therefore, a value of 3‰ could be 
suggested as a threshold for the presented method. Finally, the low mean ∆13CVPDB 
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value of 0.24‰ indicates that the additional carbon atoms, at position 20 and 21 of 
the progestagens, originate from a source with the same  13C/12C ratio when 
compared to androgens or estrogens.  
 
 
Figure 5.6. ∆13CVPDB values of urine samples issued from a compliant control population, with AEdiol 
as ERC and BAA-PD as metabolite of PG. The red line marks the compliance threshold (mean + 3 x 
SD). 
 
Results from progesterone treated animals 
The urine samples from the three cows treated with progesterone were analyzed, 
and the obtained results are summarized in figure 5.7 and 5.8.  
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Figure 5.7. ∆13CVPDB values of urine samples from 3 cows, treated with PG at day 0 and 1 for cow A 
and B, and at day 0, 1 and 2 for cow C, with AEdiol as ERC and BAA-PD as metabolite. 
Measurements below the limit of quantification are not shown.  
 
The method developed allowed confirmation of the treatment of all three animals, 
based on the threshold determined from the compliant control population. However, 
for cow A, this was only possible after the second intramuscular injection. This can be 
explained by the higher presence of PDs in this animal before the treatment, as 
illustrated in figure 5.3, causing a significant endogenous dilution of the measured 
BAA-PD 12 hours after the first treatment. Remarkably, 24 hours after the first 
treatment, all pregnanediols were below the limit of quantification, being the lowest 
concentration still providing a sufficient IRMS signal intensity (20 µg L-1), in the same 
animal. As for cow C, even though injected with a higher dose of PG, the BAA-PD 
level only allowed IRMS-measurement and distinction from the control population 
after 24 h, while for cow B, this was already possible after 12 h. The  difference 
between the treated animals and the control population remained observable  until 
the end of the experiment for the three animals. BAB-PD generally provided fewer 
measurements within the linear range. However, when it was present in a sufficient 
amount, the ∆13CVPDB values were larger than for BAA-PD, except in samples from 
cow A, in which ∆13CVPDB (AEdiol - BAB-PD) remained below 3‰.  
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Figure 5.8. δ13CVPDB values for AEdiol (blue), BAB-PD (green) and BAA-PD (red) of urine samples 
from cow A (upper), cow B (middle) and cow C (lower), intramuscularly injected with PG. 
Measurements below the limit of quantification are not shown. 
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It was expected that the elevated dose of PG, in combination with the inclusion of 
corn into the feeding regime, would result into higher ∆13CVPDB values for the samples 
from cow C, when compared to the samples from the other two animals.101 However, 
with the highest measurements of 6.89‰ and 5.78‰ for cow B and C, respectively, 
this was not the case. This observation suggests the presence of a significant 
endogenous production of PD by cow C, because the diet did have the expected 
impact on the δ13CVPDB values of the ERC, which augmented from -27,79‰ up to       
-19,93‰, as can be seen in figure 5.8. The average δ13CVPDB values for AEdiol, from 
T0 until the end of the experiment, were -26.71‰ and -25.69‰ for cow A and cow B, 
respectively, representative for a feeding regime very low in C4 plant material 
content,84 while for cow C, this was -20.91‰. Even though the last sample was taken 
3 weeks after the feed change, the data suggest that a steady state has not yet been 
reached at the end of the experiment, which is in line with previous findings, 
indicating adjustment periods close to 30 days.84,94 More remarkable is the observed 
difference between AEdiol and BAA-PD in response to the feeding change. While the 
values for AEdiol changed gradually over the total time, as previously reported for 
androgenic compounds,84,94,191 rising 8.84‰ in total, they already augmented 5.74‰ 
within the first 3 days for BAA-PD, resulting in a significant offset up to 5.04‰ 
between AEdiol and BAA-PD before the treatment. This offset could also explain the 
large impact of the endogenous dilution observed through the relatively small 
∆13CVPDB values obtained after the treatment. A similar impact of a dietary change on 
BAA-PD in humans has not been reported, although the experimental setup would 
not have allowed to reveal such an effect since the dietary change was less radical, 
and time intervals between samples were much larger.96 It is clear that this 
observation is a cause for concern if changing from a C4 to a C3 plant material based 
feeding regime would be applied by the farmer. If a sudden feeding regime change of 
that nature has an impact of the same proportion on the δ13CVPDB values of the PDs, 
the calculated threshold ∆13CVPDB value would be succeeded, and this would result in 
a false non-compliant result. It is clear that this scenario needs to be further 
investigated by additional animal experiments.  
Eventually, to assess whether the PG administration influences the δ13CVPDB values 
of other steroidal compounds, i.e. to assess the specificity of the analytical method, 
the samples collected after treatment were also analyzed with the previously 
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published method for the detection of androgen and estrogen abuse.191 As expected, 
all the results for the androgens were compliant, with a largest observed ∆13CVPDB 
value of 1.38‰ for the ERC – metabolite couple AEdiol – etiocholanolone, which is 
similar to findings reported for an administration experiment in humans.197 
Unfortunately, the level of 17α-estradiol was too low to provide accurate IRMS-
measurements.  
 
Impact of a testosterone/estradiol treatment on BAA-PD  
BAA-PD is the ERC of preference for human doping control,152 and the results from 
the compliant control population indicate that it might be able to fulfill a similar 
function in cattle, when no PG was administered. Therefore, 9 urine samples from a 
bull and 11 from a heifer treated with a single intramuscular injection containing 17β-
testosterone propionate and 17β-estradiol benzoate, from the animal experiment 
which was discussed in detail in chapter IV, were analyzed using method B, 
consisting of the measurement of AEdiol, BAA-, BAB- and BBA-PD after acetylation, 
and the data was combined with that obtained during the previous study. Using BAA-
PD as ERC, the 17β-estradiol treatment was successfully confirmed in both animals. 
However, for the 17β-testosterone treatment, this was not the case: the treatment 
could only be demonstrated in the heifer, and the detection windows were 
significantly smaller (up to 11 and 19 days using 17α-testosterone and 
etiocholanolone, respectively). This indicates that BAA-PD would not be a suitable 
ERC to be used in bovine urine.  
When looking at the ∆13CVPDB values of all the metabolites together, using AEdiol as 
the ERC, as illustrated in figure 5.9, it becomes clear that the δ13CVPDB values of 
BAA-PD are significantly affected by the 17β-testosterone/estradiol treatment, even 
up to the point where the compliance threshold of 3‰ for PG treatment is crossed, 
which would indicate a PG-treatment. In the bull, the impact of the treatment on the 
δ13CVPDB values is even more significant than for the androgen metabolites. These 
findings were highly unexpected.  
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Figure 5.9. ∆13CVPDB values for 17α-testosterone (aT), 17α-estradiol (aE2) and etiocholanolone (Etio), 
and BAA-PD, with AEdiol as ERC, in urine samples from a bull (lower) and a heifer (upper), treated 
with a single intramuscular injection of 17β-testosterone propionate and 17β-estradiol benzoate.  
 
At the moment there is no explanation for this observation, and further study is 
required to evaluate the specific role of 17β-testosterone and 17β-estradiol in this 
process, and if these results can be repeated in a new administration study. 
Therefore, even though the presented method was used to adequately illustrate 
abuse of PG in cattle, it is advised to include additional analytes into the analytical 
strategy and create a clearer image regarding possible treatments.  
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5.5. Conclusions 
 
The ability of GC-(MS/C-IRMS) to differentiate between urine samples from bovines 
treated intramuscularly with progesterone and a compliant control group has been 
demonstrated. Through analysis of urine samples from pregnant cows, and verified 
by results from treated animals, the 5β-pregnane-3,20-diols were selected as 
promising target metabolites of progesterone. Although 5β-pregnane-3,20-dione, 
obtained from urine samples as the single oxidation product of the four 5β-pregnane-
3,20-diols using K2Cr2O7, could be successfully measured using GC-(MS/C-IRMS), it 
was evaluated that there was not enough gained advantage over a strategy using 
acetylation. Eventually, a method retaining only the most abundant pregnanediol, 5β-
pregnane-3α,20α-diol, as progesterone metabolite, and 5-androstene-3β,17α-diol as 
endogenous reference compound, was successfully validated. The developed 
sample preparation was a multistep process, consisting of a hydrolysis, SPE, LLE 
and two HPLC purification steps before acetylation. Although the treatment could be 
demonstrated in three progesterone treated cows, with ∆13CVPDB values up to 6.89‰, 
the changes in level of the pregnanediols, in response to the treatment, were highly 
variable between the animals. As a result, the treatment was traceable in a first 
animal already 12 h after a first administration, whereas in a second this was only 
after 24 h, and in a third, the treatment was only detected after the second 
progesterone injection.   
However, the impact of a sudden shift in the diet, and of the combined 17β-
testosterone/estradiol treatment are a serious cause for concern, and must be 
studied further through additional animal experiments. It is clear that the presented 
method, as such, is not adequate to be used for official food safety analyses at the 
moment, since it would be impossible to conclude if a non-compliant result would be 
due to a shift in feeding regime or another treatment. However, a deviating result is 
most certainly atypical, and the integration of BAA-PD into existing methods for the 
detection of abuse of androgens and estrogens could provide valuable additional 
information.  
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6. General discussion and future perspectives 
 
6.1. Analytical strategy and used sample preparation techniques 
 
As indicated in chapter I, the primary objective of this research was to develop an 
analytical method for the detection of abuse of synthetic analogues of endogenous 
sex steroids in cattle using IRMS, starting from knowledge gathered from literature. 
As thoroughly discussed in chapter II, published methods employ an extensive 
combination of multiple hydrolysis, SPE and LLE steps, followed by normal phase 
HPLC fractionation and acetylation. Then, if GC-MS analysis indicates impurities 
coeluting with the targeted analytes, an additional reversed phase HPLC purification 
is performed before GC-C-IRMS analysis.100,101,172 Attempting to provide a method 
more suitable for routine analyses, a number of adaptations were done to the existing 
protocol, as discussed in chapter III.179  
First, the analysis of the sulphate fraction was not included in the current approach. 
Although at the loss of DHEA as an additional ERC, the gained simplification of the 
method was significant. Second, through the use of PTV-injection, the sample 
volume was successfully reduced to half, greatly facilitating the work when dealing 
with a large number of samples. Third, by coupling a mass spectrometer in parallel to 
the C-IRMS, separate GC-MS analyses were successfully eliminated from the 
analytical protocol. However, due to this omission, the HPLC-purification steps 
needed to be revised. Because of the fact that the identification and purity evaluation 
are performed simultaneously with the 13C/12C measurement, and because all 
fractions originating from the same sample are preferably measured as subsequent 
injections to reduce variability on the calculated ∆13CVPDB values, an additional HPLC-
fractionation step after a first GC-(MS/C-IRMS) analysis is not optimal. It was 
originally hoped that one C18 HPLC purification step would be sufficient, as this was 
described in most analytical methods for routine sports doping control published in 
the meantime.130,183,198-200 Unfortunately, the extracts obtained in this way for αT and 
AEdiol were insufficiently pure, and it was decided to replace one of the SPE steps 
with an additional HPLC purification using a diol functionalized column for all fractions 
to assure unhindered IRMS measurements. This strategy proved to be successful, 
since no coelutions or impurities have been encountered during the analyses until 
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now. Additionally, the parallel coupled MS proved to be a valuable diagnostic tool 
upon system failure, allowing to faster pinpoint the exact problem within the setup. 
Furthermore, the use of an HPLC-based sample preparation strategy has proven its 
benefits throughout this research. Due to its flexible nature, it provides a relatively 
open platform, which allows the inclusion of additional steroid analytes through 
adjustments in mobile phase composition and fractionation windows. This allowed to 
start off with a method for the detection of estrogen abuse (chapter III), and gradually 
extent the palette of analytes to include the detection of androgen (chapter IV) and 
progestagen (chapter V) abuse.  
 
However, even though the presented method provided a number of optimizations 
compared to previously published ones, the resulting protocol is still extensive and 
time consuming, resulting in a relatively low sample throughput and a relatively high 
detection limit (20 ppb). Therefore, a number of suggestions are in order for future 
ameliorations and explorations in sample preparation, some of which more readily 
applicable than others.  
First of all, analysis of the estrogen fraction of urine samples from the animals treated 
with βE2, described in chapter IV, with and without the normal phase HPLC 
purification, provided highly comparable results for αE2, suggesting that the second 
HPLC preparation step can be omitted from the method for this particular fraction.  
Second, the full power of the PTV-injection has not yet been harvested. Due to the 
long run time of the GC-(MS/C-IRMS) measurement series, usually performed over 
the weekend, the minimal volume of the final extracts was limited to 30 µL to avoid 
evaporation of the samples at the end of the run, resulting in failed injections. Using a 
new type of GC-vials, with a narrow cone shaped interior, the sample volume could 
be drastically reduced. Of course, amplification of matrix noise is to be expected. 
However, preliminary results indicated that the extracts are sufficiently pure to allow 
the sample volume to be reduced to 12 µL without substantial hindrance of 
background noise, resulting in more than doubled sensitivity.  
Finally, the use of selective sorbents could provide the means to shorten the sample 
preparation strategy. Recently, Doué et al. described that the use of supercritical fluid 
chromatography (SFC) with a molecularly imprinted polymer (MIP) stationary phase 
allowed to reduce their sample preparation protocol prior to GC-C-IRMS analysis, for 
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the detection of abuse of synthetic analogues of endogenous steroids in bovines, 
with three steps.201 Although early studies favored the use of preparative HPLC over 
immunoaffinity chromatography (IAC) because of its flexibility,113,138,155 this selective 
antibody-based sorbent could serve a similar purpose, and is already successfully 
applied as a sample preparation tool for exogenous steroid analyses of urine and 
fecal samples for almost two decades.85,202,203  
 
6.2. A method for official food safety analyses 
 
6.2.1. Method validation 
An important objective of this study was to provide an analytical method to be used 
for official food safety inspections. In Belgium,204 as in most countries worldwide, this 
requires the analysis to be performed under ISO 17025:2005 accreditation, the 
international standard laying down the general requirements for the competence of 
testing and calibration laboratories.205 An important requirement is that a thorough 
and well documented validation study needs to demonstrate the method’s potential of 
providing reliable results.  
 
The performed validation of the developed GC-(MS/C-IRMS) methods was extensive, 
and consisted of at least ten parts. Criteria for each of the parts were established in 
advance, based on information found in the literature and specifications provided by 
the system manufacturer.  
The stability and linearity of the ion source of the IRMS apparatus was established 
using CO2 pulses giving identical and different peak heights, respectively.   
Intermediate precision was assessed through the repeated analysis of a spiked urine 
sample under reproducibility conditions. The absence of isotope fractionation caused 
by the sample preparation, or the sample preparation induced bias, was verified by 
comparing the results of spiked aqueous samples with those of the pure standards 
used for the spiking. The trueness, or system bias, was evaluated through the 
measurement of steroid standards with known and certified δ13CVPDB values. The 
combination of these three parameters provides the necessary information on the 
accuracy of the method. The resulting estimated combined measurement uncertainty 
for AEdiol, αE2, αT and Etio were 0.70‰, 0.99‰, 0.80‰ and 1.24‰, respectively.  
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The specificity of the method was verified by the evaluation of the mass spectra 
according to the legal criteria, for every sample analyzed during method validation.24 
Additionally, peak purity was assessed by manual control of the mass spectra 
throughout the whole of the analyte peak. Additionally, the use of AMDIS, specialized 
software applying specific algorithms to evaluate analyte purity and identity was 
validated.  
The linear range of the GC-(MS/C-IRMS) system, or the intensity interval in which the 
instrument provides accurate results, was determined for each analyte specifically 
through repeated standard injections at different concentrations.  
A threshold ∆13CVPDB value was determined for each ERC-metabolite pair through the 
analysis of urine samples from a compliant control population. Finally, the aptitude of 
the method and the adequacy of the determined threshold were verified through the 
analysis of samples from treated animals.  
All the required information could be gathered through four to five analytical series, 
containing approximately ten samples each. The validation was successfully 
performed for the estrogen, androgen and progestagen method, and details on the 
execution and results are unraveled in the previous three chapters.  
 
However, three important shortcomings need to be highlighted. First of all, the level 
of the spiked urine samples to determine the within lab reproducibility must be 
revised. Since results are expected to be more variable at the lower end of the linear 
range, the reproducibility should be determined using urine samples with steroid 
concentrations at the level of the LOQ.  
Second, the procedure to determine the system bias could be seriously improved by 
using standards of all the analytes targeted in the method, with traceable and 
certified δ13CVPDB values obtained through EA-IRMS. This would allow to calculate a 
measurement uncertainty which is more specific for the individual components, and 
therefore, together with the above mentioned adaptation to the determination of the 
within lab reproducibility, would result in a calculated measurement uncertainty closer 
to reality. 
Third, by using a calibration standard mixture with more steroids, of which the  
δ13CVPDB values are spread across the entire range of interest, from approximately -
14‰ down to -32‰, the calibration can be significantly improved, and the calibration 
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bias would be more evenly spread across the entire range, whereas now, the higher 
δ13CVPDB values are expected to be more biased.  
 
It is clear that the validation procedure is difficult and cumbersome for multiple 
reasons, which all could be remedied to a certain extent.  
The first difficulty lies within the large number of parameters to be validated. 
However, if adequate reference material were available, under the form of non-
compliant urine samples with known δ13CVPDB values, reproducibility, method bias 
and system bias could be evaluated together through repeated analysis of this 
material. This would allow to replace the combined analyses of spiked urine samples, 
spiked aqueous samples, certified standard injections and non-compliant samples. 
Together with the data from a compliant control population, and the determination of 
the linear range, this would provide a complete method validation. 
The second difficulty lies within the unclarity regarding the method validation: which 
parameters should be validated, how should this be done and which criteria need to 
be applied? Official guidelines should be made available, including these three 
aspects, to harmonize the validation approach.  
For doping control, both aspects are covered by the WADA, which provides reference 
materials to the official doping laboratories, and which lays down technical 
requirements for official analyses. With regard to GC-C-IRMS method validation, the 
currently active WADA technical document indicates the necessity of determining the 
linear range for each analyte, the analysis of samples from a compliant population to 
verify the threshold values, and the determination of the combined standard 
measurement uncertainty, which needs to be below 1‰.152 The new technical 
document, which will be in force starting January 2016, will add verification of the 
linearity of the ion source with CO2 pulses to the validation requirements, and will 
provide practical guidelines on how to test and evaluate the linear range per 
analyte.153 
 
In 2014, the EURL published a reflection paper on natural growth promoting 
substances, encouraging official control laboratories to implement GC-C-IRMS 
analyses,29 and is currently working on the development of GC-C-IRMS methods 
itself. It can be hoped that the EURL can fulfill a similar role for growth promoter 
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control as the WADA for doping control, providing clear guidance and useful 
reference materials, which could eventually evolve into inclusion of GC-C-IRMS 
analysis guidelines in official legislation, the need for which has already been 
discussed in literature.30  
 
6.2.2. Quality control 
As a second important requirement to obtain ISO 17025:2005 accreditation, a 
thorough and well documented quality control system needs to be put in place to 
allow continuous verification of the reliability of the analytical results in time. The 
quality control procedure, employed for all analyses until now, is described below.  
First of all, a number of samples are added to every analytical series. A urine sample 
from a treated animal functions as a positive control sample. When no samples from 
treated animals are available, a urine sample spiked with all the measured 
metabolites, but not with the ERC, can be used to replace it. Also, a urine sample 
from the control population is added as a negative control sample. Additionally, two 
spiked aqueous samples, are included. The first, spiked at 100 µg L-1 is used to verify 
the absence of isotope fractionation during sample preparation. This sample was also 
spiked with 17β-testosterone glucuronide to evaluate the activity of the used 
glucuronidase. The second, spiked at the LOQ, 20 µg L-1, is used to verify the 
efficiency of the sample extraction. Finally, a blank aqueous sample is added to 
assess possible contamination of the samples during analysis. 
Prior to analysis with GC-(MS/C-IRMS), the functionality of the system is evaluated in 
a three stage process. First, absence of leaks in the system is verified by performing 
a background scan. Second, linearity and stability of the ion source are evaluated 
through pulses with the CO2 reference gas. Finally, a steroid standard is injected to 
evaluate the functionality of the complete setup.  
When all controls are satisfactory, the analytical series can be started. Next to all the 
separate fractions obtained from the official and control samples at the end of the 
preparation, a number of additional controls are injected. At the beginning of every 
series, six standard injections are included to assure stability of the system before 
measurement of the samples. Next, a solvent blank is injected to evaluate system 
contamination. Certified steroid standards were included to verify the absence of a 
system bias. Standards of all measured analytes were included as well for a twofold 
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purpose: verification of peak identity and purity, and evaluation of sample preparation 
induced bias by comparison with the spiked aqueous samples.  
Processing the GC-(MS/C-IRMS) results from the obtained fractions, after sample 
purification, comprises four steps. First, the peak purity check and the analyte 
identification are done through evaluation of the obtained mass spectra. Next, it 
needs to be verified if the intensity of the obtained IRMS peak is within the linear 
range. Finally, the measured δ13CVPDB value needs to be corrected for the acetate 
moiety, as discussed in the previous chapters.  
Besides the controls performed for each analytical series, the calibration of the used 
CO2 reference gas using certified steroid standards with known and traceable 
δ13CVPDB values, needs to be performed periodically.  
 
The extensive validation and quality control procedures, covering all aspects also 
included in the WADA doping control prescriptions,153 resulted in a positive 
accreditation audit, and the method for the detection of estrogen and androgen 
abuse have been performed for official control purposes since 2013 and 2014, 
respectively. However, it became clear that the elaborate quality control resulted in 
large injection series, and time consuming processing of results. The validation of the 
AMDIS software to assess peak purity and analyte identification, as discussed in the 
previous paragraph, proved to be a very helpful automation tool for the processing of 
large numbers of samples. Still, a number of additional suggestions can be made to 
streamline the quality control process. 
First, the certified steroid standards, included in every analytical series, revealed that 
the calibration of the CO2 reference gas remains stable over large periods of time, 
with the measured δ13CVPDB values not deviating more than 0.6‰ from the certified 
value. This corresponds with observations from routine doping analyses,183 and 
indicates that calibration of the reference gas only needs to be performed and 
checked periodically, in accordance with the WADA guidelines. Additionally, the 
WADA indicates that the linearity check of the ion source is only required periodically 
as well.152  
Second, it became clear that, when the same compliant or non-compliant control 
sample is used over large periods of time, the control charts of these samples were 
sufficient to indicate isotope fractionation during sample preparation. Hence, the 
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aqueous sample spiked at 100 µg L-1, included to identify this process specifically, 
could be omitted from the procedure. Moreover, these control charts proved to be a 
valuable source of additional information to the method validation. For all measured 
androgens, AEdiol, αT and Etio, the calculated standard deviations obtained from 14 
measurements, of both the compliant, illustrated in figure 6.1, and non-compliant 
control sample, over a time span of approximately nine months, were close to 0.8‰. 
This value can be considered a more realistic approximation for the reproducibility of 
the method than the results obtained during the method validation, which are 
discussed in chapter III and IV.  
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Figure 6.1: Control charts of the compliant control sample, containing the measurements of 
etiocholanolone (Etio) (upper), 5-androstene-3β,17α-diol (AEdiol) (middle) and 17α-testosterone (αT) 
(lower). The black line indicates the average, the orange lines indicate the first action level (average ± 
2 x standard deviation) and the red lines indicate the second action level (average ± 3 x standard 
deviation). 
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Third, through evaluation over time of the six standard injections, performed at the 
beginning of each injection series to stabilize the system, it is concluded that already 
after three injections, accurate and stable values were obtained.  
Fourth, contamination caused by both the sample preparation and the                   
GC-(MS/C-IRMS) can be simultaneously assessed through one injection by 
combining all the fractions from the blank water sample, and eliminating the solvent 
blank. Of course, when a contamination is observed, it will not be possible to locate 
the source instantaneously, and additional research will be in order. However, 
through the past three years of official control analyses, contamination has not been 
observed. 
Finally, the analytical procedure prescribes that when a sample is found to be non-
compliant, this result needs to be confirmed with a second analysis as a 
precautionary matter. It can be proposed that, since the first analysis fulfills a 
screening function, the compliant control sample is only included during the 
confirmation analysis.  
 
6.2.3. Screening strategies 
Since GC-(MS/C-IRMS) analysis remains laborious and time consuming, a screening 
strategy needs to be in place to select suspicious samples. The original approach 
was that the samples were selected by the National Investigation Unit (NIU), the 
inspection unit of the Federal Agency for the Safety of the Food Chain (FASFC) 
specialized in investigation of hormone abuse in cattle in Belgium, based upon the 
weight of the animals and other information (prior convictions, police information,…). 
Additionally, all samples were screened using LC-MS/MS prior to GC-(MS/C-IRMS) 
analysis, to determine if the targeted analytes were present above 20 µg L-1, the 
lowest level which still provided a sufficient amount of CO2, after combustion, to 
provide an accurate IRMS measurement, or the limit of quantification (LOQ). This 
screening method, described in chapter IV, was officially included in the analytical 
strategy and performed under accreditation.  
For αE2, this concentration-based screening proved to be sufficient, allowing sifting 
out 96% of the official samples provided in 2013 and 2014. The applied strategy 
related closely to the one given by Scarth et al., suggesting GC-C-IRMS analysis 
after two out of two samples were found above 5 µg L-1 and 10 µg L-1 for steers and 
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heifers, respectively.32 Following the same strategy for the androgens, 65% of the 
samples was eventually analyzed with GC-(MS/C-IRMS), all giving compliant results.  
 
Regarding IRMS analysis for the detection of abuse of synthetic analogues of 
endogenous androgens, the above clearly illustrates that research into an adequate 
and more selective screening technique is of high importance. In chapter I, it was 
discussed that a lot of screening approaches are under investigation, with the current 
attention shifting towards multiple indirect biomarker measurement in various types of 
matrices.43 However, because of the grave consequences of a non-compliant result 
for the farmer, a direct confirmatory analysis will remain mandatory.29 As discussed in 
chapter IV, alternative confirmation methods are currently limited to analysis of intact 
steroid esters in hair or plasma, of which the MS detection is a direct proof of 
administration and therefore require no additional screening approaches. Therefore, 
a urine-based screening method, including the quantification of the targeted steroids 
besides an additional, more selective criterion, would be the ideal and directly 
applicable approach at the moment, worthy of immediate research. Additionally, a 
powerful screening strategy prior to IRMS analysis significantly reinforces the 
reliability of a non-compliant result. This is now the fact in anti-doping analyses, 
where a combined atypical result from the biological passport together with a non-
compliant IRMS result provides a very strong statistical result.  
 
6.2.4. Endogenous versus exogenous δ13CVPDB values 
Of the 365 official urine samples, analyzed under accreditation since the beginning of 
2013 for the detection of abuse of synthetic analogues of endogenous androgens 
and/or estrogens, none were found to be non-compliant. The ideal hypothesis to 
explain this observation would be that none of the sampled animals had been treated 
with these substances. However, since preparations containing esters of βT and βE2 
were still confiscated by the Belgian authorities during the past years, this is not 
necessarily true. The described developed analytical strategy has a number of critical 
weaknesses, which could very well be the cause of this.   
First of all, the detection window for GC-(MS/C-IRMS), especially with regard to 
androgen abuse in male animals, is very small, as discussed in chapter IV. Moreover, 
when an even smaller dosage is used, it is expected that the detection window will be 
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smaller as well. It could be possible that samples were not taken within the suitable 
timeframe after treatment. For this reason, the competent authorities have been 
informed that sampling of live animals at the farm is preferred over sampling at the 
slaughterhouse for this particular analysis.  
Another explanation could be that the diet of the animals influences the outcome of 
the IRMS analyses. It has been suggested that GC-C-IRMS would be an unsuitable 
technique to demonstrate illegal treatment in cows from the United Kingdom, 
because the use of corn in the feeding regime is rather uncommon there. As 
discussed before, low quantities of C4 plants in the feeding regime greatly reduce the 
difference in δ13CVPDB values between endogenously produced steroids and steroid 
preparations, which severely compromises a successful detection of abuse.113 
However, when evaluating the obtained δ13CVPDB measurements for AEdiol from the 
official control samples, depicted in figure 6.2, ranging from -14.12‰ to -25.97‰ 
around an average of -19.73‰, this does not seem to be the case.   
 
 
Figure 6.2: Distribution of the δ13CVPDB values of 5-androstene-3β,17α-diol (AEdiol), measured in 
official control samples from Belgian cows. 
 
The other way around, the existence has been reported of preparations of synthetic 
analogues of endogenous anabolic steroids, observed through the analyses of 
confiscated doping products, having δ13CVPDB within this range.88,180-182 Although it 
was only the case in a minority of the analyzed samples, these unusual 13C/12C ratios 
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are a serious cause for concern, and were also observed in the BAA-PD standard, 
used at the laboratory.  
 
Unfortunately, the preparations containing synthetic analogues of endogenous sex 
steroids, confiscated at Belgian farms between 2011 and 2015, were unavailable for 
analysis due to legal confiscation. Therefore, it is advised that, once they are 
released from legal custody, analysis of these preparations would be the subject of 
future research. As for the limited amount of available preparations, confiscated in 
2011, all had δ13CVPDB values below -28‰. 
 
6.3. Results from the animal experiments 
 
When developing an IRMS-based method to demonstrate treatment of bovines with 
synthetic analogues of endogenous steroids, analyses of real non-compliant samples 
is a crucial step, since it is the only way to confirm whether the designed strategy is 
successful. Since non-compliant reference material, being urine samples from treated 
animals, is not readily available, an administration experiment is indispensable. 
However, animal experiments are very costly, mainly due to feed consumption, man-
hours for collecting samples and destructions of the animals afterwards. This also 
explains why carbon isotopic data from animal experiments in literature are 
scarce,67,84,94,100,101,113 rendering additional administration results into a valuable 
asset for the community. Even though using young calves could be a way to lower 
the costs and increase the number of tested animals, older animals were preferred in 
this research since veal farming is not of equal importance and magnitude in 
Belgium. 
However, it is understandable that it is not possible to obtain statistically significant 
conclusions from the limited number of treated animals used in the current study. 
Therefore, conclusions drawn from the animal experiments should be regarded as 
preliminary, but certainly not invaluable.  
 
The first animal experiment was primarily set up to assess the method’s potential to 
demonstrate treatment of bovines with βT and βE2, injected intramuscularly as a 
propionate and benzoate ester, respectively. From a zoological point of view, animals 
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of different sex would receive different concentrations of the steroids, as male 
animals respond better to female sex steroid treatment and vice versa. However, 
treating a bull and a heifer identically, and varying the amount of maize present in the 
feed, allowed to take a glance at the influence of gender and diet on the δ13CVPDB 
values of targeted ERC and metabolites as well. Finally, the analysis of the large 
number of urine samples collected up to four weeks after treatment provided more 
detailed pharmacokinetic data than available from previous studies, and allowed to 
accurately determine the detection window of the GC-(MS/C-IRMS) method for the 
treatment.  
The results, discussed in detail in chapter IV, confirmed the earlier described impact 
of a feeding regime, mainly consisting of maize, on the endogenous androgens,84,94 
whose δ13CVPDB augmented to almost -13‰. The pharmacokinetics revealed a 
substantially narrower detection window for testosterone treatment in the male animal 
(three days) compared to the female (24 days), due to a larger endogenous 
androgen production. The detection window for estradiol treatment (24 days), on the 
other hand, was not limited by endogenous dilution in both animals, but by the 
current LOQ of the method.   
 
However, the influence of the nature of the treatment was not included in the 
described experiment, and provides an interesting topic for future research. By 
treating animals of the same age and gender with a different dose and/or by varying 
the type of ester side-chain used for the steroid preparation, interesting insights on 
the impact on the detection window can be obtained.  
 
The primary objective of the second animal experiment was to evaluate if the 
combination of AEdiol and BAA-PD would provide a suitable ERC – metabolite pair to 
confirm PG treatment in bovines. Therefore, three heifers were treated with multiple 
intramuscular injections of PG, with a 24 h interval, and urine samples were collected 
before, during and after treatment. Additionally, the third animal was treated with a 
five times higher dose than the other two, and also the feeding regime of this animal 
was changed to include more maize, as the influence of these factors on the level 
and δ13CVPDB values of PDs in urine had not been studied previously. Unfortunately, 
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no male animals were available for the experiment, which should be included in 
future studies.  
The results of this experiment, discussed in detail in chapter V, revealed a 
significantly varying response to the treatment between the animals. In the first 
animal treated with the lower dose, the ∆13CVPDB value only became sufficiently high 
12 h after the second injection, whereas the treatment could already be elucidated 12 
h after the first injection in the second animal. As for the third animal, treated with a 
higher dose, the treatment could only be detected 24 h after the first injection, since 
the level of BAA-PD was below the LOQ in the sample taken 12 h after this 
treatment. Furthermore, the change from a C3 to a C4 plant based feeding regime, 
revealed an abrupt augmentation of δ13CVPDB values of BAA-PD, whereas this 
change was more gradual for AEdiol.  
 
This last observation opens important perspectives for future research. First of all, an 
additional feeding experiment is advised, in which the regime is changed in a 
different direction, from a C4 to a C3 plant based feed. If a comparable but opposite 
response to this change is observed, the created offset between the δ13CVPDB values 
of the ERC and the metabolite could result into a false positive result. It is clear that 
this study is very necessary, since it is impossible to declare a sample definitively as 
non-compliant based on the measured ∆13CVPDB  until this issue is clarified.  
Circumventing this problem would be to include a reference compound which 
responds in the same way to the feeding change as BAA-PD. When looking at 
scheme 2.1, a direct PG precursor such as pregnenolone would provide a likely 
candidate. However, the limited data available regarding the presence of 
pregnenolone in bovine urine indicate that its concentration will not be sufficient to 
make it a suitable ERC.41 17α-hydroxypregnenolone, for which no urinary 
concentration data are currently available, could provide an alternative. Therefore, 
evaluation of its abundance in routine bovine urine samples would be the first step in 
evaluating this approach.  
Another interesting approach to the detection of progesterone abuse can be 
suggested. Substantial levels of progesterone have been reported in faecal samples, 
and are used as a diagnostic marker for pregnancy in cows.206-208 It is likely that after 
administration, progesterone would be present in a sufficient amount in faecal 
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samples, to be used as target metabolite for GC-C-IRMS analysis. In combination, 
cholesterol could be suggested as an ERC candidate, since it has been reported to 
be present in bovine faeces in concentrations up to almost 7000 µg g-1,209 and has 
already successfully been used as an ERC for the detection of testosterone 
administration in bovines, using bile as matrix.113 
 
Finally, measuring the progesterone metabolites in the samples from the first animal 
experiment, revealed a highly unexpected impact of the combined βE2 and βT 
treatment on the δ13CVPDB values of BAA-PD. As discussed in chapter V, the 
difference between the ERC, AEdiol, and BAA-PD exceeded the threshold 
determined from the analysis of samples from the untreated control population. 
Therefore, although still a usable metabolite to indicate steroid abuse, BAA-PD does 
not seem to be specific for the indication of progesterone abuse. To exclude the 
option that analytical errors are responsible for this observation, some of the samples 
were reanalyzed using the oxidation protocol, discussed in chapter V, instead of the 
acetylation, and were send to other laboratories as well, which confirmed the initial 
findings. This interesting phenomenon raises multiple questions, which can only be 
answered by additional administration studies.  
First of all, it needs to be confirmed that this observation is repeatable.  
Second, it should be investigated if either the testosterone, the estradiol, or the 
combined treatment is responsible. Of course, bovine and human steroid 
metabolism, although similar, are not identical, but it needs to be noted that a similar 
observation has never been made in the context of sports doping control, where 
BAA-PD is a commonly used ERC, but where estradiol is not likely to be used as a 
doping agent.130,152 
Third, the mechanism causing this effect needs to be elucidated. Based on the 
current knowledge of the steroid metabolism, it seems unlikely that testosterone or 
estradiol themselves would be converted to pregnanediol. Using 13C-labeled 
preparations in an administration experiment should allow to clarify this.  
 
 
 
Chapter VI 
135 
 
 
6.4. Research project AFFIRMS 
 
Over time, evolutions in chromatographic and mass spectrometric techniques 
revealed the possible endogenous presence of substances which were previously 
believed to be xenobiotic, such as nortestosterone,68 and more recently prednisolone 
in cows and pigs.45,210 Elucidation of the origin using GC-C-IRMS has been 
suggested as the confirmatory technique of choice when the presence of these 
substances is detected in routine samples.29 However, when these substances are 
detected in urine samples, their concentrations are generally low, and therefore, 
IRMS based techniques have not yet been applied for this purpose.  
In the context of this problem, a joint research project, for the following four years, 
was started by the FLSFCG and the CER Groupe under the name AFFIRMS. The 
objective of the first stage of this project is to investigate the possibility of using IAC 
as a sample preparation technique prior to GC-(MS/C-IRMS) analysis, with the 
development of specific antibodies for the ERC and metabolites presented in this 
work. In the second stage, it will be assessed if IAC provides an extraction which is 
sufficient to allow GC-(MS/C-IRMS) to be used as a confirmatory analysis when 
prednisolone is detected above its maximum residue limit (MRL), being 5 µg L-1.26 
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8. Summary 
 
The positive effects of steroid hormones on growth and feed conversion are well 
known since the middle of the past century. However, as a precautionary measure, 
their use as growth promoting agents in stock farming remains prohibited in the 
European Union, and is actively monitored. Still, when it comes to synthetic 
analogues of endogenously produced steroid hormones, detection of abuse remains 
difficult. Although the capability to elucidate the origin of these compounds in urine 
samples using gas chromatography-combustion-isotope ratio mass spectrometry 
(GC-C-IRMS) has been demonstrated since the late 1990s, its application for food 
safety purposes remained rare. The aim of the current research was to provide fully 
validated IRMS-based methods for the detection of abuse of synthetic analogues of 
endogenous sex steroids, which could be implemented as such for official control 
purposes.  
 
In chapter I, an introduction to endogenous steroid hormones, with particular focus 
on the group of sex steroid hormones, is given. After providing the basic rules of 
steroid nomenclature, an overview is given of the compounds of interest in the 
present study. Next, the different types of endogenous steroid hormones are defined, 
describing their natural functionality in the body, as well as their growth promoting 
characteristics. Afterwards, information is provided on the currently active legislation, 
regulating the use of steroid hormones as growth promoters in the European Union, 
and Belgium specifically. Then, different analytical approaches to screen for abuse of 
synthetic analogues of endogenous hormones are described, ranging from steroid 
concentrations and profiling, over holistic fingerprinting techniques, to indirect 
biomarker screening. Finally, the outline of this doctoral thesis is presented.  
 
In chapter II, an extensive literature review is provided, covering all published 
aspects related to the detection of abuse of synthetic analogues of endogenous 
steroids in cattle using GC-C-IRMS. First, both the bovine steroid metabolism and the 
production process of steroid preparations are described, illustrating that the 
difference in the 13C/12C ratio of the respective source materials provides the 
theoretical basis to distinguish between endogenously and synthetically produced 
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steroids which are structurally identical. Then, the different factors influencing the 
steroids’ 13C/12C ratio, expressed as δ13CVPDB values, are discussed, illustrating the 
need to measure at least two different steroids in a urine sample: a metabolite of the 
target compound of which the δ13CVPDB value will be affected by the treatment, and 
an endogenous reference compound (ERC) of which the δ13CVPDB value will remain 
stable. The difference between both, the ∆13CVPDB value, will provide the 
unambiguous indication of the treatment. Next, the analytical application is 
thoroughly discussed, describing the functionality of the used GC-C-IRMS apparatus, 
the used sample preparation techniques and the combined analytical strategies. 
Finally, a link is provided to other IRMS-based detection techniques, and to the field 
of sports doping control, where GC-C-IRMS is more commonly applied to detect 
abuse of synthetic analogues of androgenic-anabolic steroids.  
 
In chapter III, a confirmation method to detect abuse of synthetic analogues of 
endogenous estrogens in cattle using gas chromatography coupled to both mass 
spectrometry and combustion-isotope ratio mass spectrometry in parallel             
(GC-(MS/C-IRMS)) is presented, which allowed to eliminate the need of additional 
GC-MS analyses. The sample preparation protocol consisted of a hydrolysis, a solid 
phase extraction, two liquid-liquid extractions, two HPLC fractionations and an 
acetylation, after which the δ13CVPDB values of 5-androstene-3β,17α-diol, the ERC, 
and 17α-estradiol, the metabolite, could be successfully measured. The method was 
thoroughly validated and allowed to distinguish between samples from treated and 
untreated animals. 
 
In chapter IV, the developed method was fine-tuned and extended to include the 
detection of abuse of synthetic analogues of androgens, which was possible by 
additional measurement of 17α-testosterone and etiocholanolone. After thorough 
validation, the detection method was used to analyze multiple samples from a bull 
and a heifer, treated intramuscularly with esters of 17β-estradiol and 17β-
testosterone. The results from this administration study allowed to adequately 
determine the detection windows of the method, and provided detailed 
pharmacokinetic data. Finally, the developed method was directly compared with 
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alternative confirmatory approaches, being the detection of intact steroid esters in 
hair and blood samples using other mass spectrometric techniques.  
 
In chapter V, the development of a GC-(MS/C-IRMS) method to detect progesterone 
abuse in bovines is described. First, four pregnanediol isomers were identified as 
candidate metabolites of progesterone. Next, two analytical methods were developed 
and evaluated against each other. In the first, three selected 5β-pregnane-3,20-diol 
isomers were separately measured after acetylation, whereas in the second, the four 
5β-pregnane-3,20-diols were converted to one oxidation product, 5β-pregnane-3,20-
dione before measurement. Eventually, an approach in which only 5β-pregnane-
3α,20α-diol and 5-androstene-3β,17α-diol as metabolite and ERC, respectively, were 
measured after acetylation was preferred, validated and successfully applied to 
distinguish between samples from treated and untreated animals. Finally, it was 
observed that a sudden shift in feeding regime, as well as the treatment with 17β-
estradiol and 17β-testosterone, could cause an unexpected and significant offset 
between the δ13CVPDB values of the ERC and the metabolite.  
 
In chapter VI, the results are discussed in general and a number of suggestions are 
made for future research. The combination of the developed methods allows to 
successfully detect abuse of synthetic analogues of endogenous androgen, estrogen 
and progestagen steroid hormones. However, the sample preparation protocol is still 
extensive, and perhaps the use of immunoaffinity chromatography could provide a 
solution. Also, method validation and quality control remain a cumbersome labor. 
Official guidelines and reference material for GC-C-IRMS analysis of samples from 
animal origin would provide powerful means for simplification. Finally, additional 
animal experiments are required to obtain more insight on the unexpected 
phenomena influencing the δ13CVPDB values of 5β-pregnane-3α,20α-diol. 
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9. Samenvatting 
 
De gunstige effecten van steroïdhormonen op groei en voederconversie zijn 
welbekend sinds het midden van de vorige eeuw. Toch werd uit voorzorg hun gebruik 
als groeibevorderaars voor voedselproducerende dieren verboden en actief 
nagegaan en opgevolgd binnen de Europese Unie. De detectie van misbruik van 
synthetische equivalenten van natuurlijk voorkomende steroïdhormonen blijft echter 
moeilijk. Hoewel de mogelijkheid om de oorsprong van dergelijke stoffen in urine met 
behulp van gaschromatografie gekoppeld aan verbrandings-isotoop ratio 
massaspectrometrie (GC-C-IRMS) aan te tonen reeds gekend is sinds het einde van 
de negentiger jaren, wordt deze techniek nog steeds slechts zelden gebruikt in het 
kader van voedselveiligheid. Het doel van het huidige onderzoek was om volledig 
gevalideerde IRMS-methoden voor de detectie van misbruik van synthetische 
equivalenten van natuurlijk voorkomende sekssteroïdhormonen te verschaffen, die 
als dusdanig kunnen geïmplementeerd worden in het kader van officiële controles.  
 
In hoofdstuk I wordt een inleiding gegeven rond natuurlijke steroïdhormonen, met 
verhoogde aandacht voor de groep van sekssteroïdhormonen. Nadat de basisregels 
rond naamgeving van steroïden worden verschaft, wordt er ook een overzicht 
gegeven van de verschillende componenten van specifiek belang binnen dit 
onderzoek. Vervolgens worden de verschillende types van natuurlijke 
steroïdhormonen besproken, en wordt zowel hun natuurlijke functie in het lichaam 
evenals hun werking als groeibevorderaar verduidelijkt. Nadien wordt de wetgeving 
opgesomd die het gebruik van hormonale substanties als groeibevorderaars beperkt, 
zowel op Europees als specifiek op Belgisch niveau. Daarna worden de verschillende 
pistes besproken die kunnen worden aangewend voor screeningmethoden, variërend 
van concentraties en profielen van steroïden, via holistische technieken, tot de 
screening van indirecte biomarkers. Tenslotte wordt de opbouw van de 
doctoraatsthesis voorgesteld. 
 
In hoofdstuk II wordt een uitgebreid literatuuroverzicht gegeven, dat alle 
gepubliceerde aspecten rond de detectie van misbruik van synthetische equivalenten 
van natuurlijk voorkomende steroïdhormonen in vee met behulp van GC-C-IRMS 
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omvat. Eerst worden zowel het steroïdmetabolisme van runderen als de 
productieprocessen van steroïdhormoonpreparaten uitgelegd, en wordt er 
verduidelijkt dat het verschil in het overeenkomstige bronmateriaal, en meer specifiek 
in de 13C/12C verhouding van dat bronmateriaal, de theoretische basis is die toelaat 
om een verschil waar te nemen tussen natuurlijke en synthetische steroïden die 
identiek zijn wat betreft hun chemische structuur. Vervolgns worden de verschillende 
factoren besproken die de 13C/12C verhouding van steroïden, die wordt uitgedrukt als 
δ13CVPDB waarden, beïnvloeden. Hieruit wordt duidelijk dat op zijn minst twee 
steroïden moeten gemeten worden in een urinestaal: een metaboliet van de 
toegediende stof, waarvan de δ13CVPDB waarde zal worden beïnvloed door de 
behandeling, en een endogene referentiecomponent (ERC), wiens δ13CVPDB waarde 
stabiel blijft. Het verschil tussen beiden, de ∆13CVPDB waarde, kan de behandeling 
duidelijk aantonen. Vervolgens wordt de werking van het daartoe gebruikte GC-C-
IRMS toestel toegelicht, en worden de individuele  staalvoorbereidingstechnieken 
evenals integrale staalvoorbereidingsprotocols besproken. Tenslotte wordt het 
verband met andere IRMS-gebaseerde opsporingstechnieken en met het domein 
van de humane dopingcontrole gelegd, waar GC-C-IRMS een veelgebruikte methode 
is voor het opsporen van misbruik van synthetische equivalenten van natuurlijk 
voorkomende anabole steroïden.  
 
In hoofdstuk III wordt een bevestigingsmethode voor het opsporen van misbruik van 
synthetische equivalenten van natuurlijke estrogenen met behulp van 
gaschromatografie, parallel gekoppeld aan zowel massaspectrometrie als aan 
verbrandings-isotoop ratio massaspectrometrie (GC-(MS/C-IRMS)) gepresenteerd. 
De gebruikte opstelling liet toe aanvullende GC-MS analyses te schrappen uit het 
analyseprotocol. De gebruikte staalvoorbereiding bestond uit een hydrolysestap, 
gevolgd door een vaste fase extractie, twee vloeistof-vloeistofextracties, twee HPLC 
opzuiveringen en een acetylering, waarna de δ13CVPDB waarden van 5-androsteen-
3β,17α-diol als ERC, en van 17α-estradiol als metaboliet, succesvol konden worden 
gemeten. De ontwikkelde methode werd grondig gevalideerd en liet toe om 
onderscheid te maken tussen stalen van behandelde en onbehandelde dieren.  
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In hoofdstuk IV wordt de ontwikkelde methode verder verfijnd en uitgebreid, zodat 
eveneens misbruik van synthetische equivalenten van androgenen kan worden 
opgespoord, wat mogelijk wordt door de toegevoegde meting van 17α-testosteron en 
etiocholanolon. Na uitgebreide validatie werd de methode aangewend voor de 
analyse van stalen van een stier en een koe, die intramusculair behandeld werden 
met 17β-estradiol-3-benozaat en 17β-testosteronpropionaat. De resultaten van deze 
behandelingsstudie lieten toe om het detectieluik van de methode te bepalen, en 
verschafte gedetailleerde farmacokinetische data. Tenslotte werd de ontwikkelde 
methode rechtstreeks vergeleken met alternatieve opsporingsmethoden, zijnde de 
detectie van intacte steroïdesters in haar- en bloedstalen met behulp van andere 
massaspectrometrische technieken.  
 
In hoofdstuk V wordt de ontwikkeling van een GC-(MS/C-IRMS) methode 
beschreven die toelaat misbruik van progesteron bij runderen op te sporen. Eerst 
werden vier pregnaandiol-isomeren geïdentificeerd als kandidaat metabolieten. 
Vervolgens werden twee analytische methoden ontwikkeld en met elkaar vergeleken. 
In de eerste methode werden drie geselecteerde isomeren van 5β-pregnaan-3,20-
diol apart gemeten na acetylering, terwijl in de tweede methode de vier isomeren van 
5β-pregnaan-3,20-diol eerst werden omgezet tot één oxidatieproduct, 5β-pregnaan-
3,20-dion, dat vervolgens werd geanalyseerd. Uiteindelijk werd een strategie waarbij 
enkel 5β-pregnaan-3α,20α-diol, als metaboliet, en 5-androsteen-3β,17α-diol, als 
ERC, werden gemeten na acetylering. De methode werd gevalideerd en liet toe om 
onderscheid te maken tussen stalen van behandelde en onbehandelde dieren. 
Tenslotte werd waargenomen dat een plotse verandering van voederregime, evenals 
een behandeling met 17β-estradiol en 17β-testosteron, een onverwacht en 
aanzienlijk verschil kunnen veroorzaken tussen de δ13CVPDB waarden van de ERC en 
de metaboliet.  
 
In hoofdstuk VI worden de algemene resultaten besproken en worden een aantal 
suggesties voor verder onderzoek gedaan. De combinatie van de ontwikkelde 
methoden laat toe om misbruik van synthetische equivalenten van zowel androgene, 
estrogene als gestagene steroïdhormonen op te sporen. De staalvoorbereiding blijft 
echter uitgebreid, en mogelijk kan het gebruik van immunoaffiniteitschromatografie 
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hiervoor een oplossing bieden. Validatie en kwaliteitscontrole blijven eveneens een 
omvangrijke taak. Officiële richtlijnen en referentiemateriaal voor GC-C-IRMS 
analysen van stalen van dierlijke oorsprong zouden dit aanzienlijk kunnen 
vereenvoudigen. Tenslotte wordt duidelijk gemaakt dat aanvullende dierproeven 
nodig zijn om de onverwachte vaststellingen rond de δ13CVPDB waarden van 5β-
pregnaan-3α,20α-diol te verklaren. 
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10.5. Professional employment 
 
2009 – present:  Coordinator chemistry, Directorate-general Laboratories, Federal 
Agency for the Safety of the Food Chain, Belgium. 
2009: Quality manager, Federal Laboratory for the Safety of the Food 
Chain Tervuren, Belgium. 
2004 – 2009: Food safety inspector, National Investigation Unit, Directorate-
general Control, Federal Agency for the Safety of the Food 
Chain, Belgium. 
2003 – 2004: Teacher, chemistry and Physics, Sint-Albertus High School, 
Haasrode, Belgium.  
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